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Abstract
Significant gaps in the practical transformation of clinical knowledge into practices,
increasing healthcare costs, costly medical errors, healthcare institutions’ obligations
towards improving safety, clinical outcomes, and efficacy of care from one side; and the
rise of disruptive innovations, the adoption of electronic health records and novel
diagnostic tools, and the plethora of data from the other side has made the need for a new
approach in managing the U.S healthcare systems an imperative. Continuous learning has
been utilized to mitigate some of these issues have been in healthcare organizations.
Continuous learning is especially important in the research centers that act as innovation
hubs within University Hospitals. These centers align with learning and improving current
systems and practices in a specific area of healthcare with goals of better serving the
population in need of those specific services or treatments. Maturity Models are
organizational management tools that have been used as a way of responding to the
constant pressure of trying to achieve and maintain competitive advantage through
concurrent innovation, quality improvement, and cost reduction. In the context of
continuous learning in healthcare organizations, a mature system can be defined as a
system that generates timely actions to the information that it derives from internal and
external data to create meaningful measurement regarding system learning and increased
efficacy and effectiveness in health outcomes. However, there is a lack of a model that
provides managers and decision-makers with a systematic, multi-criteria, validated,
quantifiable, and repeatable maturity model to assess and enhance health organizations'
performance in continuous learning and technology management. This research proposes
i

a multi-criteria model to assess technology management maturity and continuous learning
in research centers within university hospitals by using Hierarchical Decision Model
(HDM). The model can help these research centers with pinpointing their strengths and
opportunities in terms of continuous learning from the data they have access to while giving
them organizational self-awareness and guide them in setting their strategies and resource
allocation. The model will serve as a much-needed technology management tool for
healthcare organizations to assess their technology management maturity and continuous
learning efforts and assist them in creating more effective roadmaps.
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1. Introduction
In 1983 the prospective payment system (PPS) was introduced as a part of the Social
Security Amendments Act of 1983 with the goals of addressing the high cost of healthcare
by establishing fixed fees for provided services which were later modified to include a
prospective payment system for Medicaid and Medicare in 2000 (CMS.gov, 2020). These
changes have forever changed the way healthcare systems are managed in the United
States (Ginter, Duncan and Swayne, 2013). Externally, the healthcare environment has
been constantly changing in terms of technology, economy, and socio-political context
and with each election (congress, senate, or presidential), different healthcare
organizations are faced with new opportunities and risks due to the new political and
legislative directions (Santilli and Randy Vogenberg, 2015; Shaygan, 2018). Internally,
healthcare practices deal with long delay times for the transfer of clinical knowledge to
clinical practice in the US (about 17 years) (Balas and Boren, 2000; Morris, Wooding and
Grant, 2011; Kitson and Harvey, 2016). Furthermore, there are also studies indicating that
adult patients receive only approximately half of recommended therapies (McGlynn et
al., 2003). An Institute of Medicine report refers to this problem as “Too much care that
is important is often not delivered, and too much care that is delivered is often not
important.”(Institute of Medicine (IOM), 2007; National Health Service (NHS), 2014).
To pile on these challenges, medical errors are the third leading cause of death in the US
(Makary and Daniel, 2016). The United States consumes more health care services as a
proportion of its total economic output than any other country in the world while having
the largest economy in the world representing a greater ratio of the country’s total
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economic output (Shi and Singh, 2019). The cost of care that has been increasing in US
is signified by both per capita payments, and also by measuring health care expenditures
as a percentage of the Gross Domestic Product (GDP) (Weiss and Lonnquist, 2000;
Conklin, 2002). The US care spending has grown from $3708 (per capita) to $9990 from
1996 to 2015 (CMS.gov, 2016). Some studies suggest that up to a third of this spending
is avoidable waste (IOM, 2011). As researchers form Stanford Medical school point out,
in the healthcare system, “we do a lot, without knowing what works” at scientific,
medical, and practice levels (Shah, 2016). In his book, Graban also mentions that the US
has world-class doctors and treatments parallel to an utterly broken system (Graban,
2016). There is also the public health concern which with all the new technology and
methods, the already disadvantaged are going to be even further disadvantaged in their
access to the clinical and medicinal innovations (Faden et al., 2013). Moreover, the
problem of health disparities based on Racial Ethnicity and Language (REAL) and Sexual
Orientation and Gender Identity (SOGI) needs to be addressed. Although the healthcare
systems in the United States have the ability to provide some of the best clinical care in
the world, they lack delivering equitable services to every American. The healthcare
system in the US certainly fails in terms of providing cost-efficient services (Shi and
Singh, 2019). Due to the mentioned changes, there have been many attempts at improving
managed care systems.
The United States has a unique system of healthcare delivery. The term “delivery” refers
to the provision of healthcare services by various providers (Shi and Singh, 2019). Almost
all developed countries have national health insurance programs managed and delivered
2

by the government and financed through taxes and almost all their citizens are entitled to
receive healthcare services. This is not the case in the United States, where Americans
are not automatically covered by health insurance (Shi and Singh, 2019). Wolinsky
(1988) disagrees with calling the American health care delivery a “system” as a true,
cohesive system that does not exist in the US but for the sake of consistency, the research
is going to use the word “system” for the US healthcare. One of the other significances
of the healthcare system in the United States is that employs a significant amount of
people with total employment that exceeded 16.4 million people in 2010 in various health
delivery settings. This number included more than 838,000 professionally active Medical
Doctors (MDs), 70,480 osteopathic physicians (DOs), and 2.6 million active nurses (U.S.
Census Bureau, 2012). The majority of healthcare and services professionals (5.98
million) work in ambulatory health service settings, such as the offices of physicians,
dentists, and other health practitioners, medical and diagnostic laboratories, and home
health care service locations. Smaller proportions of these professionals are employed by
hospitals (4.7 million) and nursing and residential care facilities (3.13 million). The wide
spectrum of health care organizations in the United States includes around 5,795
hospitals, 15,700 nursing homes, and 13,337 substance abuse treatment facilities (US
Census Bureau, 2012).
There have been some offered solutions for different challenges in US healthcare. Health
IT adoption and diffusion of meaningful use can expedite the purgatory time for newly
discovered knowledge (CMS.GOV, 2017). As a result of the new technologies and
research, health organizations try to become more mature as in an organization that
3

generates timely actions to the information that it derives from data to create meaningful
measurement regarding systematic learning and increase efficacy and effectiveness in
health outcomes. Challenged by internal and external factors, health care organizations
need guidance regarding how to achieve improved maturity (Shaygan and Daim, 2019).
Continuous learning may be one of the keys leading to more mature systems (Ainsworth
and Buchan, 2015; Singer, Benzer and Hamdan, 2015; Priestman et al., 2019).
One of the ways in which health organizations can apply continuous learning into their
practices is to use the acquired data beyond its original purpose (delivery of care) to
increase the rate of speed from applying knowledge from laboratories to patient’s rooms
in hospitals (Friedman, Wong and Blumenthal, 2010). This change in looking at data can
be implemented in any health system regardless of its level and scale by self-studying and
self-improving continuously and routinely (Friedman et al., 2014, 2017). By using the
data from drugs, diseases, clinical processes, devices, claims and with the newer data
generated from technologies such as genomics and wearable devices, there is a volume
of data that health systems can learn from like never before. Continuous feedback of
learnings from data to patients, clinicians, managers, and policymakers can act as a
catalyst for change while generating evidence and a science base for bolstering clinical
practice and quality of care (Deeny and Steventon, 2015; Bhandari et al., 2016)
However, as interesting as the idea of this self-learning system sounds, its practical
implementation is indeed a daunting and developing task. Morrain et al. (2016) pinpoint
leadership, funding, regulatory and political influences, and company culture as some of
the important factors in making a continuously learning health system (Morain, Kass and
4

Grossmann, 2017). Friedman et al. (2013) stress the importance of technology, policies,
and standards in turning the learning health system into reality (Bloomrosen and Detmer,
2010; Blumenthal, 2010; Friedman, Wong and Blumenthal, 2010).
Continuously learning health systems are being studied from a wide range of different
perspectives in terms of adoption and implementation (Kelley et al., 2015; Brooks et al.,
2017; Cahan and Cimino, 2017; Daniel et al., 2017; Kraft et al., 2017; Okun and
Goodwin, 2017; Rubin, 2017; Tegenege et al., 2017). However, there is a need to look at
these perspectives together to gain some insights on the bigger picture opportunities and
barriers surrounding these health systems. In other words, although many health
organizations are trying to bolster their continuous improvement and consequently their
maturity, there is no particular way for them to know or assess if they are on the right path
or the extent to which they are adopting or implementing this way of doing things.
With the current unaddressed deficiencies and the new groundbreaking innovations, there
are hopes of a paradigm shift in US healthcare systems like never before. Continuous selfstudying and self-improving healthcare systems can be the answer to many of these
problems by leveraging many of the discussed technologies and innovations. However,
as a substantially complex environment due to the many involved stakeholders, health
organizations face many challenges and are provided with many opportunities from
different aspects in the area of continuous learning and improvement. Although
researchers should keep on studying this topic from detailed and specific perspectives, a
multi-perspective study of the different impacting aspects of this promising and nascent
technology is vital. The cross-criteria study of the health organizations with the ability of
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continuous learning can help provide a bigger picture of what needs to be considered to
initiate the constantly improving and waste eliminating healthcare systems. One of the
goals of this study is to act as the first step in the multi-perspective study of this topic.
There is imperative to look deeper and with further detail into the political (regulatory,
organizational), economic, social (patient, public health), and technical factors
contributing to how successful health organizations are in terms of technology
management maturity. Challenged by internal and external factors, health organizations
need guidance regarding how to achieve improved maturity (Shaygan and Daim, 2019).
Continuous learning in different areas specific to the health organizations may be one of
the keys to this improvement (Singer, Benzer and Hamdan, 2015; Priestman et al., 2019).
There is also a need for studies on how the new technologies, innovations, and policies
affecting healthcare should be managed in order to raise the chances of success for this
nascent area. The potential positive results of studies in the field of continuous learning
health organizations (in terms of increased quality of care, decreased medical errors, and
cost) may encourage knowledge cross-pollination and further adoption and diffusion of
the culture of continuous learning across the United States. It should however be
understood that becoming a continuously learning health organization is not something
that its effects can be felt immediately, and it may take years of cultural adaptation and
practice concurrent to the sufficient funding and socio-technical infrastructure to start
fulfilling its promises.
From the organizational self-awareness point of view, there is a need for health
organizations to assess their performance and maturity from different aspects that
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contribute to the adoption, implementation, and management of the technologies they
possess. It is also important to take a deeper look into the multi-perspective management
of technology maturity in health organizations. This need for maturity has become more
important with advances in technology, the plethora of data, and an increase in the
pressure to be more effective and consistent.
1.1.Problem Statement
As it was explained in the previous section, significant-gaps in the practical
transformation of clinical knowledge into clinical practices ever-increasing healthcare
costs, high rates of medical errors, healthcare institutions’ obligations towards improving
safety, clinical outcomes, and efficacy of care, the extrinsic fluctuant nature of the
healthcare industry, and the advances in technology and available information has put
more pressure on healthcare organizations to adopt new ways of doing things to cut costs,
bolster care in terms of quality, safety, accessibility among other goals. Some of these
goals include engaged patients and patient-centered communication, evidence-based care
to include clinical trial and comparative effectiveness research, learning health IT system,
turning evidence into practice and improvement in performance and quality, and
affordable care for all patients (IOM, 2013; Shah et al., 2016). Some of the other goals
based on literature include the promotion of improvement science, the impact of research
findings, and faster implementation and translation of research findings and evidencebased treatment in practice (Kilbourne et al., 2017).
There has also been research on quality improvement in specific administrative and
clinical issues in healthcare organizations. Mottes, Goldstein, and Basu (2019) discuss
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the benefits of adopting quality dashboards and the adoption of continuous quality
improvement strategies in adherence to institutional standards and delivery of renal
replacement therapy while Fried et al. (2011) applied a lean improvement process to
further improve process and outcomes in successful sepsis protocols. Moreover, there has
been literature focusing on quality improvement in other clinical and administrative issues
such as diabetes care in populations and outpatient clinics (Solberg et al., 1997; Nicolucci
et al., 2008), minimizing medical and medication errors (Becher and Chassin, 2001; Lee,
2013), improving care in patients with severe sepsis and septic shocks (Seoane et al.,
2013; Armen et al., 2016), reducing avoidable readmissions (Kripalani et al., 2014),
nephrology (Nunes et al., 2016; Mottes, Goldstein and Basu, 2019), outpatient cancer
surgery centers (French et al., 2019), chemotherapy wait times in pediatric oncology
clinics (Elsaid et al., 2019), TNM classification in cancer (Gospodarowicz et al., 2004),
management of Chronic Obstructive Pulmonary Disease (COPD) (Tiep et al., 2018),
supply chain performance measurement (Swinehart and Smith, 2005), and complications
and cost after high-risk surgeries (Dimick et al., 2003).
One of the ways of addressing these changes and moving towards the mentioned goals is
to increasing efficiency by generating more timely actions to the information that they
derive from the available data to generate meaningful conclusions regarding fields such
as systematic learning in order to increase efficacy and effectiveness in health outcomes.
The systematic continuous learning by health organizations can be aligned with
continuous improvement and innovation from scientific, informatics, incentives, and
culture aspects, and knowledge about best practices is consistently captured, assimilated,
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and embedded within the system. Moreover, continuous feedback of learnings from data
to patients, clinicians, managers, and policymakers can act as a catalyst for change while
generating evidence and a science base for bolstering clinical practice and quality of care
(Morain, Kass and Grossmann, 2017). A paradigm shift in looking at data can be
implemented in any health system regardless of its level and scale by self-studying and
self-improving continuously and routinely (Deeny and Steventon, 2015; Friedman et al.,
2017). Health IT adoption and diffusion of meaningful, and using the acquired data
(drugs, diseases, clinical processes, devices, claims and with the newer data generated
from technologies such as genomics and wearable devices (Shah, 2016)) beyond its
original purpose (delivery of care) can expedite knowledge transfer from laboratories to
patient’s rooms.
With all this promise, this concept mostly remains as a concept than a reality (Budrionis
and Bellika, 2016). Many health organizations have some idea of how to become a
learning health system or think that they are one while they are not. A lot of these
problems are caused due to the lack of a systematic assessment tool for health
organizations to measure and assess their maturity in terms of adoption, implementation,
and management of technologies and in this case, becoming a continuous learning
practicing health organization. Moreover, there needs to be a multi-criteria decisionmaking model for the management of the different aspects of the factors leading to more
maturity.
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Therefore, there is a need for a model to give health organizations a sense of selfawareness in terms of adoption, implementation, and management of these new sociotechnological mentalities. This model should be able to:

•

Identify potential common factors that have a major impact on the maturity of a
health organization’s continuous learning approach while considering its
complexity and multi-perspectives.

•

Assess the health organization’s performance against each of those factors
potentially leading to important conversations around the next steps and
improvement initiatives.

•

Help in identifying the areas of strength and where there is a need for
corrective/preventive actions based on the assessment, giving the organization a
sense of self-awareness and direction.

•

Assist decision-makers in their strategic management and leadership and resource
allocation.

Health organizations can get a better sense of direction in order to prioritize their
improvement paths and agenda while having a better grip on their performance and
maturity of the intended socio-technological solutions leading them to be more mature
organizations.
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2. Literature Review
2.1 Healthcare Landscape in United States
Shi and Singh (2019) posit that U.S. health care delivery does not function as a rational
and integrated network of components designed to work together coherently. They
describe it as a kaleidoscope of financing, insurance, delivery, and payment mechanisms
that are not integrated efficiently as they represent a mixture of the public (government)
and private sources. The public sector, finance and ensure health care for eligible groups
of people while delivering direct care services (less volume) to certain groups such as
veterans, military personnel, American Indians/Alaska Natives, and some uninsured
people. Outside of this, however, the majority of financing, insurance, payment, and
delivery services remain private in the United States. Private financing, mostly via
employers, accounts for around 52% of total health care expenditures while the
government finances around 48% (DeNisco, 2019). Moreover, as the United States
possesses a market-driven economy, private entrepreneurs seek to profit from it by
improving important functions of the delivery of health. Most people in the United States
receive health services through the private sector as the health insurance is bought by the
employers while the government provides public insurance for health services through
programs like Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) for
a significant portion of the country’s low-income, elderly, disabled, and pediatric
populations (although being public, the health services for the enrollees of these programs
are provided through private health organizations and providers such as maintenance
organizations (HMOs). In general, in this research, the term provider refers to any entity
that delivers health care services and either independently bills for those services or is
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supported through tax revenues such as physicians, dentists, optometrists, and therapists
in private practices, hospitals, and diagnostic and imaging clinics, and suppliers of
medical equipment.
The healthcare delivery system in the US lacks standardization as a system that is
functionally not centralized with non-integrated parts since a central agency such as the
government does not govern its coordination. This can cause challenges such as
duplication, overlap, inadequacy, inconsistency, and waste and consequently a costly and
complex system that lacks planning, direction, coordination, and efficiency manipulated
by private entrepreneurial system trying to change the monetary incentives towards their
goals without worrying about the effects on the system as a whole resulting cost control
to be merely a mirage (Shi and Singh, 2019).
Some of the other characteristics of the healthcare delivery system in the United States
which makes it different than other countries on top of the absence of the central
governing agency are insurance coverage-based access to health, and the presence of
third-party insurance companies and multiple payers. Moreover, the US healthcare
system deals with legal risks as influencers of the practice behavior or physicians through
“defensive medicine” by prescribing additional diagnostic tests, follow-up visits, shy
away from using the newer technologies due to lack of experience with those technologies
and creating comprehensive documentation to avoid litigation risks. The United States is
the world leader in terms of research and development and innovation in the field of
medical technology and as helpful as these new technologies are, they create demands
while tightening the resources for health organizations to finance the latest and best
12

technologies. Therefore, managing these new technologies is a very critical task
especially in the health organizations in the United States.
In the last several decades, the healthcare industry in the US has become more complex
and difficult to manage (Guterman and Dobson, 1986; Zook, 2007; Ginter, Duncan and
Swayne, 2013). Some of the factors influencing this state are the changes in legislative
direction with each election, domestic and global economic climate, social changes, and
emergence and improvement of related technologies which can affect the health care
delivery dramatically. In the light of these changes, the healthcare manager’s task of
comprehending the surrounding environment and hence, preparing the organization to
cope with or strategically take advantage of the changes in it becomes vital. Since the
changes in the healthcare industry in the early 80s, managers have found out that focusing
solely on financial aspects of planning is not enough and health organizations should be
dynamic in order to deal with the dynamic environment (Zook, 2007).
Taking the made points into account, the U.S. health care delivery system is a gargantuan
thing that is almost impossible for any single entity to manage or control (Shi and Singh,
2019). In short, this costly system is not effective in the most important missions of an
acceptable health care delivery system which are:
•

Enable all citizens to obtain needed health care services.

•

Ensure that services are cost-effective and meet certain established standards of
quality.
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While the U.S. healthcare delivery system falls short of both these basic ideals, the United
States leads the world in providing the latest and the best in medical technology, training,
and research. It offers some of the most sophisticated institutions, products, and processes
of health care delivery Thus, the constant analysis and assessment of strategy is
imperative to healthcare organizations in the US. In order to do this, managers should
have a clear understanding of the prospective changes to act proactively and plan.
However, since the dynamic healthcare environment is affected by multiple elements,
identifying these changes poses a big challenge to organizations.
2.2 Healthcare External Environment
In the turbulent environment of US healthcare, like any other business or organization,
identifying ways to add more value compared to competitors in order to gain a vying
advantage is an important task and challenge (Mallard et al., 2004). This is a big problem
for care organizations as value creation is the perceived relationship between
contentedness and price (Hart and Milstein, 2003). Going through a smooth appointment
and billing system, high quality of professionals and equipment, good insurance alliances
are just some of the ways health organizations can create value internally (Mallard et al.,
2004; Testik et al., 2017a). However, concurrent to these internal issues and
opportunities, care organizations should pay immense attention to the factors happening
and changing in their external environment. Out of date management styles, disregarding
demographic changes and emerging legislations and technologies are some of the telltales
of organizations that are either unable to anticipate changes, ignoring them, or resisting
them before their imminent demise. Although, completely predicting the looming
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changes and opportunities is not feasible, health organizations and managers can bolster
their chances of dodging or taking advantage of changes by keeping abreast of the
possible changes in the healthcare environment. Perera and Peiro (2012) proposes
“Analyzing the external environment” as the first stage in strategic planning for health
organizations (Rodríguez Perera and Peiró, 2012).
It is important to mention that different entities existing in the healthcare environment
have impacts on each other and can affect healthcare organizations both directly and
indirectly. Figure 1 shows the interrelationships of different components of healthcare’s
external environment. As an example of these interrelationships, government institutes
regulate laws for businesses and education while funding some research institutions while
research institutions provide R&D for businesses and a chance of better quality or access
to individuals. Education institutes provide researchers for research institutes and have
the power to raise care awareness for individuals. Businesses provide the government
with tax money and researchers, hospital and education establishments with real-life data,
sponsorship, and funding as well as jobs, products, and services for individuals.
Individuals shape the demographic aspect of the environment in general while providing
revenues and workforce for business, tax money for governments, individuals for
education, and data for research centers. Other than government’s regulative impacts
(Department of Health and Human Services, Center for Medicare, and Medicaid
Services), organizations such as “Public Health Department”, “State Health Planning
Agency”, “Joint Commission on Accreditation of Healthcare Organizations” and
“Council on Education for Public Health” have regulatory and planning impacts on
15

healthcare organizations. These interrelationships would pose great impacts on hospitals
and healthcare organizations in both direct and indirect manners. Hence, a better look into
these approaching changes in order to better understand and consequently prepare to
mitigate their harms or benefit from them is critical to health organizations. For this
purpose, impactful perspectives and their sub-criteria will be explained in the following
sections.

Figure 1:External Components of Healthcare Environment

2.2.1

External Change Perspectives

It is a difficult task to categorize the different perspectives affecting healthcare
organizations due to the complexity and inter-relationships of different categories and
criteria. Schuman (2001) points out that more studies have focused on external
perspectives causing concern in health organizations compared to the distress caused by
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the internal environment of the respective organizations (Such as management styles and
policies (Suchman, 2001). However, the literature on healthcare external environmental
analysis is not an abundant one. Casalino et al. (2003) discuss the effects of incentives,
IT, and structured process in order to bolster the quality of care for chronic patients
(Casalino et al., 2003). Also Ginter (2013) groups the external change categories as
“Legislative”, “Economic”, “Technological”, “Social”, and “Competitive” (Ginter,
Duncan and Swayne, 2013). Although this book mentions some of the sub-categories
relating to the perspectives, it does not offer clear explanations on what those sub-criteria
are. Santilli et al. also identify the trends affecting decision-making processes and roles
in healthcare organizations in order to bolster firms’ ability to act better in market
transformations (Guterman and Dobson, 1986). This study continues to use the
perspectives from Ginter and Santilli while exploring the current change catalysts falling
under each category.
2.2.1.1 Legislative/Political Changes
The legislative and political changes can significantly affect the environment for
healthcare organizations and each change in administration or swing in senate power can
mean big changes coming healthcare’s way. The passing of the Affordable Care Act
(ACA) for instance, undoubtedly restructured the role of healthcare stakeholders.
Healthcare providers have a more serious role in terms of contributing to savings, risk,
and establishing relationships compared to the time before ACA.
Since being passed on March 23, 2010, the Patient Protection and Affordable Care Act
has had significant impacts on the healthcare environment in different ways. The bill
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tended to transform hospitals’ way of doing things financially, technologically, and
clinically in order to achieve a better quality of care and its accessibility at fewer costs.
As an example, ACA paved the way for the emergence of accountable care organizations,
switching from fee-for-service to bundled payments (CMS.gov, 2019a), Hospital
Readmissions Reduction Program (HRRP) (CMS.gov, 2019b), and new insurance
standards, among other things. Also, it has had a great impact on the technological
structures of hospitals due to cost/quality initiatives in terms of electronic health/medical
records. In 2013, about 93% of hospitals had certified EHR technology, increasing by
29% since 2011 (Charles, Gabriel and Searcy, 2015). This number rose to 96% percent
by 2015 in terms of EHR systems with functionality, capability, and security measures of
the Department of Health and Human Services (Henry et al., 2014). The Medicare and
Medicaid EHR Incentive programs incentivize professionals, eligible hospitals, and
critical access hospitals to adopt and implement meaningful use of certified EHR
technology. As mentioned in the previous section, ACA rebuilt the role of healthcare
organizations by giving them a bigger role in terms of contributing to savings, risk, and
establishing relationships. A more efficient system would allow hospitals to cut costs by
focusing on preventive care and wellness in long term. ACA has also paved the way for
more trends such as consumers with stronger roles, more structured quality measures, and
healthcare consolidations which will be discussed in the next sections (Santilli and
Vogenberg, 2015). Also, post-ACA, the attention has switched to outcomes as quality
metrics such as the success rate of treatments, morbidity rate, length of hospital stays, and
patient satisfaction, among others.

18

Although ACA has had many great impacts on the way healthcare is provided in the
United States and its shift from transaction-based rewards to outcome-based ones, it is
not a panacea for the problems in the healthcare structure and needs reforms. However,
like insurance and financing for healthcare is mostly employment-based in the United
States, it has left some employed individuals uninsured due to some small businesses’
inability to afford group insurance (therefore not offering insurance to their employees)
and/or voluntary participation in health insurance programs in some work settings (Shi
and Singh, 2019). Some employees choose not to sign up, mainly because they cannot
afford the cost of health insurance premiums. Moreover, some individuals cannot afford
the premium cost-sharing provided by their employees (paying a portion of the cost to
their employers) and some have to deal with higher individual rates as self-employed
people and other individuals who are not covered by employer-based plans.
Although ACA greatly has somewhat mitigated the rise in the percentage of healthcare in
US GDP, it has been the constant repealing by the republican party. This kind of volatility
poses a great uncertainty for healthcare organizations in terms of strategic management
and finding ways of achieving competitive advantage in a highly volatile unstable
environment. The changes inherent in legislative reforms offer stakeholders numerous
opportunities and threats that have to be analyzed and ways to prepare for them or take
advantage of them thought through. Executive, legislative, and judicial branches of the
US government will all have effects on future bill changes, and companies should pay a
great amount of attention to changes and prepare themselves in terms of strategies for
different outcomes. What makes a change in legislation such as ACA so important is the
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inevitable effects it will have in different change perspectives for healthcare companies
in terms of the external environment (Shaygan, 2018).
Politics have significant effects on the lack of balance socioeconomic health as well
(Borrell et al., 2007). Changes brought up by the elections and union densities have the
power to affect labor markets and welfare states resulting in income and socioeconomic
disparities and consequently impacting healthcare and the organizations in that area. This
means that not only legislations and politics can have direct effects on healthcare, but they
can also have indirect impacts by influencing other change perspectives such as
social/cultural.
2.2.1.2 Economic Changes
Issues such as increasing average age of the population, health care, and treatment costs,
and changes in the number of insured people can have effects on the country’s economy
and certainly be affected by it. Many of the changes that have led to a managed care
system can be traced back to economic changes. The increasing cost of health care in the
US is signified by both per capita payments, and also by measuring health care
expenditures as a percentage of the Gross Domestic Product (GDP) (Weiss and
Lonnquist, 2000; Conklin, 2002). The US care spending has grown from $3708 (per
capita) to $9990 from 1996 to 2015 which is about 70 times bigger than the per capita
health spending of $141 in 196 (CMS.gov, 2016). Moreover, faster growth in total health
care spending in 2015 was caused by bigger growth in private health insurance, hospital
care, physician and clinical services expenditures, and the growth in Medicaid and retail
prescription drug expenditures.
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Many of the factors that have had impacts on this growth can be rooted back to other
change perspectives such as social, technological, and legislative. US population has had
an increase of 79.25% between 1960 and 2015 (Bureau, no date), and based on Kinsella
and Gist (1995), the percentage aged 65 and older in the United States will be tripled from
1944 to 2033 (Kinsella and Gist, 1995; Shaygan, 2018). Some of the other factors which
affect the economic perspective and consequently the health care environment are the rise
in the cost of insurance, increase in the alliance of health care organizations,
improvements in technology, and rise in malpractice insurance and case settlements
(Weiss and Lonnquist, 2000).

2.2.1.3 Social/Demographic Changes and Disparities
In 1991 Stromborg pointed out the dramatic change that is going to happen in the balance
of the American population (Frank-Stromborg, 1991). This change in the composition of
the population in terms of Social and demographic diversification is happening much
faster today. As an example, the Hispanic population has gone from around 6 million to
52 million from 1960 to 2012 and Asian and Pacific Islander population from 980
thousand to 15 million in the same time frame (US Census Bureau Public Information
Office, 2012). From the age aspect, based on Day (1992), from 2010 to 2030 the
population of 65 and over is estimated to go from about 40 million to 70 million
accounting for more than 20 percent of the population (Day, 1992). With the increase in
the number of insured people in the Obama administration, many people who were added
to the insurance pool had a lot of health conditions due to avoiding medical care for the
sake of their costs. Some people also needed time to adapt to and learn the system and
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this experience curve costs money and time. Although in short term the number of
increased insured people has had dramatic effect on the cost of care, it will become
smoother as time goes by. These shifts will pose great demands on US health-care
organizations. In a 2010 report issued by the Institute of Medicine, the healthcare
workforce is estimated to be too small and under-equipped to satisfy the demands of the
rising and aging population (Stall, 2010).
Parallel to these changes, health organizations need to address the racial and ethnic
disparities that are extremely prevalent today. Racial disparities in health care delivery
and patient outcomes exist and persist in the health care system in the United States
(Haider and Pronovost, 2011). Minorities tend to receive lower-quality health care even
when insurance status and income are controlled (Baker, 2001). Fiscella et al. (2000)
discuss that Black patients receive less intensive hospital care such as receiving fewer
cardiac procedures, lung resections for cancer, and kidney and bone marrow transplants
(Fiscella et al., 2000). Similarly, Haider et al. (2012) argue that minority patients tend to
seek care at a relatively small number of lower-performing institutions (sometimes due
to location) and due to that, are disproportionately affected by the suboptimal quality of
care by looking at 434 hospitals and concluding that trauma patients seen at hospitals with
more than 50% minority patients have 37% higher adjusted odds of death compared to
similarly injured patients treated at hospitals with less than 25% minority patients (Haider
et al., 2012).
During the 2020 COVID-19 pandemic, based on the Center for Disease Control’s data,
the cases, hospitalization, and death for American Indian or Alaska Native on-Hispanic
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persons were 2.8, 5.3, and 1.4 times higher compared to white, non-Hispanic persons,
respectively. The numbers for Black or African American, Non-Hispanic persons were
2.6,4.7, and 2.1 times higher for the same metrics and 2.8, 4.6, and 1.1 times higher for
Hispanic or Latinx persons (COVID-19 Hospitalization and Death by Race/Ethnicity |
CDC, no date). To better serve their community, health organizations need to address
things such as engineered inequality, default discrimination, and the misconception that
all technologies are always benevolent for everyone. Creating roadmaps for establishing
the systems needed to support health organization’s path towards addressing health
disparities can increase the patients’ trust in them which can include investigation of racial
and ethnic disparities faced by their population, learning where to start with strategies in
order to achieve a reliable collection of race and ethnicity data in electronic health systems
and consequently taking the needs of the community population into account and
stratifying quality measures based patient demographics. It should be noted that the path
towards addressing disparities should include efforts by health organizations’ information
technology groups to build systems that support those initiatives. These efforts can be in
the forms of (but not limited to) mapping legacy data to CDC criteria, adopting standards,
developing business intelligence data infrastructure, and stratifying artificial intelligence
quality measures based on Racial Ethnicity and Language (REAL) and Sexual Orientation
and Gender Identity (SOGI). Improvement of data governance, using analytical tools to
identify data quality improvement opportunities, and addressing data anomalies can be
named as big opportunities for improvement in this area for healthcare organizations.
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2.2.1.4 Technological Changes
With all the changes in population and demand, healthcare organizations are in necessary
need of leveraging the value of technology advancements in order to be cost-effective,
competitive, and responsive. Technological tools assisting decision-makers in Analyzing
data, leveraging the power of big data, and information technology systems have become
pillars of improving quality of care, identifying trends, anticipating changes, and
controlling costs. Electronic Health Records (EHR) have shown to have great benefits in
increasing outcomes for healthcare organizations in 92% of studies in the literature
despite low patient engagement numbers (Buntin et al., 2011; Furukawa et al., 2014).
Healthcare organizations should leverage the developments in technology and computing
in order to increase patient engagement and satisfaction, reduce costs, anticipate changes,
and learn to develop intangible assets in orders to integrate and intelligently use their
resources. Based on a report published by the Institute of Medicine (IOM) of the National
Academy of Sciences, the quality of health care in the United States is weaker compared
to biomedical knowledge, and that this gap in quality due to organizational incompetency,
rather than of individual physicians’(Beckles et al., 1998; Chassin, Galvin and Quality,
1998; Corrigan, 2001).
Every year new technologies are emerging focused on empowering patients and providers
in order for organizations to better manage changes and costs. Furthermore, innovation
in biotech and pharmaceutical industries has led to faster market entry and stronger
research and development pipeline. As an example, a sudden change of speed in cost per
genome has occurred in 2008 reflecting the transition from Sanger-based sequencing to
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next-generation genome sequencing technologies (Mardis, 2008). Besides, rare diseases
have gained more attention from pharma companies due to significantly less time needed
in terms of patient testing, government financial incentives, and higher approval rates
from the US Food and Drug Administration (FDA) (Seoane-Vazquez et al., 2008).
It is healthcare managers' and organizations’ duty to leverage, coordinate, and manage
emerging technology tools to bolster increased data transparency, patient involvement.
This perspective can be affected by and affect other change perspectives such as
legislative, social, competitive, and the economy in a great way as mentioned before.
Innovations in computing and big data services are causing a transformation in the manner
that health data is stored and transferred among patients and providers. Healthcare
organizations are embracing technologies and innovations such as EHRs and EMRs,
clinical documentation tools, big data, and telemedicine devices in order to improve the
process of health information collection and consumption. Wearable technology, mobile
health, and big data analytics are becoming progressively valuable in healthcare delivery
systems. Although these innovations and technologies will significantly facilitate
diagnosis, prevention, and treatment more efficiently, they dramatically increase the need
for organizations to care about the security of their data (Shaygan, 2018). However, Lyon
et al. (2014) suggest that as more patients adopt new information technologies, the
importance of data analysis for organizations surpasses privacy and security concerns.
As for big data analytics, the healthcare environment is one of the areas which is going to
be most affected by it. The cost of healthcare in the US is undeniably high (approximately
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17.6% of the nation’s GDP increasing from 8.9% in 1980) (Nambiar et al., 2013;
Christopher G. Worley and Mohrman, 2014). It is also estimated that one-third of that
spending is due to waste caused by (as listed by the Institute of Medicine) unnecessary
services, administrative waste including unproductive and duplicate documentation,
inefficiently delivered services, high prices, fraud and missed prevention opportunities
(Nambiar et al., 2013). In addition to that, the current reimbursement model favors the
number of patients over treatment effectiveness: “physicians have been compensated
under a fee-for-service system that only considers treatment volume, not outcomes” and
patients have “little responsibility for the cost of the health care services they demand”
(Kayyali, Van Kuiken and Knott, 2013). On top of the financial loss, other consequences
of this problematic system include statistics such as: “one out of five elderly patients are
readmitted within 30 days of discharge for no known reason” (Nambiar et al., 2013). Big
Data analytics may hold the key to solving some of these issues. Barham (2017) conducts
a literature review on how big data can create value for organizations and discusses the
challenges hindering its adoption. Health organizations to leverage the power of big data
in order to gain competitive advantage in terms of being more cost and time effective and
improve their quality and experience of care for their patients. Barham (2017)
recommends companies to acquire experienced data scientist, learn from successes and
failures of other organizations, and embrace the benefits of data integration and sharing
with partners, and finally working closely with software developers to develop more userfriendly applications for patients and professionals.
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Like in other developed countries, the public sector of the U.S. has started to act
concerning big data in order to leverage its potential in overcoming various complex
challenges. In 2012, for instance, the Obama Administration invested $200 million in the
“Big Data Research and Development Initiative”, with goals including the advancement
of state-of-the-art core technologies of the big data era, acceleration of the pace of
discovery in science and engineering, strengthen national security, and transform teaching
and learning and to expanding the workforce needed to develop and use big data
technologies (Jee and Kim, 2013).
Social media is increasingly being used as a tool by governments, communities, and
organizations for a range of purposes in disaster preparedness in areas such as disaster
management. In recent years, the government is bolstering the ease of data release and
accessibility, which enables better access to and standardization of public data of patients,
clinical trials, and health insurance (Christopher G. Worley and Mohrman, 2014).
Moreover, ACA has also started the process of fundamentally re-shaping the industry and
the interrelationships between healthcare entities. The private sector is also being
affected. Hospitals, providers, clinics, insurance companies, pharmaceutical companies,
researchers, physicians, nurses, and patients are all impacted by the changes that the use
of big data is bringing into the industry. Meanwhile, traditional pharmaceutical retailers
such as CVS Health are developing internal Digital Innovation Labs, that are rolling out
Apple-Watch apps and facilitating the process of filling medications remotely (CVS
Health, 2015).
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All in all, new IT innovations can give health organizations insight and advantage.
However, managers and organizations leveraging the fruits of these innovations should
manage the ethical, security, and privacy risks that come along with them. The use of data
and analytics in patient care opens up new opportunities for boosting care effectiveness
and efficiency even though the full realization of the importance of data-driven insights
has been clouded by some barriers. United States’ health information technology website
lists some of these barriers as current data input and output limitations of medical record
systems, scarcity of robust business models for interoperable data exchange across
organizations, and wider organizational barriers that require coordinated solutions across
stakeholders (HealthIT.gov, 2018).
In the second decade of the 21st century, social media has become a significant part of
many industries and organizations, and the healthcare environment is not an exception.
Vance et al. (2009) hint at the increasing evidence showing that social media use among
patients and health professionals is rising significantly. Personal social networks use
between health professionals and physicians-in-training reflect the general trend in the
environment and as for the Patient–doctor interactions, most of them are initiated by
patients which demonstrates the level of awareness and interest from patients’
perspective.
There is also a growth in online social media awareness in Western European hospitals,
but different countries have applied social media to address different issues. Van der Belt
et al.( 2012) mentions that other than the Netherlands and UK, there is a small proportion
of hospitals using social media among European countries. As an example, hospitals use
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LinkedIn to hire professionals. Again, there is a need for further research to define metrics
and connect the effects of social media in healthcare quality improvement. Chou et al.
(2009) suggest that new technologies such as social media are reshaping the patterns in
communication in the United States.
A very important issue in leaning towards social media for health organizations is the
consideration of the targeted group’s age, socioeconomic status, and racial ethnicity in
order to assure enough awareness and interest among that specific target. In more rural
structured areas, there may be less inclination, awareness, and confidence by patients to
use social media. This inertia, however, can be mitigated by education and promotion of
the benefits and conveniences of using social media. Clinicians also use online social
networks, specifically the newer generation of clinicians for both personal and reference
aims.
However, a big portion of respondents have a cynical attitude towards online interactions
and see them as being ethically problematic (Bosslet et al., 2011). Quantification of social
media effects is a nascent area of research due to the lack of used terminology and
research methods (von Muhlen and Ohno-Machado, 2012). Antheunis et al. (2013) argue
that the literature has mostly focused on the benefits of social media on healthcare and
suggests that their study has found dis-concordance in patients’ and professionals’
motives, barriers, and expectations regarding health-related social media use. Hawn
(2009) discusses the impact of social media on health care and its benefits such as
“Improving quality through “better communication” and “Empowering Patients”
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resulting in happier patients. The study also pinpoints the privacy, standard, and cost
downsides of social media in healthcare.
In sum, health organizations and managers should carefully monitor the potential effects
and implications of social media in the environment and industry to be prepared for the
challenges and clinch opportunities in order to reach or manage competitive advantage.
2.2.1.5 Competitive Changes
The last change perspective reviewed in this section is the competitive changes
perspective. As the healthcare environment is becoming a harsher vying one for
providers, there is significant pressure for providing a better quality of care at a lower
cost. As mentioned before, these changes are causing a paradigm shift from the
conventional fee-for-service models to value-based ones and focus on the quality of care
as supposed to the number of services provided. This pressure is stronger in areas with
more demand which there is buyer power. According to a report by Stanford Medicine,
Physician practices in less vying areas cost more for office visits compared to more
competitive areas of care (Baker, 2014). From another aspect, these pressures are leading
to the consolidation of healthcare entities to increase efficiency, cost-effectiveness, and
share risks. Although there is research evidence for the benefits of consolidation of
healthcare entities in terms of information sharing and flow, there is not much supporting
the same effect for cost-effectiveness. Dranove and Lindrooth (2003) Find robust,
significant, and persistent results showing that consolidations into systems do not create
savings whereas acquisitions and mergers generate savings from 3rd and 2nd consolidation
years respectively (Dranove and Lindrooth, 2003).
However, if these consolidations lead to prevention of medical errors, avoidable hospital
admissions, and readmissions and/or improve hospital efficacy, an increase of shareddecision making, and improvement of targeting costly services, achieving better quality
at lower costs may be possible (Olsen, Saunders and Yong, 2010). Other change sub30

criteria such as healthcare networks becoming narrower and health quality measures
becoming tighter have been discussed in the literature (Santilli and Vogenberg, 2015;
Shaygan, 2018).
2.2.2

Summary

Accumulation of information is becoming more significant for health organizations
(Sutcliffe and Weber, 2003). With the methodical study of adaptive systems, healthcare
organizations can provide managers with great insights and assistance in the preparation
for emerging issues within the organization as well as healthcare delivery management
(Shaygan, 2018). In this sense, being familiar with the external environment can be the
key to leading a successful and competitive health system (Ginter, Duncan and Swayne,
2013).
Due to the involvement of several volatile change perspectives, the healthcare
environment is currently a very erratic one making the extrinsic environmental analysis a
daunting task for health organizations and managers. This study aims at contemplating
emerging extrinsic changes happening in the United States healthcare environment in
different areas. A literature review is performed to define and identify the different current
change perspectives and their subcategories. To better illustrate these issues, the Ishikawa
diagram (Cause and effect diagram) is used in this study as shown in Figure 2. Five
perspectives were identified (Political/Legislative, Economic, Social/ Demographic,
Technological, and Competitive) and each of their sub-criteria was studied.
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Figure 2: Cause and effect diagram for extrinsic change in the healthcare environment (Shaygan, 2018)

An interesting finding of this study is the inter-dependence of different change
perspectives through literature and to better reflect that finding some modifications were
applied to the cause-and-effect diagram with the aims of better showing the effectiveness
of change perspectives on each other.
The Healthcare industry, in general, is very complicated and dynamic as many nascent
trends and potential political changes are emerging and happening nationally and
globally. This is even a bigger issue in the United States which is facing waves of political,
social, economic, competitive, and technological changes. Healthcare organizations need
to be better prepared in predicating, identifying, adapting, being proactive and taking
advantage of these changes, and cope with the potential harms coming their way. They
should be vigilant in sensing valuable tangible and intangible assets, efficiently seizing
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them, and finally be flexible enough as an organization to transform and mold these
resources to their advantage (Teece, 2007).
In the same sense, healthcare organizations should sense the changes, seize the
opportunities, or dodge the threats, and develop organizational flexibility to reconfigure
themselves and gain a competitive advantage in the industry through learning
mechanisms, alliances, innovation, and being cognizant of surrounding changes on
national and global levels. As Eisendhardt (2000) suggests, in the highly dynamic
environments (such as healthcare) no matter how valuable, rare, inimitable, and nonsubstitutable the resources (such as tacit and explicit knowledge), they are going to give
companies a fleeting and finite competitive advantage as opposed to a sustained one and
the important thing is how firms reconfigure their “best practices” in unique ways
(Eisenhardt and Martin, 2000). Health managers need to sense new opportunities and
threats, seize them for the advantage of the company and reconfigure them in order to
provide the organization with a sustained competitive advantage (Teece, 2007).
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Figure 3: Modified Cause and Effect Diagram for Extrinsic Change in US Healthcare (Shaygan, 2018)

Shi and Singh (2019) discuss the external forces on the United States healthcare delivery
system as being national political climate, economic development, technological
progress, social and cultural values, physical environment, population characteristics (i.e.,
demographic and health trends), and global influences which can be a great complement
to aspects mentioned in this sections.
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Figure 4:External forces affecting health care delivery (Shi and Singh, 2019)

2.3 Learning Health Systems (Continuous Learning)
The term Learning Health Systems (LHS) was first used in a 2007 report by the National
Academies of Medicine (formerly known as the Institute of Medicine) as a system with
some distinguishable characteristics (Institute of Medicine (IOM), 2007). The patient
information, experience, and characteristics of every patient (consenting ones) is an
opportunity for the health system to learn from. Moreover, evidence and science-based
knowledge regarding best practices are instantly available to bolster the decision-making
processes in a continuous and iterative quality improvement manner. Finally, the LHS
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way of thinking becomes a piece of the employees’ and stakeholder’s culture through
appropriate leadership as a part of a socio-technical infrastructure (Friedman et al., 2017).
Milstein (2013) emphasizes that adopting LHS is one of the three things that the US
should pursue in order to cut down care costs as a percentage of its GDP (Milstein, 2013).
However, there is an imperative for infrastructure for continuous improvement which
will result in cost decrease through learning and economies of scale. In a perpetual cycle,
the ongoing accumulation and analysis of data lead to result interpretations which assist
decision-makers in taking actions and deciding what to study next. The continuous quality
improvement has the potential to not only bolster the clinical evidence and research-based
data and update the best practice in real-time but also will be able to address a lot of
administrative and practice wastes which their elimination can cut care costs without the
need for layoffs as the lean and continuous improvement philosophy is parallel with
respect for people (Graban, 2016). Concurrent to this waste reduction, the accumulation
of research and practice-based knowledge can take a substantially shorter time in terms
of a transitional gap.
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Figure 5: Learning Health System Platform (Friedman et al., 2017)

As much as health systems need to assimilate and gain knowledge, they must jettison the
knowledge and resources that are impeding quality progress or have become obsolete due
to innovation. Coicera (2017) stresses the importance of forgetting in LHSs as a procedure
of programmatically decommissioning obsolete data and practices which their existence
hinders change and lead to unnecessary complexity (Coiera, 2017).
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Taking all these different benefits and challenges into account points out that there are
many players and impacting the continuous learning and consequently the maturity of
health organizations. These factors can be government legislations, funds, and initiatives
concurrent to the acceptance of its culture in terms of organizational and personal levels.
The role of community and socio-technical infrastructure among many other aspects
cannot be underestimated either.

Figure 6:Five pillars of a learning health system (Institute of Medicine (IOM), 2007; Milstein, 2013)

It should be noted that in the second characteristic of continuous learning maturity, the
data is referring to the internal data generated by the health organization. However, it can
be argued that health organizations can and should use the data generated externally (by
other organizations) concurrent to the ones they generate themselves. This may lead to a
significantly higher amount of data and a better understanding of some issues that they
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may not have enough data regarding themselves and eventually more mature health
organizations.

2.3.1

A Multi-perspective Approach for Continuous Learning in Healthcare
Organizations

2.3.1.1 Political
The road for aligning care with individual patient needs has been paved in recent years
more than ever with goals of population and patient outcome betterment (Epstein et al.,
2010). One of the areas that can benefit from the patient input and proliferation of clinical
data is the federal and state organizations in terms of regulatory decision-making.
Historically, the actions of the regulatory departments such as the FDA have been more
reactive than overactive (The increased speed of approvals for specific drugs in times of
crisis and rare disease-related and orphan drugs). The new paradigm means that
regulatory decision-makers such as FDA can reflect patient needs better and more
proactive in their actions. There have been studies regarding topics such as the
incorporation of the needs of patients into the risk-benefit evaluation of the medical
device and the effects of patient-generated data in systems such as LHS on regulatory
decision making (Levitan, Phillips and Walker, 2014; Irony et al., 2016; Tegenege et al.,
2017). In addition to the patient preferences and needs, the continuous improvement
mindset will help demonstrate the benefits and challenges of LHS implementation and
adoption in a clearer way and as a result, enables the more efficient allocation of federal
and state funds into the needed areas. As Travis et al. (2004) discuss, in many countries,
despite the decrease in prices and increase in funds, the move towards healthcare goals
remains tedious and slow.
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Some of the other challenges based on the mentioned study lie in the delay in knowledge
and practice and the weak evidence-based information (Travis et al., 2004). Continuous
learning can mitigate the weak data and significantly shorten the delay times between
clinical research and practice. All in all, although there have been studies on the political
and regulatory aspects of the adoption and assessment of learning health systems, more
research can paint a clearer picture on how this health paradigm shift can impact the
regulatory players with goals of increasing the quality of public health.
2.3.1.2 Economic
One of the main drivers behind the endeavors for new healthcare systems and
management is the current high costs of US healthcare. Although the Affordable Care Act
(ACA) has positively impacted the way healthcare is provided in the US through actions
such as shifting from transaction-based rewards to outcome-based ones, it is not a panacea
for driving down the healthcare costs. Although ACA has toned down the increasing
percentage of healthcare costs in United States GDP (0.124% increase from 2010 to 2014
compared to 1.863% from 2005 to 2010), about 18% of the GDP is still a staggering
figure (compared to 8.9% in 1980) (McKinsey&Comapny, 2014.; The World Bank,
2014.; Worley & Mohrman, 2014). The desire to drive down the costs of care merged
with the surfacing of translational research’s importance and the adoption of EHRs has
proliferated the calls for the development of systems that can drive down the costs and
increase the quality of care (Lowes et al., 2017).
As LHSs follow the continuous quality improvement philosophy they are aligned with
the practices of some of the existing lean hospitals. In lean hospitals, it is important to
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know that employee lay-offs are not the solution and hospitals focus on eliminating the
different types of waste that are going on in their organization. This is especially
important since up to a third of care spending in the US is considered as avoidable waste
(unnecessary services, administrative waste including unproductive and duplicate
documentation, inefficiently delivered services, high prices, fraud, and missed prevention
opportunities) (Institute of Medicine (IOM), 2007). Lowes et al. (2016), study the impact
of the learning health systems implementation called “Learning From Every Patient
(LFEP)” on 131 children with cerebral palsy which resulted in a 43% decrease in inpatient
days, 27% fall in inpatient admission, 30% decrease in emergency room admissions, and
210% and 176% cost reduction compared to time control group and program activities
control group respectively (Lowes et al., 2017). Even if the costs aspect of the care would
play second fiddle to the important topic of quality of care and its betterment, cost cuts
would happen as a result of improved quality and decreased waste. There is an
opportunity for research on how the LHS would affect the costs in hospitals in order to
generate more evidence-based data on the challenges, benefits, and cost-cutting
capabilities of continuous learning.
2.3.1.3 Social
One of the main drivers behind the emergence of LHSs is the need to deliver safe and
efficient care to patients (Kelley et al., 2015). The need for clinical care to be both
evidence and science-based concurrent to the increased pressure on quality improvement
in care systems, the data and knowledge accumulation in practice and research can
complement each other more than ever (Altman et al., 2013; Faden et al., 2013; Kass et
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al., 2013). In researching to improve the quality of care, however, some social and patientrelated points should be considered. Firstly, although some patients welcome the
increased convergence in research and practice, many others would not want themselves
or their loved ones to take part in randomized clinical trials for comparative-effectiveness
research. One of the concerns is about the proliferation of paper works, consent forms
needed due to the increase in connected clinical research and practice adding to the
organizational wastes. However, conditioned on robust practices and transparent
mechanisms, many low-risk randomized clinical trials would not need any patient consent
while the higher-risk procedures would get their needed concentration resulting in a safer
system (Faden et al., 2014).
Faden et al. (2014) also stress the importance of the thorough participation of patients and
other stakeholders for mining the suitable specification of the institutional implications
of the LHS decision making frameworks Faden et al. (2014) proposes an ethics
framework for an LHS which is iconoclastic to traditional held thought about the
separation in research and clinical ethics. This framework includes seven pillars for the
ethical implementation of LHSs which are: 1-Respect the right and dignity of patients, 2Respect clinician judgments, 3- provide optimal clinical care to patients, 4- Avoid
imposing non-clinical risks and burdens on patients, 5- Address health inequalities, 6Conduct continuous learning in order to improve the quality of clinical care and health
care systems, and 7-Contribute to the common purpose of improving the quality and value
of clinical care and health care systems (Faden et al., 2013). The mentioned paper also
discusses the issue that patient protection actions can sometimes hinder the improvement
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of the healthcare system. Although protecting patients is a very important subject, several
hundred thousand people die needlessly each year from medical mistakes which can be
avoided through quality improvement (Kohn, Corrigan and Donaldson, 2002). One of the
important factors in the adoption of LHSs from the patient perspective is the clinician. As
patients have more trust in their doctors compared to the researchers, there should be
collaboration and teamwork between the clinicians and researchers in order to bolster the
acceptance of LHSs and increase patients’ participation through shared decision making
(Barry and Edgman-Levitan, 2012). Patients, for their good, should feel the need to
contribute to and participate in the learning process just as health professionals and
systems are obligated to learn. Kelley et al. (2015) points out that patients’ interest in
individualized care correlated with the value they put on the relationship they have with
their physician. So, the adoption of LHSs not only does not undermine the role of
physicians but also highlights their role as an influential part of the system (Kelley et al.,
2015). This element turns clinicians’ attitude towards LHSs, quality improvement, and
comparative efficiency research into an important factor. Health systems should involve
clinicians more effectively in quality improvement in order to boost their attitudes and
the diffusion of LHSs (Butler et al., 2017). Wolf et al. (2009) emphasize the importance
of patients’ “health learning capacity” that should be considered. This capacity includes
a wide spectrum of cognitive and psychosocial skills assisting patients or family members
in effectively promoting, protecting, and managing their own or a loved ones’ health
(Wolf et al., 2009). The need for this capacity shows that the education and structure of
LHS culture should not be limited to the health system employees and educating patients
on these matters can be critical in the adoption and acceptance of these systems. Roth et
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al. (2016) hint at the reciprocal benefits that LHS and human factors can have on each
other through gaining access to new research fields and adoption of a range of tools to
pinpoint and address the implementation challenges respectively (Roth et al., 2016). To
conclude, the social and patient side of LHSs is a very crucial one which includes many
other aspects that should be looked into in terms of patient privacy, inclusiveness,
transparency, accessibility, adaptability, governance among others (Rubin, 2017).
One of the other areas that have been the focus of some research papers for LHS, is the
area of public health and equity. Many are concerned that the improved quality and
outcomes in healthcare would be limited to premium health services and people who can
pay for them by themselves or through their insurances. Faden et al (2013) focus on the
societal goal of a just healthcare system with the objective of high-quality care and
economic welfare through LHSs (Faden et al., 2013). With the continuation of care
quality disparities for racial and ethnic minorities, LHS can potentially bolster the care
quality through applications such as data analysis, continuous quality improvement, and
patient-centered care (Brooks et al., 2017). Brooks et al. (2017) posit a framework for
integrating health equity into LHSs. This method includes prioritizing health equities,
engaging the community, targeting health disparities, acting on data, learning, and
improving. Some of the other factors that are important in the implementation of LHSs
are the type of city and community that they are going to be structured in. As Khurshid
(2016) puts it, working with champions and backbone organizations in the community,
not being limited with the legacy systems, and looking at data sharing (among different
levels of healthcare employees) as a tool for transforming healthcare and not as a health
44

solution (Khurshid, 2017). Through literature, there are also examples of data‐fueled
learning health community constantly powered by the people and for the people (Okun
and Goodwin, 2017). With the rise of new technologies such as genomics, the opportunity
of gaining so much data from a wide range of different people is within reach. However,
there are still barriers that hinder this access. Blizinsky and Bonham (2017) identify three
barriers that face the LHS data that are provided by genomics. The challenges are
inequality in the use of genomic medicine, lack of pharmacogenomics access in clinical
care, and insufficient integration of social and environmental data into EHRs (Blizinsky
and Bonham, 2017). Integration of technologies such as genomics and wearables as
feeding factors for the data in LHS can play a vital role in LHSs’ adoption and their impact
on public health through gaining more data about racial and ethnic, socio-economic,
economic backgrounds, and age of people and the health issues they deal with. As the
racial diversity is increasing in the US and by 2050 it is estimated that about one-fifth of
the US population is going to be over 65, it is imperative to use opportunities like LHS to
promote and improve public health and equity and deal with these extrinsic changes
(Shaygan, 2018).
2.3.1.4 Technical
As the implementation of LHS needs a socio-technical infrastructure, the technical side
of its adoption of assessment has significant importance. The adoption of EHRs in the US
from one side and the development in fields such as genomics and wearable devices from
the other side are paving the path for the collection of great amounts of data for health
systems. Especially with all the demographic and demand changes, healthcare
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organizations are forced to leverage the value of technology advancements to be costeffective, competitive, and responsive. Concurrent to the mentioned advances, acquiring
experienced data scientists and leveraging the benefits of data integration, sharing with
different stakeholders, and acquisition and curation of data are some of the areas that can
help healthcare organizations with their goals of increasing quality care, patient
satisfaction, and public health while driving down the costs (Krumholz, Terry and
Waldstreicher, 2016; Barham, 2017). The ongoing adoption of smart wearable devices is
an important part of contributing to the body of patient-data in general and specific fields
(such as diabetes, surgeries, and user empowerment and health promotion) (Lukowicz,
Kirstein and Tröster, 2004; Kolodzey et al., 2017; Shaygan, Ozdemir-Gungor, D. Kutgun
and Daneshi, 2017). The shift to LHS can provide the needed infrastructure for the
development of new generation learning decision support tools in order to mitigate the
diagnostic errors (Corrigan et al., 2017). As mentioned before, the adoption of EHRs can
play a vital role in clinical research and consequently smoother implementation of LHSs
and there are already new studies trying to build upon what has been done it terms of
EHRs showing further interest in LHSs. A study by Daniel et al. (2016) tries to build on
a platform called EHR4CR which is developed in order to provide communication,
security, and semantic interoperability services between twenty-one European hospitals
and pharmaceutical companies in five countries by proposing the need for cross border
semantic interoperability for LHSs (De Moor et al., 2015; Daniel et al., 2017). There are
also studies, seminars, and conference talks on the connections of LHSs, precision
medicine, and implementation sciences. Chambers et al. (2016) stresses the importance
of LHS and investing in its intellectual and physical infrastructure in achieving high
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quality and efficient healthcare system on pillars of precision medicine (Chambers, Feero
and Khoury, 2016). This study goes on to talk about the synergy areas between LHS and
implementation science in terms of improving the implementation of effective practices.
Machine learning is one of the main enabling technologies behind LHS in terms of
enabling and improving pattern recognition. Translation of the textual knowledge into
machine-learned knowledge will enable the integration of the knowledge with a specific
patient. Cahan and Cimino (2017) propose a self-growing and self-maintaining patient
knowledge base that can be in reach of health professionals worldwide which can benefit
low resource health systems, practitioners, and researchers concurrently (Cahan and
Cimino, 2017). A 2017 report by the Office of National Coordinator for Health IT (ONC)
and Agency for Healthcare Research and Quality (AHRQ) discusses the convergence of
factors such as being fed up with the legacy systems, widespread adoption of networked
devices, and increased public acceptance and exposure to systems like Amazon is paving
the way for the increased integration of artificial intelligence in Healthcare (Derrington,
2017).
More evidence and research studies into the outcomes of the implemented LHS can
provide insights into technical and infrastructural needs aligned with bolstering the
systems and mitigating their shortcomings. There are studies in the literature which
discuss the implementation of LHS cluster for specific diseases and areas (Hobbs, 2012;
Kwon et al., 2012; Mandl et al., 2014; Shah et al., 2016; Turley, 2016; Johnson et al.,
2017; Pronovost et al., 2017; Schmittdiel et al., 2017).
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2.4 Maturity Models
Maturity models are instruments to facilitate organizational management (Vidal
Carvalho, Rocha and Abreu, 2017). These models have been used with different goals
and purposes for benchmarking system development or organizational management for
years. They are built on entities such as people, organizations, functional areas, processes
among many others (Rocha, 2011). Maturity models normally are used to evaluate these
entities in terms of predicted patterns in the form of stages or levels.
Maturity models have been proven to be useful in a myriad of different fields such as
software, system engineering, project, and program management, energy management,
technology road mapping, healthcare technology management, and other areas with goals
of facilitating process improvement (Kappel, 2001; Kerzner, 2001; Paulk, 2002, 2009;
Garets and Mike, 2006; Dunbrack and Hand, 2013; Introna et al., 2014; Sanders and
Burton, 2016).
In the field of software, Paulk et al. (1993) came up with the Capability Maturity Model
(CMM) which could be used as a maturity framework for bolstering organizational
processes with goals of development and management of software and it encompasses
five levels of maturity including initial, repeatable, defined, managed, and finally,
optimizing (Paulk, 2002). The Software CMM has been replaced by CMM Integration
(CMMI) since 1997, which integrates System Engineering with Software Engineering
and Integrated Product Development in a single model (Paulk, 2009). Also, on the project
management side, there are maturity models such as OPM3, P3M3, and the project
management maturity model (PMMM). The P3M3 has the same levels compared to the
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CMM model with the exception that the first step in P3M3 is awareness instead of initial.
The project management maturity model (PMMM) includes a common language,
common processes, singular methodology, benchmarking, and continuous improvement
as its maturity levels (Kerzner, 2001; AXELOS, 2018). Demir and Kocabas applied the
PMMM in education with the same maturity levels (Demir and Kocabas, 2010). In 2002,
Knowledge Process Quality Model (KPQM), was introduced to aid companies to evaluate
their knowledge management structures and finding ways for future improvements
(Paulzen et al., 2002). Many current maturity models have different levels of maturity in
order to describe the current state of the measured entity. Most of these models include 5
levels and are based on CMM or CMMI which were discussed earlier with the level labels
including but not limited to:
Level 1 -getting started/awareness/initial/ common language.
Level 2 -developing/focusing/repeatable/knowledge/ common process/ basic
knowledge.
Level 3 -complying/practicing/competence/defined /singular methodology/process
definition.
Level 4 -sustaining/exploiting/managed/excellence /benchmarking/ process control.
Level 5 -advocating/transforming/optimized/ optimizing/mature/continuous
improvement/process improvement.
There are studies that have revised the CMM model and added some stages to the
conventional maturity models. Galliers and Sutherland propose a seven-stage maturity
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model for information system management and strategy (Galliers and Sutherland, 1991).
These levels include Ad hocacy, foundations, centralized, cooperation, entrepreneurial,
and harmonious. This research evaluates maturity for strategy, structure, systems, staff,
style, skills, and superordinate goals.
As it can be seen, maturity models have been proposed to address different issues, in
different aspects of different areas and industries. The Healthcare industry has been no
exception in using maturity models as models have been created to address specific parts
and dimensions of the healthcare industry. The healthcare maturity models will be
discussed next. Table 1 presents a myriad of maturity models in areas such as software,
energy, systems engineering, project management, road-mapping, safety, knowledge and
change management, risk and capability management, social media, manufacturing
engineering, organizational design, quality engineering, education, and their number of
stages in terms of maturity.
Table 1: Maturity Models in Different Fields

Model

Area

Stages

Reference

Capability Maturity Model
(CMM/CMMI/QMMG)

System Engineering Capability,
Software Engineering, and
Integrated Product Development

5

(Paulk, 2002, 2009)

Complex Product Systems (CoPS)
Maturity Model

Project Risk Management

5

(Yeo and Ren, 2008)

Knowledge Process Quality Model
(KPQM)

Knowledge Management, Quality
Improvement

5

(Paulzen et al.,
2002)

OPM3

Organizational Project Management

Binary

(Project
Management
Institute (PMI),
2013)

Project Management Maturity Model
(PMMM) in Education

Project Management in Educational
Organizations

5

(Demir and
Kocabas, 2010)
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Model

Area

Stages

Reference

P3M3

Portfolio, Program, and Project

5

(AXELOS, 2018)

Project Management Maturity Model

Project Management

5

(Kerzner, 2001)

Energy Management Maturity Model

Energy Management

5

(Introna et al., 2014)

Roadmapping Maturity Model

Roadmapping

6

(Petrick, 2008)

Roadmapping Influence model

Roadmapping

4

(Kappel, 2001)

Social Media Maturity Model

Social Media

5

(Thomas and
Woodside, 2016)

Manufacturing Enterprises

5

(Neff et al., 2014)

Maturity Models and safety culture

Safety Culture

Lit Rev

(Goncalves Filho
and Waterson, 2018)

Organizational Design Maturity
Model

Organizational Design, Design
Research

4

(Mettler and
Rohner, 2009)

Cognizant Enterprise Maturity Model

Knowledge Management

5

(Harigopal and
Satyadas, 2001)

Quality Management

5

(Caballero et al.,
2008)

Change Management

6

(Zephir, Minel and
Chapotot, 2011)

Business Intelligence

5

(Raber, Winter and
Wortmann, 2012)

Business Processes

5

(Lee, Lee and Kang,
2007)

Service Systems Maturity Model

Information Quality
Management Maturity Model (IQM3)
Organizational Change Readiness
MM
Capability Maturity Model for
Business Intelligence
Business Process Maturity Model
(BPMM)

2.4.1

Technology Management Maturity in Healthcare

Maturity models have also been used in the healthcare domain specifically in the
information system technology sector (Vidal Carvalho, Rocha and Abreu, 2017). Tarhan
et al (2015) argue that only a scarce number of maturity models have been proposed with
varied focus and depth for business processes in healthcare before the last decade (Tarhan,
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Turetken and van den Biggelaar, 2015). However, there has been a myriad of studies in
the field of maturity models in healthcare in recent years.
There are models such as IDC’s mobility maturity model for mhealth and models such as
HIMSS maturity model for electronic medical records (EMRAM), patient record/content
management maturity model (Forrester model), and maturity model for electronic patient
record (EPRMM) for the field of electronic medical records (Garets and Mike, 2006;
Priestman, 2007; Clair, Brown and Moore, 2010; Dunbrack and Hand, 2013). There have
been other maturity models designed for different fields in healthcare such as
interoperability, infrastructure IT, data warehousing, analysis networking, telemedicine,
networkability, and usability among other (Nehta, 2007; Sharma, 2008; Fitterer and
Rohner, 2010; NHS, 2011; Zephir, Minel and Chapotot, 2011; Brooks, El-Gayar and
Sarnikar, 2013, 2015; Van Dyk and Schutte, 2013; Sanders and Burton, 2016; HIMSS
Analytics, 2018). As for organizations with goals of continuous learning, a mature system
is defined as a system that generates timely actions to the information that it derives (or
it can be derived) from data in order to create meaningful measurement regarding system
learning (Ainsworth and Buchan, 2015). In this research, a mature health organization
(system) in terms of technology management is defined as:
“A system that generates timely actions to the information that it derives from data in order to
create meaningful measurement regarding systematic learning and increased efficacy and
effectiveness in health outcomes.”
As an initial part of this research, Shaygan & Daim (2019) proposed an exploratory model to

assess technology management maturity in healthcare organizations by using Hierarchical
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Decision Model (HDM). The model can help health organizations with pinpointing their
strengths and weaknesses in the adoption and implementation of new technologies and
socio-technological approaches such as Learning Health Systems (LHS) and their
infrastructure while giving them organizational and competitive self-awareness and guide
them in setting their strategies and resource allocation. The mentioned study was done to
create an exploratory model to serve as a much-needed technology management tool for
health organizations to assess their technology management maturity for both public and
organization’s advantage in a more effective way.
A list of maturity models proposed in healthcare is shown in Table 2.
Table 2: Maturity Models in Healthcare

Model

Area

Stages

Reference

Governance, Risk, and Compliance
MM (GRC)

Hospital Management

5

(Batenburg,
Neppelenbroek
and Shahim,
2014)

Hospital Cooperation Maturity
Model (HCMM)

Hospital Corporation Quality

4

(Mettler and
Blondiau, 2012)

Quintegra Maturity Model for
Electronic Healthcare (eHMM)

Healthcare Information
System Technology

7

(Sharma, 2008)

Healthcare Data Quality

5

(Pinto-valverde
et al., 2013)

IDC Healthcare IT (HIT) Maturity
Model

Healthcare Information
System Technology

5

(Dunbrack and
Hand, 2013)

IDC’s mobility maturity model

Healthcare, mHealth

5

(Dunbrack and
Hand, 2013)

PACS Maturity Model

Picture Archiving and
Communication Systems in
Healthcare

6

(van de
Wetering and
Batenburg,
2009)

Healthcare Data Quality Maturity
Model (HDQM2)
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Model

Area

Stages

Reference

Networkability of Health Care

Healthcare Networkability
and Interoperability

5

(Fitterer and
Rohner, 2010)

Electronic Healthcare Maturity
Model (eHMM)

EHRs

7

(Quintegra
Solutions
Limited, 2008)

NHS Maturity Model

Healthcare

5

(NHS, 2011)

5

(Cleven et al.,
2014)

Providers

Process Management in Hospitals

DiagnosisRelated Groups (DRG)

HIMSS Maturity Model for
Electronic Medical Record
(EMRAM)

Healthcare, EMR

8

(HIMSS
Analytics,
2018)(Garets
and Mike,
2006)

HIMSS Continuity of care maturity
model (CCMM)

Healthcare, Healthcare
Information System
Technology

8

(Carvalho,
Rocha and
Abreu, 2016)

Patient records/content management
maturity model (Forrester Model)

Healthcare, EMR

3

(Clair, Brown
and Moore,
2010)

Maturity Model for Electronic
Patient Record (EPRMM)

Healthcare, EMR

6

(Priestman,
2007)

NEHTA Interoperability Maturity
Model (IMM)

Healthcare, Interoperability

5

(Nehta, 2007)

NHS Infrastructure Maturity Model
(NIMM)

Healthcare, Infrastructure IT

5

(NHS, 2011)

Healthcare Analysis Adoption
Model (HAAM)

Healthcare, Data Warehouse,
Analysis

9

(Sanders and
Burton, 2016)

Hospital Cooperation Maturity
Model (HCMM)

Healthcare, Networking,
Cooperation

4

(Mettler and
Blondiau, 2012)

PACS Maturity Model (PMM)

Healthcare

5

Telemedicine Service Maturity
Model

Healthcare, Telemedicine

5

(Van Dyk and
Schutte, 2013)

Healthcare Usability Maturity
Model

Healthcare, Usability

5

(HIMSS, 2018.)
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Model

Area

Stages

Reference

Healthcare Business Intelligence
Maturity Model

Healthcare BI

9
Success
Factors

(Brooks, ElGayar and
Sarnikar, 2015)

Healthcare Information System
Maturity Model (HISMM)

Healthcare Information
System

7

(Carvalho et al.,
2019)

2.5 Quadruple Aim of Care
In 2008, Donald Berwick et al. provided a framework for the delivery of high-value care
in the United States, revolving around three main goals: improving the individual
experience of care; improving the health of populations; and reducing the per capita cost
of healthcare also known as the triple aim of care (Berwick, Nolan and Whittington,
2008). This framework discusses that and healthcare organizations that deliver individual
care and population-based interventions that are evidence-based and highly reliable can
achieve these three qualities. The enablers of this achievement in a care system are access
to up-to-date medical knowledge, standardized definitions of quality and cost, and
evidence and measurement collected and distributed by a thoroughly trustworthy body as
indicators of the “state of the system” by its stakeholders. This state is assessed through
its reliability, adherence to evidence, cost, and progress in improvement. These goals
would ideally result in care that produces the best outcomes at the lowest cost over time
(Porter and Teisberg, 2006).
The important enablers for the positioning of the health organization for a successful
pursuit of these aims are recognition of a population as the unit of concern, externally
supplied policy constraints (such as a total budget limit or the requirement that all
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subgroups be treated equitably), and the existence of an “integrator” with the duty of
focusing and coordinating services to assist the population on all three dimensions at once.
Donald Berwick et al. (2008) define the roles of the integrators or health organizations
pushing for the achievement of the triple aim of care are partnership with individuals and
families, redesign of primary care, population health management, financial management,
and macro system integration.
As, in recent years, Physician well-being has become an increasing concern, due to
increasing evidence of an epidemic of burnout and stress among medical
professionals, the goal of improving the work-life of health care providers was proposed
to be added to the triple aim of care by Bodenheimer and Sinsky in 2014 (Shanafelt et al.,
2012; Bodenheimer and Sinsky, 2014; West, 2016). In other words, as the Triple Aim of
care focuses on improving the patient experience of care, improving the health of
populations, and reducing the per capita cost of healthcare will benefit from the
expansion, the Quadruple Aim of care also includes the goal of improving the well-being
of health professionals. The fourth aim can be addressed through different channels such
as the implementation of a documentation team (to lessen the burden from physicians,
Use of pre-visit/lab/follow up planning, expanding the role of nurses and medical
assistants, standardization and coordination of workflows, and more effective training
among others (Bodenheimer and Sinsky, 2014).

2.6 Importance to Healthcare Management
As the healthcare landscape and environment in the United States remains a volatile and
dynamic one, managers and decision-makers in both private and public healthcare
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organizations need to have an understanding of the healthcare system and its landscape
as they need to comprehend the bigger picture of the environment which they try to plan
and manage decision and strategies. This knowledge (or lack thereof) can significantly
affect the viability, success, quality, and efficiency of the delivered care in results of
impacting the timeliness of decision-making actions. Shi and Singh (2019) discuss this
significance for care manages from different aspects such as positioning and
understanding, handling threats and opportunities, evaluating implications, complying
with regulations, planning, capturing new markets, and following the organizational
mission. Moreover, pursuing goals of continuous improvement and learning in the
dynamic healthcare environment can change the roles of managers from managing
processes to people (leadership, motivation,…) (Poksinska, Swartling and Drotz, 2013).
This necessitates a continuous effort from the managers’ side to balance the new
organizational, technological, social, financial, and regulatory changes with the
organization's culture, goals, and resources.
In their book, Hegarty, Amoore, Blackett, McCarthy, & Scott (2017) divide healthcare
technology management into two groups; Supporting and Advancing Care and
Equipment Management. The former includes topics such as clinical supporting, teaching
and training, clinical information, regulatory and standards issues, quality and risk
management, adverse event investigation, and support and innovation in care processes.
The second group, however, focuses on data management, scheduled maintenance,
medical equipment, and systems support, technology assessment, performance
verification, and corrective actions. This research and the continuous learning it is
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referring to and the assessment of technology management maturity it is trying to evaluate
includes many elements from both remits of technology management in healthcare.
Knowledge of the health care system and its development is critical for the effective
management of healthcare organizations. Therefore, health organizations should pay
attention to community needs, technological progress, consumer demand, and economic
prospects, to be better positioned to achieve and maintain their organizational missions
and technology management maturity as an organization. This maturity can bolster
access, service quality, and efficiency in the delivery of services. Health organizations
should address the need to take into account which technological, social, organizational,
regulatory, and financial might affect their organization’s long-term stability. This
knowledge should enable healthcare organization's decision-makers and managers to
identify strengths, weaknesses, opportunities, and threats in a more effective and timely
manner. The same thing goes for effectively allocating resources to manage changes (both
taking advantage of them or mitigating their unwanted results). The action taken can
address certain learning and improvement areas as well in terms of what should be
learned, added, modified, jettisoned, and what sort of organizations training,
technological infrastructure, public trust, or financial/regulatory need should be
conformed with aligned with organizations goals and mission. In conclusion, knowledge
of the health care system and its development is significantly important for the effective
management of healthcare organizations. Factors such as requirements, technological
advancements, stakeholder needs, and financial prospects, the decision-makers in
healthcare organizations can be better equipped to achieve and maintain organizational
58

missions and the goals of healthcare (quadruple aims of care (Bodenheimer and Sinsky,
2014)).
2.7 Research Centers in University Hospitals
Healthcare organizations and hospitals (including university hospitals) are large
institutions and consist of a very complex structure of management. Usually, different
organizations within a hospital may have different management styles and smaller
governance silos with certain guidelines being the same across these organizations. For
this reason, this research will focus on a smaller entity inside university hospitals which
are University Hospital Research Centers (UHRC) as the unit of study for this research.
These centers focus on specific areas within a bigger health organization and have their
directors, managers, and staff with different budget sources such as grants and donations,
among others. Although they operate under the guidelines and goals of the university
hospital, they have their own goals and missions which are aligned with their parent
organization but more specific. These units also have a certain amount of autonomy that
allows them to operate aligned with their mission and goals.
A university hospital is an institution that combines the services of a hospital with
the education of medical students and with medical research. Van der Meulen, 1994
describes support from the federal government and the introduction of faculty practice
plans in medical schools as major growth factors for these academic health centers (Van
Der Meulen, 1994). The mentioned research goes on to discuss the high cost of healthcare
as an external force in the growth of university hospitals and increasing concern about the
number of people who were not covered by insurance. University hospitals undergo
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significant cost to develop the ability to treat serious illnesses at the high end and in doing
so they need to cope with a larger population with needs around different disorders as
more and more types of patients are now being treated in more specialized care centers
(Christensen, Bohmer and Kenagy, 2000).
University hospitals are typically affiliated with a medical school or university. Most of
these university hospitals have research and innovation centers as compartmentalized
units within them that may focus on one or several specific topics. These units have
different ways of financing their budgets and have certain amounts of autonomy in the
way they are managed. These units can lead to breakthrough research for new cures, new
standards of care, and better understanding of different issues in specified areas of care.
In the United States, most of the funding for the research institutes and centers comes
from publicly funded grants (such as NIH grants), private grants, industry partnerships,
foundations (benefactor), endowments, state and federal customers, and donations. These
centers focus on topics such as imaging, cancer, vaccine and gene therapy, medicine,
public health, system effectiveness, Alzheimer’s, cardiovascular, occupational health,
evidence-based practice, neuroscience, aging, immunology, orphan diseases, and
innovation, among others. Each of these centers may focus on one or several topics within
their field. One factor that may be decisive in the direction of the research in the center
can be publicly or privately funded grants. In general, funding for science has changed
throughout time and moved from largely being supported through private patronage (the
backing of a prominent person or family), church sponsorship, or simply paid by research
to a combination of grants from various government agencies, institutions, and
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foundations (Understanding Science at Berkeley, 2020). As an example, Oregon Health
and Science University (OHSU), located in Portland, Oregon, is a university hospital
established in 1887. OHSU has around 33 research centers and institutes focusing on
topics such as oncology, public health, imaging, aging, neuroscience, and systems
effectiveness among many others. Some of these centers are created aligned with federal
or state-level initiatives for specific needs.
The U.S. Department of Health and Human Services (HHS) has a mission of enhancing
the health and well-being of Americans by providing for effective health and human
services and by fostering sound, sustained advances in the sciences underlying medicine,
public health, and social services (U.S. Department of Health and Human Services
(HHS), 2020). This department has different grants under programs like Administration
for Children & Families, Agency for Healthcare Research and Quality, Centers for
Disease Control and Prevention, Food and Drug Administration, and National Institutes
of Health. The National Institutes of Health (NIH) is the primary federal agency for
medical, health, and behavioral research. It is the largest of the eight health-related
agencies within the Public Health Service (PHS) within the HHS consisting of the Office
of the Director and 27 Institutes and Centers (ICs) that focus on aspects of health, human
development, and biomedical science (Sekar, 2020). NIH activities span from basic,
clinical, and translational research, focused on particular diseases, areas of human health
and development, to more fundamental parts of biology and behavior. Research training
and health information collection and the spread of knowledge are among the mission of
this agency and over 80% of its budget funds outside research in form of grants, contracts,
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and other awards (HHS.gov, 2018). This allocated amount can fund more than 300,000
researchers working at over 2,500 hospitals, medical schools, universities, and other
research institutions in the United States (Sekar, 2020). Table 3 shows the NIH funding
and the change for each year while demonstrating the change in funding compared to the
peak year which was 2003. Figure 7 and Figure 8 demonstrate the change in NIH funding
throughout the years in current and projected constant FY2020 values respectively (Sekar,
2020). Research funded by the NIH has led to saving lives while increasing longevity and
quality of life for people in the United States and around the world. Glass et al., 2020
points at success stories such as The Framingham Heart Study, development of childhood
vaccines, and the rapid decrease in morbidity and mortality from human
immunodeficiency virus as some success stories among the countless success stories of
the results of grants fund by the NIH in different areas such as disease-specific initiatives
and various specialties (Jacob and Lefgren, 2011; Colaco et al., 2013; Blume-Kohout and
Adhikari, 2016; Glass et al., 2020; National Institutes of Health (NIH), 2020).
Carline (2014) explores grants on the medical education and educational innovation, as
an example, discussing grants such as the Edward J. Stemmler, MD Medical Education
Research Fund Awards from the National Board of Medical Examiners or awards from
the Fund for Improvement of Post-Secondary Education for the smaller research while
discussing the Undergraduate Medical Education for the 21st Century project with goals
of medical education reform and training (innovation and research) grants from the
Bureau of Health Professions in NIH (Carline, 2004).
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Table 3: NIH funding and the Change Throughout the Years (Sekar, 2020)

Fiscal Year
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020

Funding (B)
$
10.90
$
11.30
$
11.90
$
12.70
$
13.60
$
15.60
$
17.80
$
20.40
$
23.30
$
27.10
$
28.00
$
28.50
$
28.50
$
29.10
$
29.60
$
30.50
$
31.20
$
30.90
$
30.80
$
29.30
$
30.10
$
30.30
$
32.30
$
34.30
$
37.30
$
39.30
$
41.90

Change
3.1%
5.6%
6.8%
7.3%
14.3%
14.1%
14.7%
14.0%
16.5%
3.2%
2.0%
-0.1%
2.2%
1.5%
3.2%
2.3%
-1.0%
-0.2%
-5.0%
2.8%
0.6%
6.6%
6.2%
8.8%
5.4%
6.6%

Funding in 2020 values
$
23.80
$
23.74
$
24.40
$
25.30
$
26.30
$
29.20
$
32.10
$
35.60
$
39.30
$
44.20
$
44.00
$
43.20
$
41.20
$
40.60
$
39.40
$
39.40
$
39.10
$
37.70
$
37.10
$
34.60
$
34.80
$
34.30
$
35.80
$
37.10
$
39.30
$
40.30
$
41.90

% Below 2003 Funding

Figure 7 :NIH funding Throughout the Years (Sekar, 2020)
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-0.5%
-2.3%
-6.8%
-8.2%
-11.0%
-10.8%
-11.5%
-14.8%
-16.1%
-21.7%
-21.2%
-22.4%
-19.0%
-16.2%
-11.2%
-8.8%
-5.4%

Figure 8: NIH Funding Throughout the Years (Program Level Projected Constant FY 2020) (Sekar, 2020)

Consoli and Mina, 2009 present a sketch for health innovation systems and the building
blocks, interactions, and feedback between them (Consoli and Ramlogan, 2008; Consoli
and Mina, 2009). This sketch consists of different elements around a problem and the
factors it affects in the individual sphere (patient and practitioner), service provision
(training, experience, therapy, and diagnosis), technology market (drugs and devices),
regulations, and scientific community (publications).
One of the reasons behind the realization of the need for health centers within university
hospitals can be traced to the rise of evidence-based care and the opportunity for different
centers with different focuses to collect data and perform research in the respective area
of research. The paradigm shift in evidence-based healthcare was multi-perspective. The
research strategy was shifting from lack of national leadership with scattered funding
without effective communication and coordination to improve strategic nationwide
leadership with improved communications between funders and researchers which led to
bolstered coherence in the research agenda (Walshe and Rundall, 2001). Furthermore, the
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research direction shifted from being research-led to needs-led while better research
programs paved the way for higher research quality. This shift also led to improved
research methods (more appropriate use of research methods), research outputs
(improvement of clinical practice being set as the primary goal rather than publications),
dissemination, mode of access to research findings (from innovation pull to innovation
push to clinicians in a proactive manner), and practitioner understanding of research
findings (more focus on metal analyses and systematic reviews as opposed to reports of
individual research (Walshe and Rundall, 2001).
In the United States, health systems are trying to shift from decades of operational systems
designed to deliver health care as a reimbursable service and morph into systems that
deliver health as a population goal (Goldman, Kumanyika and Shah, 2016). Parallel to
these changes is the constant quality improvement efforts in areas such as reducing
hospital-acquired infections and readmissions for heart failure. In this direction, both
transformation and incremental improvement are called for the learning health system,
which can constantly improve itself in different areas using the data generated internally
and externally meaning clinicians use each patient encounter as an opportunity to make
the next one better (Krumholz, Terry and Waldstreicher, 2016). This is especially
important in the research centers within health organizations as their goal and mission are
to learn and improve in a specific area of healthcare to be able to serve the population in
need of that specific service or treatment better.
As entities within university hospitals, health centers need to manage their technology,
knowledge, and resources to ensure continuous improvement and efficient learning and
innovation. These centers need to deal with factors in different areas such as technology
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(such as devices, data, access), social (patients, stakeholders, workforce), regulations
(keeping tabs on the changes in regulations and healthcare structure), organizational
(quality improvement, training, governance, management), and financials.
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3. Research Gaps, Objectives, and Questions
As the result of the literature review provided in the previous section, this part focuses
on clarifying the research gaps, research questions, and research goals.
3.1.Research Gaps
As the result of the literature review, several gaps were identified which this research will
attempt to bridge. The themes of the gaps range from the lack of a structured assessment
tool for the technology management to the need for organized and classified categories
of dimensions and criteria and emphasis on the much-needed focus on the technology
management side of maturity in health organizations (Grossmann, Goolsby, Olsen and
Michael, 2011; Hobbs, 2012; Grant et al., 2016; Brooks et al., 2017; Foley and Vale,
2017). Some of the existing research in the literature also calls for the need for a model
to include the main influence factors and their importance levels regarding maturity
models in healthcare technologies and information systems (Carvalho, Rocha and Abreu,
2016; Vidal Carvalho, Rocha and Abreu, 2017).
As for continuous learning, its adoption, and implementation, there is a need for a multicriteria approach in studying this topic in the context of technology management maturity
of health organizations. Most of the existing research in the literature focuses on
healthcare maturity and continuous learning in healthcare organizations only through the
specific lens based on the respective research field (Shaygan, Lavoie and Daim, 2018).
Therefore, these studies may not address the complexity of health care organizations’
maturity and the multi-perspective critical issues around it.
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This section will go through each of these gaps by summarizing the existing literature
around these talking points and clarifying the underlying gaps within those areas.
Furthermore, in the research goal’s section, the ways in which the model will help
mitigate and bridge these gaps will be explained.
3.2.1. Gap I
According to the literature and as discussed in the literature review in this research, the
adoption and implementation of technology management maturity models in healthcare
and continuous learning have not been studied in a multi-perspective way. In other words,
through literature, each domain of research only talks about these topics from their lens.
Research in public health has been focusing on the equity and social aspects (There’s a
further need to strategically align maturity and learning with health equity in terms of
addressing health disparities) (Bauer et al., 2015; Brooks et al., 2017) while technical and
technological research focuses on the EHR, EMR, and machine learning aspects and
technological infrastructure (Shah, 2016; Kraft et al., 2017; Malenfant et al., 2019; Nordo
et al., 2019; Takenouchi et al., 2019). Furthermore, on the maturity models side, studies
focus on healthcare information technology and systems or business intelligence
exclusively (Brooks, El-Gayar and Sarnikar, 2013, 2015; Carvalho, Rocha and Abreu,
2016; Carvalho et al., 2019). As an example (Brooks et al., 2017) proposes a practical
framework to incorporate health equity into a developing continuous learning system and
make sure that health disparities are considered in the development of such healthcare
systems. Bauer et al. (2015) discuss the importance of learning and implementation
science for psychosocial and medical interventions for mental and physical health
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concerns (Bauer et al., 2015). Brooks et al (2013) and (2015) proposes a review of
existing business intelligence maturity models to determine their adequacy for use in
healthcare while Carvalho et al. (2016,2018,2019) develop a maturity model for
healthcare information systems (Carvalho et al., 2018). Zephir et al. in 2011 propose a
methodology that revolves around coping with organizational readiness to achieve
business goals through technological and structural improvements bringing technical and
human capabilities together with goals of measuring organizational development maturity
(Zephir, Minel and Chapotot, 2011). Again, in this research, only two general dimensions
of maturity in healthcare are integrated to determine maturity with a focus only on change
management. Batenburg et al. propose a preliminary maturity model to evaluate and
monitor factors including Governance, risk and compliance (GRC) and GRC maturity in
Dutch hospitals (Batenburg, Neppelenbroek and Shahim, 2014).
In general Most of the existing literature focuses on one aspect of maturity in healthcare
(machine learning, public health, leadership, political, regulatory, organizational,
economic, technical) (Olsen, Saunders and Mcginnis, no date; Ren, Pazzi and Boukerche,
2010; Lambin et al., 2013; Morain and Kass, 2016; Butler et al., 2017; Finkelstein and
Jeong, 2017; Malenfant et al., 2019; Takenouchi et al., 2019). According to some authors
the drivers of healthcare maturity and continuous learning adoption and maturity are
multifaceted and need to be studied that way) (Hobbs, 2012; Schmittdiel et al., 2017;
Shellum et al., 2017). Furthermore, there are no systematic attempts to investigate the
potential impacts of different aspects of maturity and continuous learning on the quality
of healthcare organizations (Foley and Vale, 2017). Brooks et al. (2013) stress the need
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for a validated maturity model by defining healthcare processes, maturity levels, and
functionality or capability at each perspective at each maturity level. Carvalho et al.
(2016) reviews a wide variety of different healthcare maturity models through a literature
review and concludes that none of the identified models has a sufficiently broad scope
covering all areas and subsystems of health care organizations (Carvalho, Rocha and
Abreu, 2016). One of the other challenges that the existing models face is regarding
important factors for maturity. Carvalho et al. (2016) points out the existence of entries
with the same name in different maturity models and entries with different names but with
the same meaning or interpretation due to selected terminologies. This can also be due to
the fact that as criteria are not grouped and organized in different categories and
perspectives, lack of context would potentially cause confusion, duplication, and
inconsistency.
All in all, the criteria for assessing technology management maturity models in
healthcare in general and adoption and implementation of areas such as continuous
learning in health organizations are not organized and classified into perspectives.
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Figure 9: Gap 1

Gap 1: The criteria for assessing technology maturity models in healthcare in terms of
management of technology and continuous learning are not organized and classified into
perspectives.

3.2.2. Gap II
There’s a need for a framework to better assess the technology management maturity in
terms of implemented and adopted technologies across all aspects of care (Grossmann,
Goolsby, Olsen and Michael, 2011; Foley and Vale, 2017). In other words, there is no
structured way of assessing the current state of the organization in terms of adoption and
implementation of different aspects of technology maturity. There is a need for analysis
to be conducted, evidence to be gathered, arguments to be constructed maintained over
time around development, design, and implementation of continuous learning across all
levels of care (Friedman et al., 2014). Moreover, there’s a need for tools for addressing
the different aspects of the enterprise (Rouse, Johns and Pepe, 2017). There is also a need
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for a tool to assist health organizations in decision-making and assessment of the adoption
and implementation of systematic learning and its socio-technological infrastructure.
Budrionis and Bellika (2016) argue that there is a lack of focus on the evaluation of the
impact of learning health systems on service quality and patient outcomes (Budrionis and
Bellika, 2016).
Carvalho et al.(2016; 2015) discuss the need for a model including the main ingredient
factors of healthcare technology maturity and the potential benefits of assigning weights
to them to understand their relative importance:
“A maturity model with a holistic approach including a comprehensive set of influencing
factors is missing. In this perspective, a new model to fill the gap should be designed.
This new model should include the main influence factors with different weights
depending on their relative importance and its development should be supported by
rigorous scientific methods of conceptualization and validation.” [106, Page 131]
Budrionis and Bellika (2016) also stress the increased pressure for the need for impact
evaluation of continuous learning in healthcare organizations due to becoming more
mature as a novel care delivery paradigm and point out that this is not a major focus for
researchers yet. In other words, although research exists around these ideas, there is a lack
of assessment tools and research in this area and more focus is being put towards the study
of the feasibility of continuous learning rather than their assessment and their impact. The
creation of learning-related methodologies may also encourage further studies about this
topic and boost its adoption speed on different scales. Furthermore, many of the existing
healthcare maturity models in healthcare merely provide the health organization with
72

scales and levels and do not provide a score or quantification of important factors
regarding maturity in the organization. Lin et al. (2011) explore the status of e-healthcare
maturity in Taiwan in light of a nationwide investigation using Nolan’s stage model
(Nolan, 1973) among others. The mentioned study offers a multi-perspective model to
better understanding the current status of e-healthcare maturity in hospitals with goals of
better formulating e-healthcare policies to encourage the adoption of electronic medical
records (Liu, Hwang and Chang, 2011). However, this model only uses surveys and
interviews and does not include any quantification of this perspective and their respective
criteria for topics such as application portfolio, integration, IT infrastructure, user
awareness, information system staff, and planning. Brooks et al. (2013) conduct a
literature review of existing business intelligence maturity models to determine if they
will be useful in healthcare organizations (Brooks, El-Gayar and Sarnikar, 2013). A
maturity model can provide a readiness assessment and plan for a business intelligence
strategy by providing insight into the important checklists and processes necessary to
achieve the desired level in business intelligence maturity. Again none of the studied
models include quantification of important factors for maturity in healthcare
organizations (Watson, Ariyachandra and Matyska, 2001; Fisher, 2005; Min-Hooi Chuah
and Wong, 2012; Raber, Winter and Wortmann, 2012; Halper and Stodder, 2014). Brooks
et al. (2013) stress the need for a validated maturity model by defining healthcare
processes, maturity levels, and functionality or capability at each perspective at each
maturity level. The validation factor is critical to confirm the accuracy and completeness
of the proposed model in the healthcare environment. Brooks et al. continued their
research in 2015 and identified the need for research into a healthcare case study to create
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a business intelligence maturity model assessment tool (Brooks, El-Gayar and Sarnikar,
2015). This potential model needs to serve as a guidance tool for business intelligence
deployment initiatives and assess hospitals’ readiness to go to the next maturity level and
eventually bolster information management’s control and comprehension across the
organization. Raber, Winter, and Wortmann proposed a business intelligence maturity
model built based on fifty-eight capabilities across five levels ranging from initiate to
perpetuate with goals of identifying business intelligence weaknesses and strengths
(Raber, Winter and Wortmann, 2012).
Pak and Song proposed a capability maturity model (HCMM) in 2016 with the goals of
improving an individual’s capability to manage their health by using personal health
records (Pak and Song, 2016). This model was created based on Capability Maturity
Model Integration (CMMI) (Paulk, 2002; Caballero et al., 2008), which helps developers
in selecting software improvement strategies by determining their current maturity and
pinpointing the issues needed for improvement which did not include any
quantification. Pak and Song identified a lack of statistically and empirically validation
test in their study as a limitation despite the fact that it was grounded on the theoretical
and empirical models and called for the need for a validated framework which takes
different dimensions into account (Mettler and Blondiau, 2012).
Similarly, Zephir et al. (2011) build on CMM to assess the organizational maturity with
goals of integrating new practices in times of structural or technological change (Zephir,
Minel and Chapotot, 2011). This methodology revolves around coping with
organizational readiness to achieve business goals through technological and structural
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improvements. This research integrated technical and human capabilities with the goals
of measuring organizational development maturity. Batenburg et al. propose a
preliminary maturity model to evaluate and monitor Governance, risk, and compliance
(GRC) and GRC maturity in Dutch hospitals (Batenburg, Neppelenbroek, and Shahim,
2014). This model contains five maturity levels ranging from forming to optimized and
contains definitions or characteristics for four different criteria in each of the governance,
compliance, and risk areas across all five maturity levels. This model, however, is not
quantitatively addressing the maturity assessment and does not have validation as a part
of its procedure and discusses a need for a statistical method, such as factor analysis, or
path analysis (using Structural Equation Modelling, SEM) to be used to find unknown
factors that may have influenced the results. Knowledge Process Quality Model (KPQM)
used to evaluate their knowledge management structures in companies pinpoints the
needs for further test into their model including analysis of suitable measures for model
validation (Paulzen et al., 2002). Fitterer and Rohner (2010) identify a future step for their
research as a longitudinal model involving before/after evaluation of organizations
regarding networkability advancing projects with analysis of reliability and validity of the
prospective maturity model (Fitterer and Rohner, 2010).
Carvalho et al. (2016) reviews a wide variety of different healthcare maturity models
through a literature review and concludes that none of the identified models has a
sufficiently broad scope covering all areas and subsystems of health care organizations
and therefore, stresses the need for a new model to encompass main maturity factors with
different importance based on their relative weights through a rigorous scientific method
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and subsequent validation (Carvalho, Rocha and Abreu, 2016). One of the other gaps
mentioned in the discussed study is that maturity models in the healthcare setting are
either highly specialized or too general in sense of healthcare information systems such
as eHMM, IDC HIT, and CCMM. Moreover, most of these models do not discuss the
design or validation for these models (Mettler and Blondiau, 2012). As for the other gaps
identified in similar research, not of the studied research included any weights assignment
or factors quantifications. Lastly, this paper points out that many of these models do not
necessarily provide organizations with an improvement roadmap of the desired maturity
through a systematized process serving as a maturity ladder. In 2018, the next level of
Carvalho et al. research was published and identified the need for involve the
development of an automatic tool for assessing hospital information system maturity
based on the important influencing factors as a future research (Carvalho et al., 2018). As
a continuation of their study Carvalho et al. proposed their model in 2019 named the
hospital information system maturity model or HISMM for short (Carvalho et al., 2019).
This model is a classic maturity model including a matrix made of different maturity
stages and six important typified factors affecting maturity in hospital information
systems. This model defines the current maturity stage, the next maturity stage and
identifies the attributes that must be met to reach a new maturity stage. These six factors
include people, data analysis, strategy, information security, infrastructure, and electronic
medical records. Each of the six stages have certain characteristics that need to be
achieved to in order for the hospital to reach that level of maturity in a certain factor. The
literature review in this study was followed by surveys, creation of the initial maturity
model, interviews, and generation of the final maturity model. However, this study the
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improvement roadmap cannot be specifically pinpointed, and the maturity model
measurements is not related to hospital performance within the hospital and does not
address the optimal diffusion of this kind of maturity within the organization (van de
Wetering, 2016). Moreover, similar to prior models, there is still no room for
quantification of the model and subsequently creation of a quantified, validated,
assessment tool for maturity in healthcare organizations. Finally, without quantification
or a resulting maturity score, comparing hospitals’ performances against their competitors
which was identified as a gap was not addressed.
Furthermore, based on the literature many maturity models are created by health national
and corporations, which advocate technological developments (IDC Health Insights and
HIMSS or even by national health organizations as the National Health Service or
National Electronic Health Transition Authority). This poses a challenge to look deeper
into the methodology, validation, and development of these models. Besides, many of the
existing healthcare maturity models are not published in academic journals and only a
small number have gone through a peer-reviewed process (van de Wetering and
Batenburg, 2009; Mettler and Blondiau, 2012). Most healthcare maturity models are in
the form of white papers, websites, or presentations which hinders researchers from
validating their validity and procedure.
Another important weakness of the current maturity models as discussed by Goncalves
and Waterson in their 2018 maturity model in safety is that results obtained during one
point in time may not prove to be repeatable during another (Goncalves Filho and
Waterson, 2018). As some of the limitations of the mentioned study, reliability, validity,
77

and overall robustness of using maturity models have been argued. Although in some
areas such as safety, industry and related literature can be used to mitigate validation
problems (as in (Flin et al., 2000)), there’s a lack of methodologies that systematically
include validation for their criteria and results.
In sum, in the studied literature around maturity models and specifically maturity models
in the healthcare-related topics there are certain types of gaps that can be merged into one
gap group. Initially, most maturity models are built based on models such as CMM which
merely categorizes performances or initiatives into different levels of maturity stages. In
other words, no amount of quantification goes into these models which increases the
amount of subjectivity which can be counted as a limitation of these models. Furthermore,
many of these maturity models are products of companies, reports, and/or whitepapers
which means they have not been through a peer-reviewed process and more importantly
validation. Lastly, on top of the need for a quantified and validated model, there is a need
for the proposed model to be repeatable for both being implemented on the same health
organization more than once and to serve as a tool for evaluation of inter-organizational
performances among different health organizations.
Hence the second gap identified in this study is as follows:
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Figure 10: Gap 2

Gap 2: There is a lack of a quantified, validated, and repeatable model for assessing
maturity in health organizations in terms of technology management from different
perspectives.
3.2.3. Gap III
Recent progress in healthcare-related fields such as information technology has led to the
proliferation of volumes of both clinical and financial healthcare data. Despite the fact
that healthcare is increasingly dependent upon these fields such as IT, the accumulation
of data has outpaced our ability to utilize it to improve operational efficiency, clinical
quality, and financial effectiveness (Mettler and Vimarlund, 2009; Ferranti et al., 2010).
Moreover,

the

technological

innovations

have

brought

upon

some

new

issues/opportunities that healthcare organizations need to leverage or mitigate. About half
of the cost growth in health care over the past 40 years has been caused by technology
innovation (Congressional Budget Office (CBO), 2008). Moreover, studies have found
causal relationships between technology and management of decisions and performance
in fields such as nursing (Li and Benton, 2006). Therefore, managing new technologies
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and innovations has become an important issue in healthcare organizations’ day-to-day
items. Technology management is needed to be developed in health organizations
alongside important practices such as patient-centered care, interdisciplinary teams,
evidence-based practice, continuous quality improvement, use of new informatics, and
integration of public health to enable and bolster policies, management, and leadership
(Frenk et al., 2010). At the same time, if healthcare organizations are considered as
complex adaptive systems due to the dynamic environment that they exist in, the task of
managing them becomes a challenge due to the constant system redesign as an adaption
mechanism stressing the importance of specific technology management further (Rouse,
2008). A technology manager, as a leader, in organizations going towards continuous and
systematic learning and maturity, needs to act as a designer of the learning process and a
steward of the vision and as a teacher assisting the whole health organization in fostering
continuous desire to increase maturity (Argyris, 1991; Mohr, 2005). At the same time,
managers should advocate local learning and standardized practices while balancing it
out with attitudes and structures that encourage exploration and discovery (Carroll, 2002).
Some of these issues and items have been explained in detail by Stephen J. Swensen, and
James Dilling of Mayo Clinic in the Institute of Medicine report “Engineering a Learning
Healthcare” in 2011 (Grossmann, Goolsby, Olsen and McGinnis, 2011). In this part, the
main issues around technology management in healthcare and continuous learning will
be briefly reviewed. Moreover, the usefulness of maturity models in assisting with some
of these issues will be highlighted. One of the important aspects of technology
management is Policies. Public policy and health insurance programs are important
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drivers of technology management. Decisions regarding what is incentivized and paid for
dictates a critical role in deciding what is done and prescribed for the patients. Public
policy and health insurance programs are culprits of high expenditures related to
technology. The fact that the fee for service to fee for value in healthcare systems in the
United States has not been completely adopted yet causes the healthcare system that has
not transitioned yet to pay for more exams, which in turn drive technology use and
subsequently cost. Appropriate technology management can expedite and finalize this
adoption and diffusion of value for service. In the current system, instead of paying for
outcomes, safety, or service which is provided through time, the service fee is considered.
When merely service fee is paid, things such as safety, accuracy, reliability are not
considered. In other words, patients/payors are charged a certain amount of dollars for
procedures with different accuracy or complication rates as use is being paid for not the
value of care. Inefficient technology management in healthcare organizations may cause
some providers to charge more as in the case of Hillman et al.’s research. According to
Hillman et al.’s research, physicians/providers that own their equipment may incline to
order more exams and charging more for less quality (Hillman et al., 1990, 1992, 1995).
These are only some of the reasons why policy and programs play such an important role
in technology purchase and management in the United States.
Another issue that is important from the technology management aspect of continuous
learning and maturity in healthcare organizations is the appropriateness of the technology
use. Health organizations must make sure that a patient receives no more and no less than
the right amount of care. Based on Thrall (2004), 30% to 40% of imaging procedures in
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the United States are estimated to be unnecessary while it is estimated that poor quality
costs a company like General Electric $127 million per year, which about $60 million
that amount is caused at by overuse of technology in the radiology department (de
Brantes, 2003; Thrall, 2004; Tosczak, 2004). There are many other examples of
technology misuse across many departments in health organizations which can be
mitigated by standard evidence-based work rooted in best-practice order sets and decision
support. In the case of imaging and pharmaceuticals specifically, due to patient’s
conceived value due to commercials and advertisements, more is desired which leads to
higher cost while not necessarily being more effective in diagnoses and treatments in
health organizations (Wennberg, Fisher, et al., 2007; Wennberg, O’Connor, et al., 2007).
Also, technology management encapsulates managing technology in terms of not only
volume but also reliability in terms of accuracy and safety (Grossmann et al., 2010). In
other words, healthcare providers, including residents and fellows, should be placed in
environments their rate of medical errors will decrease with training and management.
Training providers to work in teams is critical to ensure an increase in reliability and
safety to make sure optimal technology management is flowing in the organization.
Another important issue is the effective diffusion of best practices as well as safety nets
to support high-reliability patient care through Effective and efficient technology
management which has been slow and inconsistent in the healthcare industry (Wennberg,
Fisher, et al., 2007; Wennberg, O’Connor, et al., 2007; Ting et al., 2008). Some of the
enablers of effective diffusion is for health organizations to know what their people know
through smooth communication, dissemination of best practices, lessons learned, and
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importantly transparency. Swensen and Cortese (2008) argue that enterprise-quality
dashboards showcasing outcomes, safety, and service using common definitions and
processes as effective transparency efforts (Swensen and Cortese, 2008).
Technology itself can have a critical place in technology management. Information
technology may take important roles in the optimization of technology appropriateness.
It can also aid organizations to bridge expected knowledge gaps in healthcare delivery for
points that providers may not know some information about the care they need to provide
(not knowing what they don’t know) through knowledge repositories (Grossmann,
Goolsby, Olsen and McGinnis, 2011). Technologies such as “Ask Mayo Expert” that
demonstrate the agreed-upon standard best practice, salient risks, and references, and
frequently asked questions, and appropriate medical specialty contact information to
providers for assisting them in providing care.
Finally, Stephen J. Swensen, and James Dilling of Mayo Clinic pinpoint the importance
of sentient investment in social capital as an important part of effective technology
management strategy with goals of high-reliability patient care. Social capital investment
encapsulates the goals of transforming an organization from a collection of individuals
into an agile, coherent, and collective mind (Lynch et al., 2000; Gopee, 2002; Grossmann,
Goolsby, Olsen and McGinnis, 2011). This can be done by utilizing research engagement,
administrations, and education. Swensen and Dilling emphasize on areas like
transparency, teamwork training, horizontal infrastructure, and cross-functional, teambased simulation training as important social engineering topics. An example of this can
be utilized in health organizations' training teams to train health medical and nursing
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students and residents, together in cross-functional teams to enforce a more effective
transformation culture.
In the past couple of decades, maturity models have been introduced as reference
frameworks for fields like Information System management in organizations across a
myriad of industries (Carvalho et al., 2018). As maturity models are instruments to assess
and continually improve organizational processes, they can play an important role in
managing these new technologies or technologically enabled changes that have been
happening and significantly affecting the healthcare landscape. In the healthcare domain,
maturity models have also been used to pinpoint a wide spectrum of challenges and the
areas such as business intelligence, information system, safety, calibration, and capability
assessment (Harigopal and Satyadas, 2001; Liu, Hwang and Chang, 2011; Zephir, Minel
and Chapotot, 2011; Batenburg, Neppelenbroek and Shahim, 2014; Brooks, El-Gayar and
Sarnikar, 2015; Tarhan, Turetken and van den Biggelaar, 2015; Goncalves Filho and
Waterson, 2018; Carvalho et al., 2019). Maturity models in healthcare have been
generally used to pinpoint strengths and opportunities of maturity in different aspects of
health and subsequently, paving the path for future improvement and evolution. However,
there has been minimal focus on the management and technology management side of
maturity models in healthcare as how a health organization as a system would be assessed
in terms of maturity from different perspectives and dimensions to give management
better insight into health organization’s opportunities and strengths. Maturity models can
give technology managers a clearer picture and a sense of self-awareness on where their
organizations are currently, where they want to be, and how they can manage their
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resources to get to their desired maturity level from different aspects. Technology
management maturity goals can be reached and reliable patient care can be provided on
the condition that the healthcare industry fosters systems changes to drive continuous
learning (Grossmann, Goolsby, Olsen and McGinnis, 2011).
There is a definite need to study the maturity of health organizations in terms of adoption
and implementation of continuous learning and technology maturity from technology
management aspect as this field is significantly important in the healthcare system in the
United States due to the importance of:
•

Policies, especially those which create incentives such as payment can be central
motivators of activities and performance.

•

Managing the appropriate use of technology and ensuring the high reliability of the
technologies applied

•

Effective diffusion of best practices and safety nets is crucial for efficient and
effective technology management as it allows for the optimization of technology
use.

•

Social engineering strategies such as transparency, teamwork training, horizontal
infrastructure, and cross-functional team-based simulations, can contribute to
moving an organization toward integrated care coordination in which the decision
is made with an organizational perspective. (Grossmann, Goolsby, Olsen and
McGinnis, 2011)
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The initial action in the improvement of the business processes in terms of effectiveness
and efficiency is to be on the same page and understand the current state of the
organization or business by assessing that organization’s processes from a different
dimension. Maturity models have successfully assisted in this matter in different areas.
One of the areas that there has been a lack of such models is in the healthcare domain
(Tarhan, Turetken and van den Biggelaar, 2015). Although there are some hints at the
importance of leadership in healthcare systems maturity and implementation and adoption
of continuous and systematic learning, there is no literature focusing mainly or solely on
the management side of the healthcare organizations’ technology management maturity
and its socio-technological infrastructure (Morain, Kass and Grossmann, 2017; Pronovost
et al., 2017). There’s a gap that needs to be filled in studying technology management
maturity in healthcare organizations due to the importance of policies, managing the
appropriate use of technology, effective diffusion of best practices and safety nets, and
social engineering strategies (Yong, Saunders and Olsen, 2010; Grossmann, Goolsby,
Olsen and Michael, 2011). All in all, although technology management is a growing issue
that continues to require significant attention in healthcare, there is a lack of studies on
the technology management side of maturity models.
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Figure 11: Gap 3

Gap 3: Despite the fact that technology management is a growing issue that continues to
require significant attention in healthcare organizations, there is a lack of studies on the
assessment of technology management maturity in healthcare organizations.
3.2.4. Gap IV
The fourth and final gap identified in this research is the lack of literature on research
centers and institutes within university hospitals. This need came after the identification
of the study unit of this research. The unit of study in this research is research centers and
institutes within university hospitals in the United States as focusing on healthcare
organizations as the “unit” would be too broad and complex to tackle. The results and
methodology in this research, however, may apply to broader cases and organizational
structures. Usually, different organizations within a hospital may have different
management styles and smaller governance silos with certain guidelines being the same
across these organizations. These centers focus on specific areas within a bigger health
organization and have their directors, managers, and staff with different budget sources
such as grants and donations, among others. Although they operate under the guidelines
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and goals of the university hospital, they have their own goals and missions which are
aligned with their parent organization but more specific. These units also have a certain
amount of autonomy that allows them to operate aligned with their mission and goals.
During researching and studying about 100 health research centers in around 15
university hospitals in around 12 states in the United States, the lack of literature
especially peer-reviewed articles and conference proceedings was identified. Almost all
the information from these research centers had to be obtained using either their parent
hospital’s website or their website. Some of these websites outline detailed information
about research areas, history, and funding while others did not offer the same number of
details.
In addition to the lack of literature around the funding channels, level of autonomy, and
structural details, there is almost no literature on how these health research centers are
managed and how these entities manage innovation (specifically continuous improvement
and organizational learning).
As mentioned before, in the United States, health systems are shifting from decades of
operational systems designed to deliver health care as a reimbursable service into systems
that deliver health as a population goal (Goldman, Kumanyika and Shah, 2016). In this
direction, both transformation and incremental improvement are called for continuously
improving and learning, as in systems that can improve themselves in different areas using
the data generated internally and externally meaning clinicians use each patient encounter
as an opportunity to make the next one better. This is especially important in the research
centers within health organizations as their goal and mission are to learn and improve in
a specific area of healthcare to be able to serve the population in need of that specific
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service or treatment better. There needs to study on how these research centers manage
the technology, knowledge, and resources to facilitate and maintain continuous
improvement and efficient learning and innovations while dealing with and/or taking
advantage of multiple multi-perspective factors.

Figure 12: Gap 4

Gap 4: There is very little to no information around the structure and management of
research centers within university hospitals.
3.2.Research Goal
The objective of this research is to develop a framework for assessing technology
management maturity in healthcare organizations in the United States in an area such as
continuous learning. The model can help health organizations pinpointing their strengths
and weaknesses in the adoption and implementation of continuous and systematic
learning and its socio-technical infrastructure while giving them organizational and
competitive self-awareness.

The model will serve as a much-needed technology
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management tool for health organizations to assess their technology management
maturity for human advantage in a more effective way.
3.3.Research Questions
RQ1: What are the main perspectives and criteria in the assessment of technology
management maturity in healthcare organizations?
RQ2: What are the weights of criteria and sub-criteria related to the assessment of
maturity in healthcare organizations?
RQ3: Does the proposed framework offer a validated, quantified, repeatable, and
practical way to assess technology management maturity in healthcare organizations?

Figure 13: Research Gaps, Goal, and Questions
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4. Methodology
This section includes the methodological discussion of this study.

4.1 Hierarchical Decision Model (HDM) Model
To better understand the pros and cons of using the Hierarchical Decision Modeling
(HDM), there is a need to better understand what it is.
The Hierarchical Decision Model (HDM) was initially proposed by Kocaoglu in 1983.
HDM is a methodology to analyze strategic decisions in a hierarchical structure by
formulating consensus among participants who are mostly experts in specific areas related
to decisions.
HDM represents the problem hierarchically, enabling the decision-makers to visualize the
criteria and their sub-criteria affecting the objective/mission. It is mostly applied for
evaluating alternatives or selecting best-fitting options to accomplish an objective
previously

specified

(Turan

et

al.,

2009).

HDM

calculates

the

relative

contribution/weights of perspectives/criteria through a systematic process of eliciting and
evaluating subjective judgments of relevant experts in order to assist decision-makers in
the decision-making process. HDM may be similar to the Analytic Hierarchy Process
(AHP) introduced by Saaty (Saaty, 1977). However, HDM utilizes a different
computational approach (Constant Sum calculations as opposed to Eigenvectors).
Munkongsujarit et al. (2009), argues that HDM aids the decision-maker by presenting the
decision problem as a hierarchy of problems that are more facilitated in terms of handling
(Munkongsujarit et al., 2009). This model breaks the various elements of the problem
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down to simpler sub-problems in a way that the decision problem morphs into a hierarchy
(Taha et al., 2007). HDM is a tool used in decision-making to rank and evaluate the
available alternative that is available followed by determining the most suitable choice
among them (Munkongsujarit et al., 2009). It is a tool that assists decision-makers in
quantifying and incorporating quantitative and qualitative judgments into a complex
problem (Taha et al., 2007).
In the general form, HDM has five levels named as Mission-Objective-Goal-StrategyAction (MOGSA) (shown in figure 27), yet there is no restriction on the numbers of
levels, but elements at the same level have to be “preferentially independent” (Kocaoglu,
1983). As the HDM structure is set, pair-wise comparisons among sub-elements for each
branching node are made (figures 28 -29). The weights of each criterion are derived from
pair-wise comparisons. Thus, in the generalized form of HDM researchers need to make
pair-wise comparisons among objectives, goals under each objective, and strategies under
each goal separately (Daim and Kocaoglu, 2015).

Figure 14: MOGSA HDM Model (Kocaoglu, 1983)
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Figure 15: Mission /Perspective/ Criteria Model (Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 2017;
Shaygan et al., 2018a)

Figure 16: Depiction of the HDM Model (Gibson, 2016; Estep, 2017)

When implementing the HDM model, structured expert panels are asked to
validate/quantify the model. The quantification will result in weights for each
criterion/perspective in the model. Each item will have a “global” weight against all other
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items in the same level, and a “local” weight within its accommodating category. Then,
the alternatives are evaluated against the lowest level of the hierarchy, which is the
decision criteria, to find the best decision possible. The comparison is implemented by
the distribution of 100 points between the two elements (pairwise comparison). The
element with higher priority/importance assigned to it (by the allocation of more points
reflecting its degree of priority/importance). In models such as AHP, 1-5 or 1-9 scales are
used in the pairwise comparison process. In HDM, the Constant Sum method is used for
the aggregation of expert judgments.
To evaluate alternatives, performance scores of alternatives for each criterion are required
as well. Performance scores can be determined by using scoring for scalar scores or
desirability functions for discrete scores. A desirability function is a transformation
function that converts actual performance value to a score ranging from 0 to 100 based
on market desirability or expert opinion (Daim et al., 2015).
Simply, HDM breaks down contributing factors to an objective into perspectives and
criteria on different hierarchical levels and enables the analysis of the contribution of each
factor or criterion to the objective. Then each option is evaluated in terms of the criteria
to have a final point of achieving the objective, between 0 and 100 (Kocaoglu, 1983).
The final score for each alternative is calculated by using Equation 1.
𝐾

𝐽𝐾

𝑇𝑉𝑛 = ∑ ∑ 𝑊𝐾 × 𝑓𝑗𝑘,𝑘 × 𝑉(𝑡𝑛,𝑗𝑘,𝑘 )
𝐾=1 𝐽𝐾=1

Where:
TVN: Technology value of alternative (n)
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Wk: Weight of criterion (k)
Fjk, k: Relative importance of factor (jk) with respect to criterion (k)
Tn,jk,k: Performance and physical characteristics of technology (n) along with factor (jk)
for criterion (k)
V(tn,jk,k): Desirability value of the performance and physical characteristics of technology
(n) along factor (jk) for criterion (k) (Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi,
2017).

In the case of this research, some minor changes have been applied to the model which
are as follows:

𝐾

𝐽𝐾

𝑀 = ∑ ∑ 𝑃𝑘 × 𝐶𝑗𝑘 × 𝐷𝑗𝑘
𝑘=1 𝑗𝑘=1
Where:
M: Maturity Score
K=Number of Perspectives
J= Number of Criteria
Pk: Weight of Perspective (k), k=1...k
Cjk: Relative importance of Criterion (jth) for Perspective (kth) (k), j=1…j and k=1...k
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D(jk): Desirability value (Maturity Assessment Value) of Criterion (jth) for Perspective
(kth)
Each item in the hierarchy is given weights. Each item will have a “global” weight against
all other items, and a “local” weight within the category it belongs to. Then, the
alternatives are evaluated against the lowest level of the hierarchy, which is the decision
criteria, to find the best decision possible.
The experts evaluate criteria hierarchy and alternatives by conducting pairwise
comparisons, with a constant-sum measurement scale (1–100 scale) for comparing every
two elements. For example, each expert can evaluate the perspectives through pairwise
comparison similar to the following example: (P1 40:60 P2), which means, in terms of
importance, Perspective 1 is less important than Perspective 2 with the ratio of 40 to 60.
All experts will do the same for perspectives and criteria under each perspective. Then,
based on HDM mathematical formulas, the experts’ evaluation will be aggregated in order
to calculate the weights of perspectives and criteria, with the total sum of 1, for each level
within the hierarchy and on the whole hierarchy. As well as weights for the alternatives
against each other for each criterion. And a final score for each alternative in comparison
with the other alternatives based on the aggregated evaluations of all experts, to find out
the best decision possible (Kocaoglu, 1983; Daim and Kocaoglu, 2016).
Additionally, in instances in which there is a need in having a reusable model, or in
instances of having many alternatives, desirability curves can be used. The combination
of desirability curves with HDM is used to identify levels/ metrics for each criterion. Each
level/metric connected to a criterion acts as a useful value to assist decision-makers. Using
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the desirability curves approach, the experts need to evaluate related levels/metrics for
each criterion (desirability matrix) while giving each metric a scaled quantitative value.
This enables the normalization of the evaluation results by experts across all the criteria
(Phan, 2013; Estep and Daim, 2016; Gibson and Daim, 2016).
HDM also includes the calculations for disagreement, inconsistency, and sensitivity
analysis (explained in details in question 3) to validate the reliability and robustness of
the final model (Kocaoglu, 1983; Chen and Kocaoglu, 2008; Daim and Kocaoglu, 2015;
Estep and Daim, 2016; Gibson and Daim, 2016; Estep, 2017; Shaygan, Ozdemir-Gungor,
D. Kutgun and Daneshi, 2017; Shaygan et al., 2018a).
4.1.1

Merits of the HDM model

As mentioned in the previous section, the HDM model helps the decision-makers to
visualize the criteria and their sub-criteria affecting the objective/mission. This is
specifically helpful in understanding more complex problems, and consequently better
decision-making under uncertainty. It offers a quantified, validated, and repeatable
analysis of the decision elements by considering the expert judgments. By aggregation of
diverse yet relevant expert judgments, the decision-makers are able to propose more
meaningful and robust solutions. Furthermore, sending the survey/software links to
experts individually avoids the risk of a physical meeting being monopolized by more
vocal individuals. At the same time by hearing out each expert separately, mitigates the
risk of not hearing and considering fewer vocal experts (as the case of focus groups may
be). Furthermore, with the analysis of inconsistencies, disagreements, and model
sensitivity, and the validation of perspectives and criteria by experts, HDM provides the
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much-needed validation for creating the multi-criteria decision model (in this case,
maturity model). The use of desirability curves allows the reusability of the model in a
different case (such as different health organizations, departments, etc.). Finally, the
HDM model has been used in a vast variety of technology management areas such as
technology adoption, strategic planning, technology planning, technology transfer, and
technology assessment in a wide variety of industries such as healthcare, energy,
semiconductors, transportation, internet of things, wearable devices among others
(Munkongsujarit et al., 2009; Fenwick and Daim, 2011; Abotah, 2014; Iskin, 2014;
Kocaoglu et al., 2016; Estep, 2017; Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi,
2017; C. G. Pereira et al., 2018; Shaygan et al., 2018a).
In the case of maturity models in healthcare organizations, the HDM model can bridge
several gaps identified in the gaps analyses section. Specifically, the second gap reads
as: “There is a lack of a quantified, validated and repeatable model for assessing maturity
in health organizations”. The validation part is addressed through the validation of
perspectives, criteria, and desirability curve metrics by the experts. Moreover, the
quantification part is addressed through quantifying the perspectives, criteria, and
desirability curve metrics. Finally, through utilizing the desirability curves, the model can
be used for different cases without the need to quantify the perspectives and criteria again.
4.1.2
When

Limitations of the HDM Model
using

the

HDM

model,

the

decision-makers

may

face

several

challenges/limitations that need to be addressed. Some of these limitations are imputed to
the expert judgment nature of the HDM model which will be discussed in detail shortly.
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However, some limitations are related to the nature of the model itself. These limitations
are discussed in this section.
4.1.2.1 Expert related limitations
HDM model uses experts for validation and quantification of the decision elements. The
expert judgment is however subject to potential bias. In cases like healthcare, the experts
may have been selected from a wide variety of areas/departments and they may bring
some subjectivity and that is not always on purpose. In other words, inherent human bias
may be present and may represent a threat to achieving solid results if not treated and
mitigated properly. Some ways of coping with this limitation are to be meticulous in
selecting the experts and ensuring that different (yet relevant) backgrounds in the research
are represented. Other ways to mitigate the risk of bias have been discussed in question
3.
Another group of export-related challenges is the risk of inconsistent, inaccurate
judgments by the experts. Furthermore, expert disagreements pose a limitation to the
HDM model. Although these challenges are some of the characteristics of human
judgment, there is a way to mitigate each of these challenges. As a part of validating the
results of the model, the HDM methodology measures the inconsistency and
disagreement indexes for the collected judgments. In cases where the obtained index is
higher than the acceptable threshold (both for inconsistency and disagreement), remedies
can be applied which are explained in question 3 in detail (such as clarification of research
goals and careful expert selection).
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The last category of the limitations for the export-related category is related to the amount
of work/time needed from the experts in order to validate/quantify the model. In many
cases, the experts may be busy people and may not have substantial time to allocate to
pairwise comparisons or perspective/criteria validations. For each level of the model with
“n” elements, there is a need to pairwise compare elements “

𝑛(𝑛−1)
2

” times. This can

deem very time-consuming for a level that has 8 elements (meaning 28 pairwise
comparisons). This may lead to experts getting tired and putting less attention into
comparing the decision elements and consequently deteriorate the model’s reliability.
4.1.2.2 Model Sensitivity
In instances where the HDM model includes alternative (actions), the addition and/or
removal of new alternatives may substantially change the final weights (results).
However, in cases that use desirability curves instead of alternatives, this limitation is
avoided.
Another issue is the lack of adaptability to changes/time. In the dynamic world that we
are living in, rarely will the problems stay the same through time. The dynamic
environment may subject the model to changes in the importance of decision elements
and even the decision elements themselves. In other words, with time, some elements
(criteria) may become less important or even obsolete whereas there may be an increase
in the priority of some criteria or even emerging criteria in the model. These dynamics
can happen gradually or abruptly and based on HDM’s nature; these changes will result
in changes in the final results/weights. This may mean that there should be frequent (based
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on the importance and pace of changes) updates for the models, their components, and
weights. Sensitivity Analysis (SA) is one of the ways to bolster decision makers’
awareness by learning about how robust the model is and how resistant it is to changes in
cases where the model should be modified (Tran, 2000; Abotah, 2014; Iskin, 2014;
Gibson, 2016; Estep, 2017).
4.1.2.3 Criteria Balance among Perspectives/Criteria
Finally, it is important to point out that when using HDM, it is preferred to have a close
number of criteria under each criterion. The reason for this is that when there is a
difference (more than 1) between the number of criteria under different perspectives it
may lead to smaller weights for the criteria under the perspectives with a higher number
of criteria (although it may be the perspective with the highest weight.). The only known
remedy for this limitation is trying to keep the criteria under each perspective close to the
others.

4.1.3

HDM Justification

Earlier, in the research gaps section the need for a multi-perspective, validated, and
quantified model was stressed. Carvalho et al.(2016; 2015) discuss the need for a model
including the main ingredient factors of healthcare technology maturity and the potential
benefits of assigning weights to them in order to understand their relative importance by
specifying that there should be a model that includes the main influence factors with
different weights depending on their relative importance and its development should be
supported by rigorous scientific methods of conceptualization and validation.
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Furthermore, technology management maturity models are complex, and specifically in
the case of healthcare organizations, there is a need for a method/model that can simplify
some of that complexity. Significant time-gaps in the practical transformation of clinical
knowledge into clinical practices, ever-increasing healthcare costs, high rates of medical
errors, healthcare institutions’ obligations towards improving safety, clinical outcomes,
and efficacy of care from one side, and the rise of disruptive innovations such as
genomics, wearables, machine learning, and artificial intelligence in health systems, the
adoption of EHRs and novel diagnostic tools, and the plethora of data from the other side
has made the need for a new approach in managing the U.S healthcare systems an
imperative. These issues are multi-perspective and there is a need to take a multiperspective approach when dealing with decision-making problems in this area.
With the gaps identified in the pre-comprehensive exam proposal and more specifically
in the research gaps section, there is a need for a model which:
•

Considers the criteria for assessing technology management maturity and
continuous learning in healthcare organizations in classified categories.

•

Takes a quantified, validated, and reusable approach in assessing maturity in
healthcare organizations (weights for factors in each level of the hierarchy)

•

Allows multi-perspective and hierarchical approach in decision making.
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Figure 17: Research Gaps, Goal, and Questions (Reprise)

After reviewing several other models which are used in multi-criteria decision-making, it
is found that the HDM methodology can adequately tackle the gaps mentioned above.
HDM is indeed a multi-criteria decision-making method with a hierarchical structure that
enables a more complex analysis through pairwise comparing the important factors
(perspectives/criteria) in a certain problem/decision. Furthermore, HDM captures
experts’ judgments and turns them into the weights for important factors regarding the
problem. This data collection can be done anonymously and individually bolstering the
quality of data that can be used towards helping the decision-maker. When using HDM,
different kinds of analysis such as Inconsistency analysis and Disagreement analysis can
be done to validate expert judgments. Moreover, at each level of the hierarchy,
surveys/questionnaires/interviews

can

be

used

to

validate

the

selected

perspectives/criteria (initially found using literature review). In addition, Sensitivity
Analysis provides the decision-makers with a better understanding of the model in terms
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of flexibility while giving them a better idea of when the model will require an update.
Finally, although a heavy load of quantification may go into the quantification, validation,
and calculation of the results, HDM results are intuitive and not difficult to use/understand
by people who have a less academic background.
HDM, as result, will provide weights for each of the decision elements in the model as a
prioritization/ resource allocation tool. By learning about the importance of each decision
element in each level of the hierarchy, decision-makers can have a better idea and
understanding of the situation at hand.
The use of desirability curves in this study will bolster the model through the
identification of the desired outcome for each criterion. In the case of this study, the
desirability curves will allow each health organization to be measured in terms of predefined metrics for each criterion. Moreover, the desirability curves pave the way for the
model to become a reusable one. The reusability of the model is specifically important as
health organizations may need to measure their maturity regularly to make sure if they
are on the right path or not. The reusability factor will also allow the model to be applied
to several healthcare organizations (partners/competitors) to gain a better understanding
of their performance.
The HDM model can be used by health organizations to identify their strengths and
opportunities. This will give health organizations a sense of self-awareness as “where
they are?”, “where they need to be?”, and “how can they better reach the point they want
to be?”. The model can serve decision-making assisting tool where health organizations
can measure their maturity and better prioritize their projects and initiatives in order to
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reach the goals of continuous improvement and learning in the delivery of care. Although
cutting costs may not be an initial goal of this, it can certainly be a result of maturity in
healthcare organizations.
The HDM model has been used to tackle many multi-criteria problems in different areas
and industries. It has been used to determine the innovativeness of companies (Phan,
2013), evaluation of energy policies (Abotah, 2014), assigning technology transfer scores
to research proposals (Estep, 2017), measuring research center performances (Gibson,
2016), measuring readiness for smart city projects (Barham and Daim, 2018), forecasting
of emerging therapeutic antibodies patents (Pereira et al., 2018) , and development of
technology transfer score (Lavoie, Kim and Daim, 2017; Lavoie and Daim, 2020) among
others and is, therefore, selected as the methodology for measuring maturity in healthcare
organizations with goals of improvement in the quadruple aim of care.
4.2.Critical Issues in Forming an Expert Panel and Selecting the Experts
As a part of the methodology in this research, expert panels in the field of the study will
help with the validation and quantification of the model. This validation and
quantification are in terms of the pairwise comparisons in the model (perspective/criteria)
as well as the desirability curves for each criterion’s metrics. In order to be able to discuss
the critical issues around forming an expert panel and the selection of these experts, there
should be some clarification and definitions around what an expert is and what is not. A
short literature review has been conducted to shed some light on this issue.
The roots of the word “Expert” comes from Middle English, borrowed from AngloFrench, borrowed from Latin expertus "tested, shown to be true," from past participle
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of experīrī "to put to the test, attempt, have experience of, undergo"(Merriam-Webster,
2019a). As for the meaning, based on Merriam Webster’s definition, Expert means
having, involving, or displaying special skill or knowledge derived from training
or experience. As for the panel, it is defined as a group of persons selected for some
service (such as investigation or arbitration) (Merriam-Webster, 2019b). Martin et al.
(2012) define expert knowledge as important information on a specific topic that is not
widely known by others (Martin et al., 2012). Some technical papers refer to expert
opinion as informed opinion on a technical problem based on experience and training
(Meyer and Booker, 2001). From these definitions, we can conclude that expert panels
can be defined as: “A group of people having, involving, or displaying special skill or
knowledge derived from training or experience in a field not widely known by others,
selected for judgment and decision making of a topic in that specific field.”.
Expert panels are frequently utilized in developing and accessing projects at model
development, and interpretation of results (Fazey, Fazey and Fazey, 2005; Runge,
Converse and Lyons, 2011; Sutherland et al., 2011; Martin et al., 2012). In the fields of
technology and healthcare, expert panels have been used in the quantification and
validation of multi-criteria decision models (Daim and Kocaoglu, 2015; Shaygan and
Testik, 2017; Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 2017; Testik et al.,
2017b; Shaygan et al., 2018b)
Expert panels’ judgments, according to some studies, as well be the only or the most,
credible source of information available for making management decisions in cases where
the topic is not widely known (Martin et al., 2005; Firn et al., 2013). Holman et al. in
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2000 discuss that expert panels are invaluable in terms of addressing the multi-perspective
nature of complex problem while it is important to be wary of potential biases (Holman
et al., 2000). Moreover, expert panels can play an important role in raising qualitative
issues in the creation of conceptual models (Knol et al., 2010).
Kuhnert et al. (2010) signify that expert judgment in ecology is increasing in importance
as a tool for conservation decision-making in instances of insufficient data (Kuhnert,
Martin and Griffiths, 2010). Expert knowledge assists researchers in the science and
practice of conservation due to the complexity of problems, insufficient data, and the
imminent nature of many decision-making processes (Martin et al., 2012).
In a seminal study about expert judgments, Dreyfus and Dreyfus (2005) discuss a ﬁvestage phenomenological model of skill acquisition and thus different levels of expertise
which will be briefly introduced here to bolster the clarification of the subject (Dreyfus
and Dreyfus, 2005).
The first level of skill acquisition is the “Novice” stage which means that although the
person has no prior experience or knowledge in the field, he/she has a grasp of the basic
rules, conditions, and the environment surrounding the subject at hand. The second stage,
“Advanced Beginner”, is a novice who has now a wider understanding of the subject
matter due to a little experience/exposure. The next level is “Competence” which refers
to having more grasp of the subject in terms of elements and prioritization. In other words,
the once novice now has a better understanding of the subject and can disintegrate the
complex issue into simpler parts to make them less overwhelming and more feasible. The
person in the “Competence” level can attend, evolve, and develop the related skills in
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each of these simpler parts one at a time. As the fourth level, “Proficiency” hints at
situational subjectivity in the reasoning. In other words, as the level of expertise grows,
long and structured lines of reasoning are replaced by faster actions and decisions more
intuitively. The final level, based on this study, is “Expertise”. The final level of skill
acquisition means that the expert has a higher level of understanding and refinement to
the previous levels enabling her/him to reach faster intuitive solutions/decisions for
complex scenarios. This means that, at this stage, the expert can see what is needed to be
done and how it can be done in an intuitive way (Dreyfus and Dreyfus, 2005). Day (2002)
however, stresses that decisions based on intuitions do not necessarily turn a person into
an expert (Day, 2002). Day continues to emphasize that, in order to become experts, there
is a need to have different kinds of practice in terms of cognition and its context as
opposed to being solely based on the accumulation of practice.
As for critical issues around forming and selection of expert panels, there are a couple of
areas to consider which are discussed below:
4.2.1. Bias
The first critical issue discussed in the forming and selection of expert panels for research
is biased. Bias is indeed one of the most important challenges faces when expert panels
are used in research (in this case, validation, and quantification of the model). At times,
the bias from the experts' side can be caused to the overconfidence in the subjects known
well by the experts (Nemet, Anadon and Verdolini, 2017). In order to better understand
bias, there’s a need for a definition for it in the relevant literature. Bias happens when an
expert tends to stress and believe his/her own judgment/experience over the ones that
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challenge that judgment (Mahoney, 1977). Also, experts, as humans, are unable to get rid
of cognitive bias and overconfidence (Morgan, 2014). In addition to overconfidence, the
bias from the experts’ side can be due to the expert’s tendency to influence the outcome
of the study. Research assessment performed by expert panels may be biased because of
the factors on the organizational, the panel, or individual evaluator’s level (Langfeldt,
2004). Langfeldt also categorizes the bias in research assessment based on cognitive
constraints, and interests from one side and scholarly/professional and non-professional
side. When in professional and based on cognitive constraints, experts may only view the
decision/problem through the own scholarly view (Mullen and Goethals, 1987). At the
same time when the scholarly bias happens due to interest, there is a risk of Nepotism. In
terms of non-professional bias with cognitive constraints, there is the risk of disregarding
data/information because of the sub-optimal information seeking. As for the nonprofessional due to interest, the bias can be motivated by personal interest/Nepotism
(Langfeldt, 2004).
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Figure 18: Categories of Bias in Research Evaluation (Langfeldt, 2004)

These issues make the identification and recruitment of proper and reliable experts for the
problem a challenging and arduous process (Tran, 2000; Abotah, 2014). Being impartial
is important as impartiality in judgment ensures both the consistency and meritocracy of
expert judgment/decisions (Lee et al., 2013).
To mitigate some of the problems caused by the potential bias from the experts’ side,
models like Hierarchical Decision Models, Analytical Hierarchical Processes, and Delphi
elicit anonymous judgments from experts. However, these methods are still prone to bias
from personal judgment due to personal judgments and/or interests (gains) which may
conceal the reality of the subject as a result.
Considering the mentioned issues regarding bias, researchers need to pay extra attention
in selecting the expert panel to ensure that there are no reasons for the experts (in terms
of personal/organizational interests) to influence their assessment of the subject matter.
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4.4.1. Size
The other critical issue around forming expert panels is the size of the panel. In terms of
the size of the panel for the research/studies/dissertations using the HDM methodology,
a different number of experts have been used. Phan (2013) argues that the ideal size for
an expert panel should be around 10-15 experts while Okoli and Pawlowski suggest the
panel of between 10 and 18 (Okoli and Pawlowski, 2004; Phan, 2013). However, the size
of expert panels has varied for different studies. Tran (2013) and Chan (2013) used a
smaller expert panel of 5 and 3 members respectively (Tran, 2000; Chan, 2013). Many
research in technology management utilizing expert panels for judgment in terms of
validation of quantification of models has used between 6-12 experts as panel members
as a manageable range time-wise yet reliable result-wise (Abotah, 2014; Gibson, 2016;
Estep, 2017).
4.4.2. Balance
Other than the risk of bias and the size of the panel other important factors should be
considered when forming an expert panel. As this research revolves around maturity
models in healthcare and organizational learning, it is important to have a wide variety of
experts covering different perspectives and dimensions of the healthcare environment.
There is a definite need to have healthcare experts from the technological, social,
organizational, regulatory, and financial sides as one of the gaps of this research is that
technology management maturity in healthcare should be studied in a multi-perspective
way (Shaygan, Lavoie and Daim, 2018). A balanced expert panel is a more robust and
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significant representation of the information and knowledge in the field of the
problem/decision (Abotah, 2014).
4.2.2. Quality
Another important issue is the quality and value of the judgment provided by the experts.
The expert judgment should reflect the reality of what is happening regarding the
problem/decision which is being studied. Factors such as bias can affect this aspect of the
expert panels. Looking at this aspect from a different lens, it should be considered that
how much of an expert the selected individual is which will directly affect the potential
contribution and value of the judgment provided by the expert. This judgment will
eventually determine the value and the merit of the study itself. Another side of the expert
quality can be imputed to how much time and contribution the expert is willing to allocate
to the research. Before selecting the experts, matters such as the time, knowledge, and
meticulousness needed for taking part in the expert panel should be discussed (Chan,
2013; Abotah, 2014). Another important aspect that should be ensured beforehand is the
expert’s willingness to participate in the study.
4.2.3. Researcher’s Burden
While most of the topics discussed in this section are the issues around experts, there are
some points that the person in charge of constructing the expert panel should do. The
researcher must communicate the research goals to the experts. In instances where there
is poor communication of the goals to experts, judgments will be prone to inaccuracy. A
researcher should walk the thin line between under and over-communicating the research
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goals to the experts in order to make sure he/she is neither misleading/influencing the
experts nor providing insufficient information to experts.
Furthermore, the researcher should leverage the right communication tools to assure they
are clear, fair, and user-friendly for the experts while making sure that the output is usable
for the research. Software, survey websites, phone conversations, emails can be used to
collect the expert judgment. In the case of study groups, sometimes an expert may
monopolize the conversation or influence the other experts that are attending that study
group.
Issues such as inconsistency and disagreement and how their judgments can be validated
in terms of these issues will be discussed in detail in the following sections.
4.3.Inconsistency
One of the ways in which the Hierarchical Decision Model (HDM) ensures the validation
of the quantification done by the expert panel is the inconsistency test. The word
“inconsistent” means “Acting at variance with one's principles or former behavior”
(Oxford Dictionary, 2019b). Based on Estep (2017), inconsistency is the disagreement
within an individual’s (in this case, expert) assessment (Estep, 2017). Moreover, Abbas
(2016) defines inconsistency in the HDM context as: “Inconsistency is a slight or gross,
deliberate or unintentional error in the elicited pairwise judgment related to the rank order
and mutual preference proportionality of alternatives.” (Abbas, 2016). In addition,
Abotah (2014), defines inconsistency as “a measure that explains how reliable and
homogeneous in his or her answers each expert was through the whole questionnaire”
(Abotah, 2014). However, based on the literature, expert judgment inconsistencies are
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quite common in multi-criteria decision models such as AHP, FAHP, and HDM (Leung
and Cao, 2000; Aguarón and Moreno-Jiménez, 2003; Grošelj and Zadnik Stirn, 2012;
Chan, 2013; Gibson, 2016). This probability is invigorated in cases where the decision
models are complicated and have many criteria involved.

Figure 19: Screenshot of the Financial Pairwise Comparisons

As an example of the kind of inconsistency caused during the experts’ assessment and
quantification of the model, consider the following hypothetical scenario:
During the quantification of the “Financial” perspective’s criteria in this study, an expert
has pairwise compared the three criteria within this perspective namely, resource
allocation, funding, and cost reduction (shown in figure 26). Let us assume based on our
hypothetical expert’s judgment, resource allocation is more important than funding while
funding is more important compared to cost reduction. Based on this logic, resource
allocation must be more important compared to cost reduction based on this expert’s
judgment. In addition, if based on the expert’s judgment, resource allocation is 1.5 times
more important than funding and funding is 2 times more important compared to cost
reduction, this means that resource allocation should be 3 (2x1.5) times more important
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than cost reduction based on our hypothetical expert’s judgment. This type of consistency
is called cardinal consistency.
Another example of expert inconsistency is shown in the following scenario:
Let us assume our hypothetical expert has ranked resource allocation 2 times as important
as cost-cutting and funding. Moreover, the expert has ranked funding 2 times as important
as cost-cutting. Based on this ranking, resource allocation should be the most important
criterion. However, in this case, the ordinal consistency has been violated as based on the
expert’s judgment, resource allocation and funding should have the same importance. If
the cardinal consistency is maintained in a judgment, the ordinal consistency will
automatically be guaranteed.
Experts, as humans, are subject to inconsistency in their judgment. This issue is even
more frequent in more complex problems. This implies that inconsistencies are expected
to occur in the quantification of the HDM model (Gibson, 2016). Therefore, the result of
expert judgment in the HDM model will each contain a level of inconsistency which must
be measured and controlled to ensure the soundness of the decision (Abbas, 2016).
Here, a summary of the way inconsistency is measure in the HDM model is provided.
Inconsistency measures have been calculated for many HDM related literature through
the years (Kocaoglu, 1983; Chan, 2000; Phan, 2013; Abbas, 2016; Lingga, 2016; Estep,
2017; Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 2017; Shaygan et al., 2018a).
In the HDM model, the inconsistency is calculated using the sum of standard deviations.
For n elements of comparison, n! vectors are created using the constant sum calculation
(s1, s2…, sn). The Constant Sum Scaling is a technique in which the experts (in this case)
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are asked to allot a constant sum of units, to some items based on a specified criterion
(Chayes, 1960). Each of the resulted vectors represents an element combination (Phan,
2013). As an example, for the financial perspective, there are (3! =6) possible
combinations for the criteria as follows:
1- Resource allocation, Funding, Cost cutting
2- Resource allocation, Cost cutting, Funding.
3- Funding, Resource allocation, Cost-cutting.
4- Funding, Cost cutting, Resource allocation.
5- Cost-cutting, Funding, Resource allocation
6- Cost-cutting, Resource allocation. Funding
Consistency in providing the pairwise comparison will result in relative values for each
of the mentioned criteria combinations whereas any inconsistency will result in
inconsistent values for each combination. Therefore, the inconsistency in HDM is
obtained through calculating the standard deviation between the values calculated in the
n! combinations (Phan, 2013; Estep, 2017). In this section, the calculation of
inconsistency in HDM is presented with referencing to the HDM-related literature
(Kocaoglu, 1983; Phan, 2013).

Let:
𝐶𝑖𝑗 = relative value of the ith element in the jth orientation for an expert
𝐶̅𝑖 = mean relative value of the ith element for that expert
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𝑛!

1
∑ 𝐶𝑖𝑗
𝑛!
𝑗=1

Inconsistency in the relative value of the ith (for i=1,2,3…, n) element is calculated as:
𝑛!

1
𝐼𝑛𝑐𝑜𝑛𝑠𝑖𝑠𝑡𝑒𝑛𝑐𝑦 = √ ∑(𝐶̅𝑖 − 𝐶𝑖𝑗 )2
𝑛!
𝑗=1

Variance of the expert in providing relative values for the n elements is calculated using
the formula below:
1

1

2
̅
𝐼𝑛𝑐𝑜𝑛𝑠𝑖𝑠𝑡𝑒𝑛𝑐𝑦 = 𝑛 ∑𝑛𝑖=1 √𝑛! ∑𝑛!
𝑗=1(𝐶𝑖 − 𝐶𝑖𝑗 ) α

The acceptable threshold for the inconsistency measure in HDM models has been
discussed in the literature. Kocaoglu in 1983 established a maximum of 10% as the
acceptable threshold for the inconsistency in HDM models (Kocaoglu, 1983). In cases
where the inconsistency is higher than 10% or 0.1, several actions can be taken. It can be
requested from the expert to do the pairwise comparisons again. Moreover, a conversation
with the expert may clarify the evaluation procedure for the expert and thus, solve the
inconsistency problem in the second attempt. In cases where a consensus cannot be
reached with the expert or in cases of continued inconsistency, the expert’s judgment may
be deleted from the results. Another action that can be taken was introduced by Abbas
(2016) which argues that the threshold for inconsistency should be based on the criticality
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of the decision (Abbas, 2016). This method uses the root-sum of variances by considering
the number of pairwise comparisons made by the expert.
𝑛

𝑅𝑜𝑜𝑡 𝑆𝑢𝑚 𝑜𝑓 𝑡ℎ𝑒 𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒 = √∑ 𝛼𝑖2
𝑖=1

In the above equation, the Root sum of the variance is used as the inconsistency value. 𝛼𝑖2
represents the variance of the for the ith decision element and is calculated using the
formula below (Abbas, 2016).
𝑛!

1
𝛼𝑖 = √ ∑(𝑉𝑖𝑗 − 𝑉̅𝑖𝑗 )2
𝑛!
𝑗=1

In the equation above, Vij is the normalized relative value for the jth combination of
variable i in “n!” orientations. The value 𝑉̅𝑖𝑗 is the mean of the normalized relative values
for the jth combination of variable I and is calculated as follows:
𝑛!

1
̅̅̅
𝑉
∑ 𝑥𝑖𝑗
𝑖𝑗 =
𝑛!
𝑗=1

4.4. Disagreement
Another important topic in the validation of the quantification of the HDM model is the
analysis of the disagreement among experts. The word disagreement means lack of
consensus or approval (Oxford Dictionary, 2019a). In the context of HDM, different
experts may have different ideas in terms of the assessment of the factors and the most
important criteria and their degree of importance may be subjective and different. Thus,
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despite the fact the disagreement among experts is expected and natural, it is critical to
measure and analyze the disagreement degree among the model experts as a part of
validating the maturity model in healthcare before moving on to the data analysis
procedure. As mentioned, disagreement among experts is an expected element of the
model. However, it is critical to set a threshold for an acceptable disagreement value.
agreement on problem/decision is necessary before an analysis based on quantification of
the criteria/perspectives (Mumpower and Stewart, 1996). Disagreement among experts
can be sourced to different factors such as different approaches and ways of
thinking/ideology, lack of expertise, self-interest, lack of goal communications,
insufficient or poor quality data/ feedback (Hammond, 2000). Therefore, although some
of these disagreement risks may be mitigated through articulate and clearly defined
research goals and user-friendly and intuitive tools, some sources of disagreement may
still exist in the model.
What does disagreement entail in the context of HDM? Disagreement is defined by Estep
(2017) as “The extent to which an expert panel is in agreement with their judgment
quantification is represented by a disagreement value.” (Estep, 2017). Moreover, Tran
(2000) and Abotah (2013) define disagreement as “the agreement among the experts’
judgment is represented by a disagreement value of the expert group in a pairwise
comparison procedure.” and “the disagreement of experts can be understood as the
deviation of their judgments from each other.” respectively (Tran, 2000; Abotah, 2014).
Disagreement value has been calculated and considered as a part of model/results
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validation for literature using HDM (Tran, 2000; Abotah, 2014; Estep, 2017; Shaygan et
al., 2017, 2018a; Cowan and Daim, 2018).
Similar to the inconsistency threshold, the acceptable disagreement level should not
exceed 10% (0.1) (Chan, 2013; Estep, 2017; Shaygan et al., 2017). In instances where the
disagreement value exceeds the threshold, several remedy methods can be performed to
alleviate the disagreement among experts. In cases where a small number of experts are
contributing to the disagreement value, can be eliminated as outlier after identification
through standard deviation analysis. Moreover, in cases where the views provided by the
experts which are causing the disagreement are deemed valid and concerning, their ideas
should be shared with other experts through methods such as the Delphi method followed
which can potentially decrease the disagreement value in the next quantification
iterations. Furthermore, the Hierarchical Clustering Method (HCM) can be utilized to
categorize similar data points in a cluster (Iskin, 2014). The goal of HCM is to discover
natural groupings. Iskin defines this model as “HCM obtains homogeneous clusters of
cases based on measured characteristics. The process starts where each case is considered
as a separate cluster; and for each iteration, a new cluster is determined by combining one
case with a cluster identified earlier in a fashion that the arithmetic distance between new
and old clusters remains the shortest among all possible alternatives. The process
continues until one cluster is left.” (Iskin, 2014).
4.4.1. Hierarchical Agglomerative Clustering (HAC)
The disagreement index was proposed in Kocaoglu’s 1983 publication (Kocaoglu, 1983).
Assume the research is using “m” experts for “n” decision variables. The HDM software
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used in this research uses Hierarchical Agglomerative Clustering (HAC) method to
calculate the disagreement value for the experts’ judgment. The following formulas show
the HAC method to calculate the disagreement index.
Let vij be jth expert’s relative value for the ith decision variable. Thus, group relative value
for the ith decision variable for all “m” experts can be calculated as (for i= 1, 2… n):
𝑚

𝑉𝑖 = ∑ 𝑣𝑖𝑗 .
𝑗=1

1
𝑚

The standard deviation for the relative value of the ith decision variable can be calculated
as:
𝑚

1
𝑆𝑡𝑑𝑣𝑖 = √ ∑(𝑉𝑖 − 𝑣𝑖𝑗 )2
𝑚
𝑗=1

Consequently, the disagreement index for the m experts can be obtained by calculating
the average of the standard deviations of “n” decision variables:
𝑚

1
𝐷𝑖𝑠𝑎𝑔𝑟𝑒𝑒𝑚𝑒𝑛𝑡 𝐼𝑛𝑑𝑒𝑥 = ∑ 𝑆𝑡𝑑𝑣𝑖
𝑚
𝑖=1

4.4.2. Intraclass Correlation Coefficient (ICC)
Another method for calculating the disagreement index (the measurement of the
reliability of quantitative scales) is to use Intraclass Correlation Coefficient (ICC) (Fleiss
and Cohen, 1973; Sheskin, 2007; Estep, 2017) intra-class correlation coefficients can be
used as statistics for measuring homogeneity in cases where there is a need to study the
relationship between variables of a common class (in terms of metric and variance) (O.
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McGraw and P. Wong, 1996). McGraw et al. continue to discuss ICC as a measure of the
proportion of a variance that is imputed to objects of measurement, often called targets
(Shrout and Fleiss, 1979). In the context of this research and for the HDM methodology,
ICC calculates the disagreement among experts for a relative number of elements. In this
case, ICC determines the agreement measure among experts based on “n” elements’
relative importance which is obtained through the pairwise comparisons.
ICC can be calculated as follows (Bartko, 1966; LeBreton and Senter, 2008):

𝐼𝑛𝑡𝑟𝑎𝑐𝑙𝑎𝑠𝑠 𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 (𝐼𝐶𝐶) =

𝑀𝑆𝐷 − 𝑀𝑆𝐸
𝑘
𝑀𝑆𝐷 + (𝑘 − 1)𝑀𝑆𝐸 + 𝑛 (𝑀𝑆𝐼 − 𝑀𝑆𝐸 )

n= Number of targets (decision elements)
k= Number of experts
MSD= Mean square for decision elements
MSI= Intra-expert mean square
MSE= Mean square error (residual) (calculated using two-way ANOVA)
−1

For this case, ICC can take values in the interval ((𝑘−1) < 𝐼𝐶𝐶 < +1) with (+1) showing
total intra-expert agreement while any values that are zero or negative would show total
disagreement among experts (Bartko and Carpenter, 1976). There are different opinions
about the acceptable threshold for disagreement in the ICC method. LeBreton and Senter
(2008) argued that an ICC of 0.7 or higher would indicate an acceptable level of
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agreement among experts whereas other studies stress the importance of research
questions, objectives, and data in indicating the threshold (LeBreton and Senter, 2008;
Trevethan, 2017).
4.4.3. F-Test
Another way to determine the significance of expert disagreement is to use the F-test
through hypothesis testing (Shrout and Fleiss, 1979). The F-test can be used to justify the
disagreement values above the 10% threshold to decide the significance of the model. In
this context, the F-test will hypothesize whether the ICC value is equal to zero:
ICC= Intraclass Correlation Coefficient
MSD= Mean square for decision elements
MSE= Mean square error (residual)
Hypothesis:
𝐻0 : 𝐼𝐶𝐶 = 0
𝐻𝛼 : 𝐼𝐶𝐶 > 0
H0 implies that there is no correlation among the judgment and therefore shows complete
disagreement among experts. Hα however, implies that there is no statistically significant
disagreement among experts. The F value is calculated using the following formula:
𝐹=

𝑀𝑆𝐷
𝑀𝑆𝐸

With one and two degrees of freedom for decision and error respectively, and with 95%
(α= 0.05) confidence level, the obtained F value is compared to the critical F value. If the
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calculated F is bigger than the critical value, H0 can be rejected concluding that there is
no significant disagreement among experts.
𝐼𝑓 𝐹 > 𝐹𝐶𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑇ℎ𝑒𝑛 𝐻0 𝑖𝑠 𝑟𝑒𝑗𝑒𝑐𝑡𝑒𝑑 𝐸𝑙𝑠𝑒 𝐹𝑎𝑖𝑙 𝑡𝑜 𝑟𝑒𝑗𝑒𝑐𝑡 𝐻0

4.5.Sensitivity Analysis
In the HDM model, in order to analyze the impacts of potential changes in the values at
levels of the model, Sensitivity Analysis (SA) is used. SA is a method that can be used to
perform analysis on how different perspectives/criteria of the model will change in
scenarios where there is a change in value/weight of model elements. In other words, SA
helps decision-makers determine how much a given model depends on its input factors
(Saltelli, Tarantola and Chan, 1999). It also facilitates the process of understanding model
behavior and the extent to which its different factors interplay. Lilburne and Trantola
(2008) define SA as “the study of how uncertainty in model predictions is determined by
uncertainty in model inputs.” (Lilburne and Tarantola, 2009).
Local SA focuses on the impact of change in value one at a time, while a global SA
considers the potential impacts of simultaneous variation of model inputs over their finite
range of uncertainty. In other words, in the case of local SA, the value other than the one
changed is assumed as fixed. In the global SA however, several values would
concurrently change and the average of the changing output over the variation of all inputs
is simulated (Tian, 2013). The global SA can be performed using different methods such
as regression (SRC, SRRC, t-value methods), screen (Morris method), or variance basedmeta models (FAST, Sobol, MARS, ACOSSO, SVM methods), perturbation and
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derivative methods, multiple-start perturbation method, regional SA, and density-based
method (Morris, 1991; Park and Ahn, 1994; Storlie et al., 2009; de Wilde and Tian, 2010;
Mechri, Capozzoli and Corrado, 2010; Eisenhower et al., 2012; Tian and Choudhary,
2012; Hygh et al., 2012; Spitz et al., 2012; Tian, 2013; Paton, Maier and Dandy, 2013;
Pianosi et al., 2016).
In the field of technology management, due to its dynamic and fast-paced nature, SA has
been used to determine potential impacts of change in the importance/weights of the
perspectives as a way to ensure the robustness of the model/results (Phan, 2013; Estep,
2017). In the case of Multi-Criteria Decision Making (MCDM) models, the importance
(weights) may change due to the pairwise comparison matrix’s adjustment or
change/recalculation of the matrix after changing inputs (Chen, Yu and Khan, 2013).
Moreover, SA helps decision-makers in verifying the stability of the optimal solution and
validating the used methodology (Muñoz, Romana and Ordóñez, 2016).
Estep (2017) performed SA on her model on technology transfer score for research
proposal evaluation with test several analysis scenarios. The SA in Estep’s dissertation
was performed to better understand the impact of future-based scenarios (rank of
proposals in her case), with changes in the importance of difference model perspectives.
Moreover, SA determined how sensitive the model was to changes in expert judgment
and showed the path the organization can take to improve its technology transfer potential
(Estep, 2017).
In the context of the technology management maturity model in healthcare (HDM model),
sensitivity analysis will demonstrate the impact of changes in the perspective relevance
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on health organization’s final maturity score. In this context, sensitivity analysis can be
very helpful in comparing different health organizations, comparing different
departments within a health organization, and justification of changes in prioritization due
to changes in the importance of different perspectives (technological, social,
organizational, regulative, and financial). Furthermore, SA, in the context of this research
will demonstrate the changes in the prioritization of factors in different extreme cases
(scenarios). In other words, the model’s results will be tested in 5 different scenarios
where one perspective is utterly dominant compared to the other 4 in terms of relative
importance/weight. In summary, SA in the case of HDM, help decision-makers with the
following (Chen and Kocaoglu, 2008):
•

Assist decision-makers with clarifying the impact of changes at policy, strategy,
and operation levels.

•

Validating and testing the robustness of results/decisions.

•

Providing a wider understanding of possible outcomes based on the generation of
different rankings (for perspective/criteria) in different scenarios.

•

Facilitation of expert consensus.

•

Provide decision-makers with “what if” scenarios and questions.

This approach has been utilized by studies in the field of technology management and
multi-criteria decision-making (Abotah, 2014; Estep, 2017). The SA will need to (in this
case) determine the extent to which the model can withhold the changes before resulting
in new values/weights.
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Chen and Kocaoglu proposed a method in 2008 to determine the allowed range of values
changes which would not result in changing the final prioritization of the results (Chen
and Kocaoglu, 2008). This method has also been used in the technology management
literature (HDM methodology) (Tran, 2000; Phan, 2013; Iskin, 2014; Estep, 2017).

Based on this method, the initial prioritization of the model’s output will not be subject
to change under the following circumstance:
For the perturbation 𝑃𝑙∗𝑂 (the perturbation affecting one of the objectives (𝐶𝑙𝑂 )) where:
𝑂
𝑂
−𝐶𝑙∗
≤ 𝑃𝑙∗𝑂 ≤ 1 − 𝐶𝑙∗

The original maturity score (ranking) (Ar, Ar+n) for healthcare organization will not be
subject to change if:
𝜆 ≥ 𝑃𝑖𝑂 . 𝜆𝑂
Where:
𝐴
𝜆 = 𝐶𝑟𝐴 − 𝐶𝑟+𝑛

And:
𝐿
𝐴−𝑂
𝐴
𝜆 = 𝐶𝑟+𝑛,𝑙∗ − 𝐶𝑟𝑙∗ −
𝑂

∑

𝐶𝐴−𝑂
𝑟+𝑛,𝑙∗ .

𝑙=1,𝑙≠𝑙∗

𝐿

𝐶𝑂𝑙
𝑂

∑𝐿𝑙=1,𝑙≠𝑙∗ 𝐶𝑙

+ ∑

𝐶𝐴−𝑂
𝑟𝑙

𝑂
𝐿
𝑙=1,𝑙≠𝑙∗ ∑𝑙=1,𝑙≠𝑙∗ 𝐶𝑙

* indicates that perturbation(s) is induced on the contribution(s) related to that specific decision
element.
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The top choice will remain at the top rank if the above condition is satisfied for all r=1
and n=1, 2… I-1. The rank order of all Ai’s will not change if the above condition stands
of all r=1, 2… I-1, and n=1.
The allowance range of perturbations (𝐶𝑙𝑂 ) is obtained as:

𝐶
𝐶
[𝛿𝑙−
, 𝛿𝑙+
]

The sensitivity coefficient is obtained as:
1
𝐶
|𝛿𝑙+

𝐶

− 𝛿𝑙−|

This research will use the “Boost” approach to test the HDM model’s reliability and
sensitivity. The boosting approach is a scenario-driven method in which the analysis is
done around boosting one factor (at a time) to the maximum and observe the impact of
that on the final result and other perspectives/criteria’s relative importance. In the case of
this research, the Boost approach is performed for all of the 5 perspectives in the model.
In each scenario, one of the perspectives is given the maximum importance (without
removing any perspectives). These scenarios are performed to learn how the overall index
score of each alternative is changed, and whether that would result in re-prioritization of
alternatives (Chen and Kocaoglu, 2008; Abotah, 2014; Iskin, 2014; Gibson, 2016; Estep,
2017).
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4.6.Value/Desirability Curves
In instances in which there is a need in having a reusable model, or in instances of having
many alternatives, desirability curves can be used. The combination of desirability curves
with HDM is used to identify levels/ metrics for each criterion. Each level/metric
connected to a criterion acts as a useful value to assist decision-makers. Using the
desirability curves approach, the experts need to evaluate related levels/metrics for each
criterion (desirability matrix) while giving each metric a scaled quantitative value. This
enables the normalization of the evaluation results by experts across all the criteria (Phan,
2013; Estep and Daim, 2016; Gibson and Daim, 2016).
HDM also includes the calculations for disagreement, inconsistency, and sensitivity
analysis (already explained in the methodology section) to validate the reliability and
robustness of the final model (Kocaoglu, 1983; Chen and Kocaoglu, 2008; Daim and
Kocaoglu, 2015; Estep and Daim, 2016; Gibson and Daim, 2016; Estep, 2017; Shaygan,
Ozdemir-Gungor, D. Kutgun and Daneshi, 2017; Shaygan et al., 2018a; Estep, Daim and
Shaygan, 2021).
When using the HDM model, each criterion that is being evaluated by an entity (health
research centers/institutes in this case), can be assigned a level that best fits it for each
criterion in that research center. For example, the research center’s current status for each
factor affecting technology maturity and continuous learning will be identified by the
decision-makers after investigating the research center’s capabilities. Taking the
perspective and criteria weights already identified by the model, the decision-makers
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within the research center will use the value curves of each criterion to determine which
level in that value curve represents the research center the closest.

Figure 20: An Example of Desirability Curves
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5. Research Design
The research phases in this study will include thorough literature that delves into the
background information regarding the healthcare landscape in the US, continuous
learning in healthcare, and Maturity Models in healthcare. The knowledge and data
gathered in this section will be the basis of gap analysis and bricks of the HDM model in
terms of perspectives and criteria.
After the literature review, based on the findings of the literature review, the initial HDM
model and desirability curves will be developed. This step will, in parts, will be done
simultaneously with the next step which includes experts giving feedback in terms of
validating the model to finalize the HDM model.
In the next phase, several panels of experts will be formed with the goals of validating
and quantifying the model. Each panel will provide certain expertise that will be used to
evaluate respective parts of the model. The experts are initially asked to evaluate the
criteria and desirability curve values. Then, they will be asked to perform a pairwise
comparison based on the HDM approach to quantify the perspective and criteria.
Next, the pairwise comparisons done by experts will be initially validated by using
inconsistency and disagreement analyses. Finally, the business impact of the results and
their meaning and implication will be discussed. Leading to the conclusions of the
research. The general phases which are going to be implemented in this research are
illustrated in the figure below.
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Model
Validation and
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Initial Model

Results and
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Figure 21: Research Framework (Basic)

A more detailed breakdown of the proposed and implemented steps in this study are
demonstrated in the diagram below (Figure 22). As it can be seen the actions fall under
three categories which are “model development and validation”, “Model quantification
and analysis”, and “Case study and results”.

Figure 22: Research Framework (Detailed)

Each step and phase will require a different set of data and data collection sources which
are summarized below:
•

Literature Review: In the literature review part of this research, academic
publications will be the main source of information. These publications can be in
the form of papers that are published in peer-reviewed publications, academic
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books related to the research interest areas, and peer-reviewed conference
proceedings. In some cases, information available from reputable websites will be
used. The knowledge extraction from websites happens mainly in order to provide
recent statistics and regulations cited that are hard to get from academic
publications. Government websites (such as CMS.gov, NIH.gov), credible
business websites (Forbes.com, PWC.com), and healthcare organizations
(OHSU.edu, mayoclinic.org). Research gaps, goals, and questions are the results
of this step.
•

Determination of Critical Factors: Following the clarification of research gaps,
questions, and goals, the critical decision elements revolving around the proposed
decision should be identified. Since the HDM model is being used, in this step,
following the information collected in the literature review section, initial
perspectives and their sub-criteria should be identified.

•

Model Definition and Build: For this part of the research, the initial model should
be designed. The figure below shows the initial proposed model for this research.
As it can be seen, the initial model has a hierarchical structure including
perspectives and criteria.

133

Figure 23: Initial Model Depiction

•

Expert panel formation: with the goals of validating and quantifying the model, 5
expert panels were created. This section has already been discussed in detail in
the previous section.

•

Design of Validation Instruments: This section included creating the Qualtrics
surveys for perspectives, criteria, and desirability metrics validation. This section
also included creating the invitations, emails, and expert instructions for the
validation of the mentioned elements. These emails, instructions, and surveys are
completely shown in appendixes C and D. As for desirability curve metrics
validations, the list of metrics was sent to the respective panel of experts, and their
feedback was considered in polishing the metrics.
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•

Quantification Instrument Design: Following the model validation in terms of
decision elements and metrics, this section included creating the HDM model
using the ETM HDM software. This section also included creating the invitations,
emails, and expert instructions for the quantification of decision elements. These
emails, instructions, and surveys are completely shown in appendixes C and D.

•

Model Quantification by Experts: In this section, experts quantified the
perspectives and criteria using the instructions provided in the previous step. Each
expert conducts pairwise comparisons in both perspectives and criteria levels. In
addition to the importance weights of decision elements, the inconsistency index,
and disagreement index are products of this section.

•

Quantification of Desirability Curve Metrics: Using Qualtrics, the experts needed
to assign a value (0-100) to each criterion’s metric. Sufficient instructions are
provided to experts in this section.

•

Data Analysis: For this step, as mentioned before, the inconsistency index and the
disagreement index are analyzed to check if they are acceptable or not based on
the defined thresholds. If any of them are not within the acceptable range, actions
should be taken to solve the issue. In case the model has acceptable inconsistency
and disagreement, the weights obtained from the expert quantification are
finalized.

•

Case Study Metrics Assignment: In this step, expert(s) familiar with the research
and project (health research center) are asked to assign the proper metrics for each
criterion. Metric values are the results of the desirability metrics quantification
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steps. The experts will take the research goals into account. Furthermore, while
assigning these numbers the performance of the research center against each
criterion considering the goals of technology maturity and continuous learning.
The product of this section is the technology maturity score for the healthcare
organization.
•

Sensitivity Analysis: sensitivity analysis will demonstrate the impact of changes
in the perspective relevance on the research center’s final maturity score. In this
context, sensitivity analysis can be very helpful in comparing different health
organizations, comparing different departments within a health organization, and
justification of changes in prioritization due to changes in the importance of
different perspectives (technological, social, organizational, regulative, and
financial). Furthermore, scenario analysis, in the context of this research will
demonstrate the changes in the prioritization of factors in different extreme cases
(scenarios). In other words, the model’s results will be tested in 5 different
scenarios where one perspective is utterly dominant compared to others in terms
of relative importance/weight.

•

Results Analysis/ Conclusion: Following all the validation, quantification, and
analysis, the technology maturity score results for healthcare organizations.
Healthcare organizations can use this score to gain a sense of self-awareness of
where they are, where they want to be, and how to get there. This model’s results
will provide opportunities and strengths to the healthcare organization. Using this
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model as a decision-making assistant will bolster healthcare organizations'
efficiency and effectiveness in resource allocation and productive initiatives.
5.1. Perspectives and Criteria
During the initial literature review, using the ATLAS.ti qualitative and research software,
68 potential criteria were mined from the literature. This was done through coding the
specific parts of the papers that were being read with the tag “potential criteria”.
Following this, the criteria that were being repeated in different papers were deemed as
more important. Public health and strategic management-related criteria, data security,
standards, transparency, and cost-cutting were some of these recurring themes. Through
this procedure, as more papers’ codes were added, certain patterns and themes were
identified which eventually lead to the merge/add/removal of some identified potential
criteria. As an example, criteria such as “Public Trust”, “Physician Trust”, “Public
Acceptance”, “Respecting Clinical Judgement”, “Respecting the rights and dignities of
physicians”, and “Physician Trust” was later merged into “Stakeholder Trust”. Although
some criteria did not qualify to the initial model, they were later added to the model
through the expert validation of the criteria (such as training). The experts suggested
removing/adding some criteria. To verify that these items were aligned with the literature,
a deeper literature review which is provided in this exam was implemented for 3 of the
added or moved criteria (training, governance, privacy). Following the literature review
and then expert validation, the model was finalized before being quantified. Based on this
question, the criteria and perspectives were in the range of 4 to 5 decision elements at
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each stage. This research has 5 perspectives, and each perspective holds between 4 to 5
items as its criteria.
Some of the reasons for this numerical range have been discussed in the HDM literature.
When the number of criteria under a perspective increases it may turn the pairwise
comparison procedure into an arduous one. This may be a big advantage as many of the
experts may be busy professionals that may not be able to allocate a significant amount
of time to quantifying and validating the model. The number of pairwise comparisons at
each perspective is (n*(n-1)/2) with n being the number of sub-criteria. If there are 3 subcriteria there will be 3 pairwise comparisons while if there are 6 sub-criteria there will be
15 pairwise comparisons. However, if the number of criteria exceeds 6 it will need a
minimum of 21 pairwise comparisons at that perspective which may be too timeconsuming and lead to significant deterioration in terms of reliability. Looking at the
number of criteria from the other side, if the number of criteria is less than 3, basically
there would be no pairwise comparisons and it would merely be “a” comparison. Hence
the numerical range of 4-5 has been used in the HDM related dissertations and research
for each perspective node (Munkongsujarit et al., 2009; Phan, 2013; Iskin, 2014; Gibson,
2016; Mudavadi, Hogaboam and Daim, 2016; Estep, 2017; Shaygan et al., 2017, 2018a).

138

Potential Criteria
1 Analytics and Data Management
2 Data Governance(Appropriate Security and Privacy Controls (Confidentiality), Collection,Identification
4 Patient and Physician Partnership
5 Supporting Infrastructure
7 Dedicated programming resources and expertise
8 Leadership instilled culture of learning
9 Principles Adherence (Standards)
10 Health IT
11 Meaningful Use
12 Technologies
14 Public and physicianTrust (acceptance) (Respect clinical Judgement)(Respecting the right and dignity)
15 Patient Consent
16 Comparative Effectiveness
17 Public Health (Accessablity) Address health inequalities, ethics and oversight
19 External Funding
20 Regulative and legislative influences
21 Strategic Management (Mergers, Competing prioriteis,RESEARCH Partnerships,Problem Identification and Solution Prioritization)
22 Organizational Culture (training,inclusiveness)
23 Skilled Individuals
27 Data systems design
28 Internal Transpareny of quality metrics
29 Payer provider intergration
30 Academic/Clinical integration
32 Process Improvement,reengineering,QI
34 Balancing resource investment
36 Incentive Alignment
38 Patient an Family and coomunity and stakeholder Engagement
39 Evaluate
40 Adjuts
41 Disseminate
42 Culture of Learning supported by leadership
43 Real time knowledge access and sharing
44 Governance
45 Cooperative and Participatory Leadership
46 Transparency
48 Adaptability
50 Understanding the Vision
56 Decision Support Systems
59 Patient Centered Care
61 Payment Policies
62 National Assesment of Technologies
66 Scientific Integrity
67 QI and Healthcare Delivery Evaluation
68 Cost Cutting

Figure 24: Snapshot of the Initial Selected Criteria

5.1.1. Technology Perspective
Systematic assessment of technology management maturity needs a socio-technical
infrastructure and therefore, the technological side of the adoption of assessment of goals
such as systematic and continuous learning has significant importance. The adoption of
EHRs in the US from one side and the development in fields such as genomics and
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wearable devices from the other side are paving the path for the collection of great
amounts of data for health systems. Especially with all the demographic and demand
changes, healthcare organizations are forced to leverage the value of technology
advancements to be cost-effective, competitive, and responsive. Concurrent to the
mentioned advances, acquiring experienced data scientists and leveraging the benefits of
data integration, sharing with different stakeholders, and acquisition and curation of data
are some of the areas that can help healthcare organizations with their goals of increasing
quality care, patient satisfaction, and public health while driving down the costs
(Krumholz, Terry and Waldstreicher, 2016; Barham, 2017).
Information technology (IT) which is the transformation of data into useful information
involves identifying data needs, collecting the right data, storing and analyzing it, and
turn it into a useful and ideally automatic reporting system in a format desired by its end
users. Several types of information exist for specialized uses by health care professionals,
managers, payers, patients, researchers, and the government. IT departments in health
care organizations play a significant part in decisions to adopt new information
technologies to improve health care delivery, increase organizational efficiency, and
comply with various laws and regulations (In terms of clinical information systems,
administrative information systems, and decision support systems) (Shi and Singh, 2019).
IT departments in healthcare organizations use medical records systems to collect,
transcribe, and store clinical data; radiology and clinical laboratory reporting systems;
pharmacy data systems to track medication use and mitigate the risks of errors,
medical/drug reactions/interactions; scheduling systems for patients (both in terms of
room and participating professionals); and financial systems for billing and collections,
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materials management, among others. Moreover, Health informatics (application of
information science to improve the efficiency, accuracy, and reliability of health care
services) necessitates the use of IT but transcends it by stressing the improvement of
health care delivery (such as design and assessment of the effectiveness of clinical
decision support systems). As mentioned among the goals of learning healthcare systems
and continuous learning in those organizations, using health data beyond their primary
use can play a pivotal part in turning health organizations into learning ones. Some of the
topics covered in this perspective are:
•

Management of big data resources in terms of security, privacy, governance, and ethics.

•

The socio-technical infrastructure needed to improve and provide the capacity to capture,
compile, and protect clinical and financial data, which enables the evaluation, adjustment,
analysis, and dissemination, and integration of learned knowledge into clinical care
processes to secure the promised improvements.

•

Data systems and tools are used to capture, share, and integrate data, information,
visualizations, and knowledge gained from research into the organization in real-time.

•

Ensuring that technologies and IT products are user-friendly (e.g., considering health
literacy and technology competence) to all users (stakeholders).

This perspective covers topics such as data management and handling of technology in
terms of infrastructure, security, privacy, and knowledge flow and sharing in healthcare
organizations.

5.1.2. Social Perspective
This perspective encapsulates topics such as public acceptance, trust, accessibility, equity,
and engagement.
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The mission of public health has been defined as fulfilling “society’s interest in assuring
conditions in which people can be healthy.” by the institute of medicine in 1988 dealing
with a spectrum of concerns to make sure that optimal health is disseminated for society
(Institute of Medicine (US) Committee for the Study of the Future of Public Health,
1988). Enabling this mission and goal requires support and engagement from the involved
stakeholders. The stakeholders can take the shape of patients, providers, policymakers,
payers, and physicians.
These social and public health-related issues may involve the application of scientific and
technological know-how to avoid, mitigate, or cope with any public health and safety
threats. The wide scope of topics in terms of the social aspect of technology in healthcare
can have effects on topics varying from nutrition issues to health policy. Shi and Singh
(2019) discuss public health’s activities that of which include dissemination, both to the
public and to health professionals, of timely information about important health issues,
particularly when communicable diseases pose potential threats too large segments of a
population.
Some of the topics covered in this perspective are:
•

Key components of establishing stakeholder (patients, providers, payors, policymaker,
purchasers, families) trust include:
o

Garnering buy-in and trust from stakeholders so they contribute to a culture of
continuous improvement and learning.

o

Transparency with stakeholders regarding current limitations and plans to
address and mitigate them through a system that supports clinical and
translational research, public health information, and comparative effectiveness.
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o

Maintaining trustworthiness as a research center by following through on
promised commitments and ensuring new knowledge is used to improve the care
of those who contributed to its generation via an enhanced use of their data.

•

The degree to which the stakeholders are benefiting from the clinical and research
advantages of continuous learning. Health research centers must carry out consistent and
innovative outreach efforts to ensure that services are accessible to diverse populations to
reduce racial, ethnic, sexual orientation/gender, and other disparities.

•

The degree to which a health research center can engage stakeholders (patients, providers,
payors, policymaker, purchasers, families) to participate in continuous improvement and
learning projects and initiatives.

•

Research centers’ ability to acquire and retain talented and diverse staff in different areas
(physicians, nurses, researchers, data scientists, public health professionals, managers,
epidemiologists, administrative staff, etc.)

5.1.3. Organizational Perspective
This perspective covers certain organizational aspects of technology management in
healthcare such as leadership, change management, organizational culture and
transparency, strategic management, and quality improvement.

The topics covered in this perspective are:
•

Broad leadership can expand and guide stakeholders’ commitment to the goals of
continuous learning and increased technology maturity.

•

Research centers’ ability to improve through strategic decisions, management of
competing priorities, internal and external partnerships/collaborations, problem
identification, and finding solutions.
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•

The extent to which a research center’s employees have adopted and are committed to a
culture of continuous learning and practice transparency to safeguard stakeholder trust to
improve the health of individuals, communities, and diverse populations.

•

Training employees and stakeholders on the latest technologies and best practices within
the health research center.

•

Having the necessary governance to support a sustainable operation, uphold required
standards, build, and maintain trust with stakeholders, and continuously innovate.

5.1.4. Regulatory Perspective
Operating in a highly regulated environment, health care managers must comply with
government regulations, such as standards of participation in government programs,
licensing rules, and security and privacy laws regarding patient information, while
operationalizing the organization within the constraints of reimbursement rates. From the
public standpoint, the Medicare and Medicaid programs have made significant
modifications to their reimbursement methodologies that have caused the need for
operational changes in the way services are organized and delivered. On the other hand,
Private agencies, such as the Joint Commission, also play an indirect regulatory role
especially in the monitoring of the quality of services. Health organizations must obey
the rules set by the various public and private agencies that regulate the health care
marketplace. Therefore, it is critical for health organizations to constantly keep abreast of
the rules and regulations governing at state and federal levels.
The implications of health policy and new reform proposals are better reacted to when
health organizations sense and comprehend the issues and their connection to the delivery
of health services in the establishments they manage. This knowledge bolsters
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organizations' ability to be flexible and dynamic in terms of being proactive or timely
reactive to the regulatory changes in healthcare. Many of these regulations or policies
may be affected by the political climate as government policy in the United States plays
a significant role in deciding which drugs, devices, and biologics are made available to
Americans. The U.S. government is also one of the largest sources of funding for
biomedical research. By controlling the amount of funding, public policy indirectly
influences medical innovation (Shi and Singh, 2019).

This perspective includes regulatory and legal aspects needed to assess the maturity of
technology management in healthcare organizations such as governance, regulative and
legal influences, and standard compliance.

The topics covered in this perspective are:
•

Research centers’ compliance with standards and regulations to ensure transparency with
stakeholders, data interoperability, and commitment to meaningful use and joint
commissions.

•

Research centers’ flexibility and agility in responding and adapting to changes (new
regulations, legislations, and policies) in terms of anticipation and readiness (resources,
policies, strategies, and management).

•

Research centers’ adherence to regulations and policies to ensure privacy in terms of
information technology, medical data, patient access, third party interactions, and ethical
use of information (IRBs), among others.

•

Research centers' ability to inform policies by participating in expert panels, providing
evidence and comments regarding policies under consideration, and securing contracts
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with the state and the federal government to complete analyses regarding policy
development, implementation, and impact.

5.1.5. Financial Perspective
In terms of technology management and organizations' maturity in this area.
Technological innovations are argued as one of the most significant factors in healthcare
cost inflation. This issue has been more highlighted in the past couple of decades,
accounting for about half of the total increase in health care spending (Sorenson,
Drummond and Khan, 2013). These technological costs can be due to the acquisition of
new technology or equipment, training, setting, logistics, and maintaining it. Therefore,
health organizations need to balance the tradeoffs using new technologies as (concurrent
to increasing costs) it may benefit them greatly in terms of incentives, attracting patients,
and competition. Hence, widespread adoption of technology has a multiplier effect.
Moreover, changes in areas such as financing, insurance, payment, and delivery can
present new threats or opportunities in the health care market. On top of the mentioned
factors, the external factors discussed in the literature section can make this task of
balancing even more difficult. Health organizations can be more effective when they
proactively deal with any threats to their institution’s profitability and viability.
This perspective encapsulates the financial side of assessing the maturity of technology
management in healthcare organizations. Topics such as investment resource allocation,
funding, and cost reduction fall under this category.
The topics covered in this perspective are:
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•

Research centers’ ability to prioritize and decide to invest its resources (financial, human,
space...) in alignment with the goals of increased technology maturity and continuous
learning.

•

The extent to which incentives and funding are aligned with the encouragement of
technology maturity, continuous learning and improvement, waste elimination, and
rewarding high care value.

•

Research centers’ ability to cut costs as a result of increased maturity, learning,
continuous improvement, and waste eliminations without compromising quality.

•

Research centers’ success in meeting reimbursement programs’ goals (policy incentives,
value-based purchasing, etc.) and

•

accessing government, foundation, and other grants (NIH, DARPA, DOD, various private
funds, etc.)
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5.2. Initial Identified Perspectives and Criteria
In this section, the tables for the initially identified perspectives and criteria and their definitions
are provided. All criteria were mined from the literature or discussion with healthcare experts
validated by literature.

Table 4:Model Perspectives

Perspective

Definition
This perspective covers topics such as data management and handling of

Technology

technology in terms of infrastructure, security, privacy, knowledge flow, and
sharing in healthcare organizations.
This perspective encapsulates topics such as public acceptance, trust, broad
accessibility, equity, and engagement. Stakeholders can take the shape of

Social

patients, providers, policymakers, payers, and clinicians. This perspective also
includes the ability of healthcare organizations to attract and acquire a skilled
and diverse workforce.
This perspective covers certain organizational aspects of technology

Organizational management in healthcare such as leadership, change management,
organizational culture and transparency, strategic management, and governance.
This perspective includes regulatory and legal aspects needed to assess the
Regulatory

maturity of technology management in health research centers, such as the
ability to adapt to and comply with changing regulations and informing policies.
This perspective encapsulates the financial side of assessing the maturity of
technology management in health research centers. Topics such as investment

Financial

resource allocation, appropriate funding, and cost reduction without
compromising quality fall under this category.
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Table 5: Initial Technology Criteria
Perspective

Criteria

Data
Management

Technology

Supporting
Infrastructure

Real-time
Knowledge
Access and
Sharing

Definition

Management of big data resources in terms
of security, privacy, and ethics

The socio-technical infrastructure needed to
improve and provide the capacity to capture,
compile, and protect clinical and financial
data, which enables the evaluation,
adjustment, analysis, and dissemination of
learned knowledge
Data systems and tools are used to capture,
share, and integrate data, information,
visualizations, and knowledge gained from
research into the organization in real-time.
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References

(Saunders and Smith,
2013; Bernstein et al.,
2015; English et al.,
2016; Rumsfeld, Joynt
and Maddox, 2016;
Shah et al., 2016;
Rubin, 2017)
(Saunders and Smith,
2013; Mandl et al.,
2014; English et al.,
2016; Johnson et al.,
2017; Kraft et al.,
2017)
(Saunders and Smith,
2013; Bernstein et al.,
2015; Cahan and
Cimino, 2017; Morain,
Kass and Grossmann,
2017)

Table 6: Initial Social Criteria
Perspective

Social

Criteria

Definition

Key components of establishing stakeholder (patients,
providers, payors, policymaker, purchasers, families)
trust include:
• Garnering buy-in and trust from stakeholders
so they contribute to a culture of continuous
Stakeholder
improvement and learning.
Trust
• Transparency with stakeholders regarding
current limitations and plans to address and
mitigate them through a system that supports
clinical and translational research, public
health information, and comparative
effectiveness.
The degree to which the public is benefiting from the
advantages of continuous learning. Health research
centers must carry out consistent and innovative
Accessibility
outreach efforts to ensure that services are accessible to
diverse populations to reduce racial, ethnic, sexual
orientation/gender, and other disparities.

Stakeholder
Engagement

The degree to which a health research center can
engage stakeholders (patients, providers, payors,
policymaker, purchasers, families) to participate in
continuous improvement and learning projects and
initiatives.

Talent
Acquisition

Research centers’ ability to acquire talented and diverse
staff in different areas (physicians, nurses, researchers,
data scientists, public health professionals, managers,
epidemiologists, administrative staff, etc.)
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References

(Friedman, Wong
and Blumenthal,
2010; Faden et
al., 2013; Kelley
et al., 2015; Kraft
et al., 2017)

(Fiscella et al.,
2000; Faden et al.,
2013; Bernstein et
al., 2015; Kraft et
al., 2017; Rubin,
2017)
(Saunders and
Smith, 2013;
Mandl et al.,
2014; PriceHaywood, 2015;
Kraft et al., 2017)
(Grossmann,
Powers, et al.,
2011; Faden et
al., 2013;
Pronovost et al.,
2017; Schmittdiel
et al., 2017)

Table 7: Initial Organizational Criteria
Perspective

Organizational

Criteria

Definition

Leadership

Broad leadership which can expand and guide
stakeholders’ commitment to the goals of
continuous learning and increased technology
maturity.

Strategic
Manageme
nt

Research centers’ ability to improve through
strategic decisions, management of competing
priorities, research partnerships, problem
identification, and finding solutions.

Organizati
onal
Culture
and
Transparen
cy

The extent to which a research center’s
employees have adopted and are committed to
a culture of continuous learning and practice
transparency to safeguard stakeholder trust in
order to improve the health of individuals,
communities, and diverse populations.

Training

Governanc
e

Training employees and stakeholders on the
latest technologies and best practices within
the health research center.

Having the necessary governance to support a
sustainable operation, uphold required
standards, build and maintain trust with
stakeholders, and continuously innovate.
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References

(Bernstein et al.,
2015; Graban,
2016; Morain, Kass
and Grossmann,
2017; Rubin, 2017)
(English et al.,
2016; Morain, Kass
and Grossmann,
2017; Shaygan,
2018)
(IOM,
2011)(Institute of
Medicine (IOM),
2007; McClellan et
al., 2008; Yong,
Olsen and
Mcginnis, 2010;
Yong, Saunders
and Olsen, 2010;
Curcin, 2016)
(Lynch et al., 2000;
Gopee, 2002;
Grossmann et al.,
2010; Grossmann,
Goolsby, Olsen and
McGinnis, 2011)
(Bevan and
Cornwell, 2006;
Institute of
Medicine (IOM),
2007; Chambers,
2012; Hastings et
al., 2014)

Table 8: Initial Regulatory Criteria
Perspective

Regulatory

Criteria

Definition

References

Standards
Compliance

Research centers’ compliance with
standards and regulations to ensure
transparency with stakeholders, data
interoperability, and commitment to
meaningful use and joint commissions.

(Institute of Medicine
(IOM), 2007; Blumenthal
and Tavenner, 2010;
Friedman, Wong and
Blumenthal, 2010;
Schmittdiel et al., 2017)

Policy
Preparedness
and
Adaption

Research centers’ flexibility in adapting
to new regulations, legislations, and
policies in terms of anticipation and
adaption (resources, policies, strategies,
and management).

(Blumenthal and Tavenner,
2010; Grossmann, Goolsby,
Olsen and McGinnis, 2011;
Morain and Kass, 2016;
Shaygan, 2018)

Research centers’ adherence to
regulations and policies to ensure privacy
in terms of information technology,
medical data, patient access, third party
interactions, and ethical use of
information, among others.

(Curran, Stearns and
Kaplan, 1969; Gostin et al.,
1993; Prentnieks and Qual,
1996; Melton III, 1997;
National Research Council,
1997; Rothstein and Talbott,
2006; Sharyl J Nass et al.,
2009; Vandenbroucke,
2011)

Privacy

Table 9: Initial Financial Criteria
Perspective

Financial

Criteria

Definition

References

Resource
Allocation

Research centers’ ability to prioritize and
decide to invest its resources in alignment
with the goals of increased technology
maturity and continuous learning.

(Rouse, 2001; Pronovost et
al., 2017; Rouse, Johns and
Pepe, 2017; Shaygan,
Lavoie and Daim, 2018)

Funding
and
Mission
Alignment

The extent to which incentives and funding
are aligned with encouragement of
technology maturity, continuous learning
and improvement, waste elimination, and
rewarding high care value.

(Institute of Medicine
(IOM), 2007; Blizinsky and
Bonham, 2017; Morain,
Kass and Grossmann,
2017; Pronovost et al.,
2017; Shaygan, 2018)

Cost
Reduction

Research centers’ ability to cut costs
through increased maturity, learning,
continuous improvement, and waste
eliminations without compromising quality.

(McClellan et al., 2008;
Yong, Olsen and Mcginnis,
2010; IOM, 2011, 2013;
Saunders and Smith, 2013)
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5.2.Model Description for Data Collection
The following actions were taken to help the experts with their judgment:
In each expert panel email that was sent out to the relevant panel, a concise and clear
summary of what is expected and what needs to be done at each level was provided.
Furthermore, files containing a more detailed research summary and perspectives/criteria
information was attached to each level’s emails and shown in detail in Appendix C.

Figure 25:Qualtrics Snapshot (Intro)
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Figure 26: Qualtrics Snapshot (Continued)

•

Enough

information

was

provided

to

experts

in

each

of

the

validation/quantification steps in Qualtrics. In each survey, description summaries
were provided to experts so they could use it as a quick reference while doing the
survey. Appendix D shows the surveys along with the related descriptions.

Figure 27: Qualtrics Snapshot (Continued II)

•

In the HDM software tool (also, in the invitation email for the perspectives/criteria
quantification), Clear descriptions appear as tooltips for each item being
quantified. Appendix D shows screenshots from the HDM software tool.
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Figure 28: ETM HDM Snapshot

5.3. Justification of the Selected Elements
As mentioned in the perspectives/criteria section, different levels of review and validation
will go into finalizing the model. Relative papers were reviewed followed by coding them
in ATLAS.ti and following pattern identification some criteria were merged or removed
from the list. Next, the initial model will be sent to an expert panel. In my comprehensive
exam run, there were 6 real experts in the field and after getting their feedback on the
model, privacy and training (separating it from talent acquisition) were recommended. It
was also recommended to while moving governance from the regulatory perspective to
the organizational perspective. The summary of the steps taken to finalize the model for
quantification is shown below:
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Figure 29: Criteria Selection Stages

In this section the further literature review to verify/validate the added/moved criteria is
provided. Privacy, training, and governance are reviewed in a deeper sense in the context
of maturity models in healthcare and continuous improvement. These three criteria were
added after the advice of the experts in my panel. A further literature review was
conducted to make sure their recommendations were aligned with the existing literature.
5.5.1. Privacy
One of the results of the criteria validation stage in this research was Privacy. Although
privacy was considered as a part of the “Data Management” criterion, some of the experts
pointed out the importance of a “Privacy” criterion in the regulatory perspective of the
model. Privacy is important in the data management sense but due to its sensitive nature
needs to be evaluated in regulatory terms as well. This can be due to fact that many health
organizations have growing concerns about patient privacy for their clinical and
epidemiological research data (Gostin et al., 1993; Prentnieks and Qual, 1996; Melton
III, 1997; National Research Council, 1997). Clinical and medical data has been stored
and used for research in health organizations repositories (paper or electronic-based) since
the early 1900s starting with Mayo Clinic in Rochester Minnesota (Kurland and
Molgaard, 1981). However, in recent years, because of privacy concerns, using previous
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data to build upon has become trickier and as Vanderbroucke argues in 2011, a
jeopardizing element in the use of patient data for research (Vandenbroucke, 2011). For
that reason, The Mayo Clinic Foundation started to obtain broad informed consent from
patients to use their data for future research as one way to ensure the continuation of
research while making sure that all the data being used in by consented patients. At the
same time, health organizations should be able to use personal health information to teach,
train, conduct research, deliver care, and ensure quality while making sure their
employers who get health information to pay claims would not use it for any non-health
purposes, like hiring, firing, and promotions (Sharyl J. Nass et al., 2009). Health
organizations should also make sure that there are proper safeguards to protect the real
interests of patients and increased perceived understanding and benefit of learning from
the historical data by society through positive promotion (Vandenbroucke, 2011).
Because of the “disruptive” transformation of health records from papers to electronic
records health organizations have the arduous task of managing both paper-based and
electronic data. This task becomes even more difficult due to the fragmentation of paperbased records especially for the older records (Rothstein and Talbott, 2006). Although
Rothstein and Talbott (2006) argue that most individuals can be confident that old,
sensitive health information that may have no current clinical usefulness is unlikely to be
disclosed when they authorize release of their medical records for employment or
insurance purposes, health organizations should still make sure that they are aligned and
compliant with privacy regulations. In past couple of years, with the adoption of
electronic health records, patient data from different health organizatoins, providers, and
geographical areas can be centered through central repositories such as “Epic” with
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privacy and confidentiality protections as a part of the architecture of the nationwide or
geographical health Information repositories. As more health organizations are sharing
patient data among them for the goals of contninuous learning and improvement, privacy
and confidentialty of patient information can be threteaned. For that reason in the United
States, laws to protect health information privacy and confidentiality are largely designed
to protect against unauthorized access to, use of, and disclosure of personal health
information. Myriad of state and federal laws attempt to make health information secure
from hackers or misuse or abuse of health data by health care employees (Dwyer III,
Weaver and Hughes, 2004). Some of these laws specify the form in which health records
may be stored or transmitted; others are focused on the penalties of unauthorized access
through civil or criminal sanctions. As the protection of privacy and confidentiality of
clinical and medical data is a major issue, state laws focus on health data disclosure are
concentrated on specific information while federal laws focus only on the data gathered
by federal agencies (Curran, Stearns and Kaplan, 1969). These concerns make health
organizations obligated to adopt a code of ethics in addition to clarifying and defining
rules and regulation which govern information protection. In other words, when a group
of health organizations is sharing their data towards the goals of maturity and continuous
improvement, proper standards of ethics and law should be ensured in the collection,
storage, disclosure, and use of sensitive data. One way of mitigating the risks revolving
around patient privacy due to centralized and shared healthcare information is to include
the participating organizations and agencies in the development of the privacy systems
and operational policies (Curran, Stearns and Kaplan, 1969).
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Hence, this criterion was added to the regulatory perspective and is defined as:
Organization’s adherence to privacy regulations and policies to ensure the privacy of
information technology, medical data, patient access, information disclosure, third party
interactions, and ethical use of information among others in terms of collection, storage,
disclosure, and use of information.
5.5.2. Governance
Another change in the criteria was “Governance” which was moved from a regulatory
perspective to an organizational. Additional literature review in the context of healthcare
was performed for the governance criterion. Corporate governance emerged as a solution
to unbalanced relations between companys’ main stakeholders (Verdeyen and
Buggenhout, 2003). In 1932, Brele Jr and Daniels argued that United State’s corporate
structure was inefficient as shareholders owned insignificant shares to have the power to
monitor and audit companies effectively(Berle Jr and Means Daniel James, 1932). This
meant that stakeholders were only investors as opposed to being owners of firms. The
creation of boards and governance would allow share or stakeholders to get a return on
their investment on top of controlling and influencing the management in effective ways.
In the stakeholder type organization such as hospitals, governance structures need to be
desgined in such manner that there would be clear ideas about power, responsibilites, and
checks and balances and this accountability and control can protect health organizations
when there is sufficient amount of disclosure and transparency (Berle Jr and Means
Daniel James, 1932; Van Den Berghe and Levrau, 2003).
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Van som (2014) defines clinical governance as: “A governance system for healthcare
organizations that promotes an integrated approach towards management of inputs,
structures and process to improve the outcome of health-care service delivery where
health staff work in an environment of greater accountability for clinical quality” (Vanu
Som, 2004). In the United States, hospitals are overseen by at least one board of directors
(trustees). While non-profit hospitals normally have a single overseeing board, for-profit
hospitals may have different boards and governance systems overseeing their matters
such as corporate, regional, and local ones (Jha and Epstein, 2010). The mentioned study
argues that the big gap in board activities between high-performing and low-performing
hospitals highlights the importance of board policymakers hoping to improve care in U.S.
hospitals. There is an emerging argument that boards, including in healthcare, need to
incorporate a culture of high trust across the executive and non-executive divide. This
should be implemented along with a robust challenge, and a tight grasp on the business
of delivering high-quality care for customers (patients in healthcare context) in a
financially viable manner (high trust – high challenge – high engagement) (Chambers,
2012).
There have been works in the literature focusing on the impacts of governance in
healthcare organizations. One important aspect that governance facilitates is
multidisciplinary teamwork, partnerships, and cooperation practices which can have great
implications for healthcare delivery and organizational culture organizations (Vanu Som,
2004). Taleb-Bndiab et al. (2006) present a modeling approach for medial guidelines in
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an electronic format using an agent-based method in order to facilitate modularization of
clinical governance concerns from the aspect of a system (Taleb-Bendiab et al., 2006).
Bevan (2008) proposes the CHI model which takes into account learning, innovation, and
improvement for clinical governance (Bevan, 2008). This model takes into account
strategic capacities such as patient focus, leadership, direction, and planning which feeds
into resources and processes while utilizing the use of information for patient experience
and outcomes. The resources and processes in the CHI model are quality improvement
processes, focus on staff, and use of information (Bevan and Cornwell, 2006).
Hastings et al. (2014) look into the interrelations of health system governance and
workforce outcomes (Hastings et al., 2014). In other words, this paper looked into how
governance bolsters change in the workforce to guarantee effective use by healthcare
providers. Although the results in this study do not show a significant correlation between
workforce and improvement in patient outcomes, it emphasizes on key strategies to
support change management in healthcare organizations. These key strategies are built
trust through the articulation of organizational goals, taking the workforce into account
in terms of planning, implementation, and evaluation, and finally making sure of the
existence of strong leadership. The governance mechanisms may include shared clinical
governance, funding schemes, and professional development with enablers such as
engagement, communication, change management, leadership, and vision. These
mechanisms while being focused on patient, financial, or clinical systems, should also
encompass workforce and human resources to guarantee that employees can and are
carrying their work as needed. Ultimately, boards in healthcare organizations have the
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responsibility to ensure the quality of care is provided by their hospital through
determining strategy (direction), evaluation of performance (control), and forming
organizational culture (values, rules, and tone) (Chambers, 2012). Chmabers (2012)
Stresses the importance of avoiding faith-based and exhortative approaches and move
towards guidance, training, and development and calls for more research and effort into
the composition, structure, processes, and dynamics of healthcare boards for the sake of
patient safety (Chambers, 2012). Garratt (2010) stresses on short-term focus on
conformance and a more long-term concentration on performance (Garratt, 2010). In
other words, although accountability and supervision are really important conformance
issues, there should be a long-term focus on policy formation and strategic thinking in
terms of external and internal focuses respectively. For this purpose (literature and expert
validation), it was concluded that governance is more of an organizational issue than a
regulatory matter.
Health organizations may have different governance systems across different and some
may work better than others. Regulatory governance is a part of the whole organizational
governance that focuses on compliance and accountability of the health organization
when it comes to regulations and policy.
As an example, one kind of governance may be data governance within health
organizations’ information technology groups. Data governance can be a program that
creates clear and functioning Standards, Policies, Procedures, Roles, Responsibilities, and
Accountabilities, in order to create an environment of trusted and high-quality data that
leads to accurate reporting.
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Data governance is important to health organizations as it deals with topics such as data
stewardship, data quality management, data access, and privacy among others. This type
of governance is critical in healthcare organizations as data can be treated a strategic asset
by these organizations since:
•

There is clear ownership within the health organizations’ business community,
and Data Stewards are accountable and responsible for the management of data
assets.

•

Data is secure and protected, and there are clear pathways to who grants access
to data.

•

Clear documentation exists to help provide users additional context and meaning
to the data they use for decision-making.

•

The quality of critical data is constantly monitored and measured, and defects
are corrected in the source system.

•

There is a clear understanding of the critical data flow of elements throughout
the organization.

•

Data is easily accessible to reach a potential audience, and data users can easily
identify data assets within the environment that can be leveraged.

To sum up, in terms of data governance, health organizations need to pay attention to
stewardship (to ensure ownership), processes (to ensure consistency), and governed tools
(to deliver access and reports. These three items will provide trusted data and reports for
continuous improvement and decision-making around it. In addition to data stewardship
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(accountability and responsibility), topics such as metadata management (business
glossaries, report catalogs, application banks,…), data quality (completeness, conformity,
consistency, accuracy, timeliness,…), and data access/protection are the key functional
area in data governance for a healthcare organization.

The other important aspects of governance in a health organization include but are not
limited to, leadership, strategies, financial matters, decision making for resources and
investments, policymaking, risk management, planning, training, and evaluation of
quality across different departments of a healthcare organization.
5.5.3. Training
As for training, it was decided that it would be separated from talent acquisition from the
social perspective to the organizational perspective. Technology management
encapsulates managing technology in terms of not only volume but also reliability in
terms of accuracy and safety (Grossmann et al., 2010). In other words, healthcare
providers, including residents and fellows, should be placed in environments their rate of
medical errors will decrease with training and management. Training providers to work
in teams is critical to ensure an increase in reliability and safety to make sure optimal
technology management is flowing in the organization.
Stephen J. Swensen, and James Dilling of Mayo Clinic pinpoint the importance of sentient
investment in social capital as an important part of effective technology management
strategy with goals of high-reliability patient care. Social capital investment encapsulates
the goals of transforming an organization from a collection of individuals into an agile,
coherent and collective mind (Lynch et al., 2000; Gopee, 2002; Grossmann, Goolsby,
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Olsen and McGinnis, 2011). This can be done by utilizing research engagement,
administrations, and education. Swensen and Dilling emphasize areas like transparency,
teamwork training, horizontal infrastructure, and cross-functional, team-based simulation
training as important social engineering topics. An example of this can be utilized in
health organizations' training teams to train health medical and nursing students and
residents, together in cross-functional teams to enforce a more effective transformation
culture.
By the help of experts validating the criteria and further literature review, especially on
the importance of technology management in continuous learning, the importance of
training was stressed in technology maturity of healthcare organizations and the fact the
continuous training is needed as an enabler of increased maturity and continuous learning
from the organizations’ point of view, initiated the move from social to organizational
perspective. Figure 14 shows the perspectives and criteria post validation.
5.6. Initial Model
After implementing the mentioned approach and justifying the added/moved elements, the model
was finalized for the proposal and the initial model in the main dissertation study. The model has
between 3 and 6 elements in each perspective with a total of 5 perspectives and 18 criteria. The
next section shows an iteration of running the model and validating/quantifying the decision
elements with the expert panels which were identified.
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Figure 30: Initial Model

5.7. Experts Identification and Selection
Several methods are used to identify and select the potential experts for validation and
quantification of the model.
1- Researcher’s Connections: the researcher may have several connections related to
learning health systems, the healthcare industry, and hospital management, based
on previous work experience and current engagement with committees related to
this research topic.
2- Advisor and Committee Connections: Help provided by advisor and committee
members in terms of the identification of local and national experts related to
technology management in healthcare and learning health systems will be
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requested. This is because these people are highly probable to be engaged directly
or indirectly in a related field of research and application.
3- Social network analysis (SNA): This process can be used to investigate social
structures by identifying networks and people in the centers of those networks
(Daim and Kocaoglu, 2015; Kocaoglu et al., 2016).SNA will be used to identify
experts related to healthcare technology management and learning health systems
which can potentially lead them to be a part of the expert panels based on their
expertise.

It should be considered that all experts may not be in all panels. In other words, experts
will be divided into panels and each expert will be matched and assigned to a certain area
of the proposed model of this research in terms of validation and/or quantification. This
means that each expert is able to join more than one panel based on relevant expertise.
Here is a table summarizing the involvement of each panel in different steps of validation
and quantification of the model.
Table 10: Expert Panel Summary
Panel

Task

# of Experts

Tool

P1

Perspective Validation

24

Qualtrics

P2

Criteria Validation

26

Qualtrics

P3

Perspectives/Criteria Quantification

30

ETM HDM

P4

Desirability Metrics Validation

11

Qualtrics

P5

Desirability Metrics Quantification

13

Qualtrics
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Table 11: Panel 1 Participants
#

Position

4
5
6
7
8
11
12
15
16
17
19
20
22
24
25
26
29
30
34
36
40
41
42
45

Project Manager
Chief Information Officer
Project Manager
Health Application Analyst
Health Application Analyst
Research Center Director
Professor of Public Health
Public Health Researcher
Vice President of Nursing
Assistant Professor in Medical Ethics & Health Policy
Chair of Engineering Division in Hospital
Professor of Health Informatics
Research Center Director
Industrial Engineering Professor (Healthcare)
Quality Engineering Professor
Professor at the Department of Healthcare Institutions Management
Research Center Director
Research Center Director
Project Manager
Health Management Researcher
Department of Industrial Engineering (Chair)
Health Informatics Analyst
Health Data Scientist
Project Manager
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Table 12: Panel 2 Participants
#

Positions

5
6
8
11
12
14
15
16
17
19

Chief Information Officer
Project Manager
Project Manager
Research Center Director
Professor of Public Health
Project Manager
Public Health Researcher
VP of Nursing
Assistant Professor in Medical Ethics & Health Policy
Chair of Engineering Division

20

Professor of Health Informatics

22
24
25
26
29
30
32
34
36
40
41

Research Center Director
IE Professor (Healthcare)
Quality Engineering Professor
Department of Healthcare Institutions Management. Professor
Research Center Director
Research Center Director
Technology Faculty Research Coordinator
Project Manager
Industrial Engineering Researcher
Department of Industrial Engineering (Department Chair)
Health Informatics Analyst

42
45

Health Data Scientist
Project Manager
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Table 13: Panel 3 Participants
#

Position

1
2
3
4
6
10
12
13
14
15
16
18
19
20
21
22
23
26
30
32
33
37
39
40
41
42
43
44
45
46

Data Scientist
Senior Information Systems Project Leader
Director of finance and Operations
BI Project Manager
Project Manager
Research Center Director
Professor at Department of Public Health
Professor at Department of Public Health
Project Manager
Public Health Researcher
Vice President of Nursing
Assistant Professor of Learning Health Sciences
Division of Engineering Chair
Professor of Health Informatics
Deputy Director for Public Health
Research Center Director
Learning Health Systems Researcher
Professor at the Department of Healthcare Institutions Management
Research Center Director
Lecturer and Faculty Research Coordinator
Professor
Professor at the Department of Healthcare Institutions Management
Performance Improvement Manager
Department of Industrial Engineering (Department Chair)
Health Data Analyst
Data Scientist
Associate Vice President for Information Systems
Senior Project Manager
Project Manager
Professor, Director, Center for Health Policy and Research
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Table 14: Panel 4 Participants
#

Position

2
6
14
17
22
26
33
35
38
41
43
46

Senior IS Project Leader (Regulatory)
Healthcare Consultant
Project Manager
Assistant Professor in Medical Ethics & Health Policy
Director of Research Center
Faculty member at Department of Healthcare Institutions Management
Professor of Internal Medicine
Senior Policy Analyst
Chief Technology Officer
Health Data Analyst
Associate Vice President for Information Systems
Professor, Director, Center for Health Policy and Research

Table 15: Panel 5 Participants
Expert #

Position

13

Associate Professor and Program Director, MPH Health Management and Policy

14

Project Manager

15

Public Health Researcher

16

Vice President of Nursing

19

Chair, Division of Engineering

20

Professor of Health Informatics

22

Director of Research Center

26

Faculty member at Department of Healthcare Institutions Management

33

Professor of Internal Medicine

35

Senior Policy Analyst

41

Health Data Analyst

43

Associate Vice President for Information Systems

46

Professor, Director, Center for Health Policy and Research
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Figure 31: Participating Experts' Affiliations
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6. Results of Model Validation and Quantification
6.1 Model Validation
In this section, to test the proposed model in theoretic and practical terms, the model was
validated and quantified using a panel of experts. In order to test the practicality of this
model, it has been applied to a department in a health organization in the United States.
As result valuation tools, the inconsistency and disagreement values will be tested with
regards to the acceptable threshold and sensitivity analysis will be performed to test the
model in different situations based on different prioritizations.
As the first of the model implementation, the perspectives of the model were validated.
All 5 different perspectives were validated by 24 experts with 100% agreeing that the
perspectives were sufficient, and no changes were needed to be made. The threshold of
80% percent was considered for passing for each perspective and criteria. The summary
of the prospective validation is shown in Table 16.
Table 16: Perspective Validation
Perspective

# of Experts

Yes

No

Validation

Technology

24

24

0

100%

Social

24

24

0

100%

Organizational

24

24

0

100%

Regulatory

24

24

0

100%

Financial

24

24

0

100%
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No
Financial

24

Regulatory

24

Organizational

24

Social

24

Technology

24

Yes

Figure 32: Perspective Validation

After validating the perspectives, each perspective’s criteria were validated by each of the
26 experts in panel 2. In this section, I received great feedback from my experts leading
to the addition of 2 criteria and reword two criteria. Although none of the criteria failed
in terms of getting a validation percentage of under threshold, the changes made in
wording and definitions were based on the comments and feedback provided by experts
and validated and verified by further literature review. The summary of the criteria
validation is shown in the Table 17-21.

Table 17: Technology Criteria Validation
Technology

# of Experts

Yes

No

Validation

Data Management

26

26

0

100%

Supporting Infrastructure

26

26

0

100%

Real-time Knowledge Access and Sharing

26

25

1

96%
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1

Real-time Knowledge Acess and Sharing

No

25

Supporting Infraustructure

26

Data Management

26

Yes
Figure 33: Technology Criteria Validation

Table 18: Social Criteria Validation
Social

# of Experts

Yes

No

Validation

Stakeholder Trust

26

23

3

88%

Accessibility

26

26

0

100%

Stakeholder Engagement

26

25

1

96%

Talent Acquisition

26

26

0

100%

Talent Acquisition
Stakeholder Engagement

26
1

25

Accessbility
Stakeholder Trust
No

26
3

23

Yes
Figure 34: Social Criteria Validation
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Table 19: Organizational Criteria Validation
Organizational

# of Experts

Yes

No

Validation

Leadership

26

25

1

96%

Strategic Management

26

25

1

96%

Culture and Transparency

26

25

1

96%

Training

26

26

0

100%

Governance

26

25

1

96%

1

Governance

25

Training

26

Culture and…

1

Strategic Management

1

Leadership
Yes

1

No

25
25

25

Figure 35: Organizational Criteria Validation
Table 20: Regulatory Criteria Validation
Regulatory

# of Experts

Yes

No

Validation

Standards Compliance

26

26

0

100%

Policy Preparedness and
Adaption

26

25

1

96%

Privacy

26

24

2

92%

2

Privacy
Policy Preparedness and Adaption

24

1

25

Standard Compliance
No

26

Yes
Figure 36: Regulatory Criteria Validation
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Table 21: Financial Criteria Validation
Financial

# of Experts

Yes

No

Validation

Resource Allocation

26

26

0

100%

Funding and Mission Alignment

26

25

1

96%

Cost Reduction

26

25

1

96%

Cost Reduction

1

Funding and Mission Alignment

1

25
25

Resource Allocation
No

26

Yes
Figure 37: Financial Criteria Validation

6.2 Validated Model
After getting the feedback from expert panels 1 and 2, three new criteria were added
which are user experience, informing policy, and financial synergy with policies and
priorities under technology, regulatory, and financial perspectives, respectively.
Furthermore, two criteria were edited in their wording. Organizational culture and
transparency were shortened to “Culture and Transparency” and the word retention was
added to talent acquisition as the importance of talent retention was realized during the
validation process. Finally, based on the feedback, some criteria definitions were
reworded or rephrased for clarity and accuracy. Here is an example of expert feedback on
“Supporting Infrastructure” which led to definition revision:
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“I think "supporting infrastructure" and/or real-time knowledge access & sharing need
to be conceived more broadly to include not only DISSEMINATION of learned
knowledge, but systems to ensure said knowledge is subsequently integrated into
clinical care processes to secure the promised improvements. It's not enough just to put
it out in the world and hope someone will do something with it.”

Another example of expert feedback on “Stakeholder Trust”:
“It must also be ensured that the institution is TRUSTWORTHY. Part of this
trustworthiness is following through on promised commitments and ensuring new
knowledge is used to improve care of those who contributed to its generation via
enhanced use of their data).”

In this section each of the added criteria will be briefly explained.
6.2.1. User Experience
Defined as ”Ensuring that technologies and IT products are user-friendly (e.g.,
considering health literacy and technology competence) to all users (stakeholders)
(Lehoux, 2004; Rudd, 2010; Vehko et al., 2019)”, this criterion was added to the model
under the technology perspective based on the expert panel’s feedback. User Experience
(UX) can enhance users’ motivation and engagement (Zaharias and Pappas, 2016). As
Lehoux (2004) argues, it is enough to only transfer the technology to the user or
stakeholders but to make sure the intended knowledge to be transferred as well. The same
study looks into the importance of user-friendliness in this transfer. Moreover, Giansanti,
Castrichella and Giovagnoli (2007) found that user-friendliness has the biggest effect on
user satisfaction with e-learning in healthcare professionals.
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One of the comments that were received during the validation phase stressed the need for
involving a criterion that touches on technological user-friendliness and literacy:
“You can think of something around how easy is it for the patients or consumers of the
service or research the center is providing can benefit from it in terms of technological
user-friendliness and literacy.”
To this end, User Experience was added to the technology perspective in the model.
6.2.2. Informing Policy
Defined as ”Research centers' ability to inform policies by participating in expert panels,
providing evidence and comments regarding policies under consideration, and securing
contracts with the state and the federal government to complete analyses regarding policy
development, implementation, and impact (Douglas et al., 2009; Bendavid and Miller,
2010; Behrns, 2015; McMahon et al., 2020)”, this criterion was added during discussions
and feedback by the regulatory focused experts in the validation expert panels. It is
important for healthcare organizations and research centers to keep abreast and improve
policies by:
•

Participating in expert panels.

•

Providing evidence and comments regarding policies that are under
consideration.

•

Securing federal and state contracts based on policy development,
implementation, and impact.
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An example would be for a research center to define the questions that society, patients,
and healthcare need and work towards providing evidence that will help inform policy.
Health research centers should reach outside of their organization to connect with
policymakers and the community and by engaging in meaningful conversations, gain a
better understanding of the existing problems and how they can address them. Moreover,
centers need to improve their ability to communicate their findings back to policymakers
leading to a more effective policy generation (Pomeroy, no date). This criterion is very
important as stakeholders collaborate to generate evidence that informs health policy, the
results can be an effective way to push research.
To sum up, academic health research centers can have a significant impact on research
and evidence-informed health policy through taking part in new collaborative models of
research.
It should be noted that research centers should remain unbiased and keep the aims of
healthcare as their moral compass and make sure their research is not misused in
politically charged policy shaping.

6.2.3. Financial Synergy with Policies and Priorities
The third added criterion is defined as “Research centers’ success in meeting
reimbursement programs’ goals (policy incentives, value-based purchasing, etc.) and
accessing government, foundation, and other grants (NIH, DARPA, DOD, various private
funds, etc.) (Weeks and Pardee, 2019)”. This criterion had been partially realized during
the literature review phase for health research centers and this realization was invigorated
in the validation phase based on expert feedback. The importance of research grants has
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been explained in section 2.7. Here are some of the comments that hinted at the inclusion
of this criterion:
“It is important to include the center’s success in accessing government and other
grants. NIH, DARPA, DOD, various private funds, etc.”
Another expert’s comment stressed the importance of policy incentives:
“Greater environmental incentives: consider policy incentives, value-based purchasing,
and other reimbursement programs; also, reputation and accreditations and the
financial benefit of meeting those requirements.”
As the result of the literature review on research centers and the feedback received from
the experts at the validation phase, this item was added under the financial perspective.
6.2.4. Finalized Model
After the completion of the validation of model perspectives and criteria, the final
model consists of 5 perspectives, each of them containing from 4 to 5 criteria. The total
number of criteria in this model is 21. The final validated model is shown in Figure 38.
Moreover, the refined criteria and their definitions are shown in Tables 22-26.

181

Figure 38:Validated Model
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Table 22: Validated Technology Criteria

Table 23: Validated Social Criteria
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Table 24: Validated Organizational Criteria

Table 25: Validated Regulatory Criteria
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Table 26: Validated Financial Criteria

6.3. Desirability Curves
The metrics provided for each criterion were validated. they were tweaked and slightly
edited based on the great comments and feedback provided by the expert panel. For the
validation of the metrics for each criterion, the initials metrics were sent to the relative
panel. Each criterion’s metric validation is shown in the tables below (Tables 27-31).
Furthermore, the experts quantified the desirability curve metrics. In other words, each
metric for each criterion now has a different quantified amount associated with it. Each
criterion’s metric/state values. These values are shown in Tables 32-52 while the curves
are shown in Figures 39-59. The quantification data for the desirability curve values were
collected using Qualtrics in the winter of 2020.
The quantified metrics will be used in the case study section which will add the unique
extra layer based on the context of the studied research centers on top of the weighted
criteria and perspectives. This is especially helpful in instances in which there is a need
in having a reusable model, or in instances of having many alternatives, desirability
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curves can be used. The combination of desirability curves with HDM is used to identify
levels/ metrics for each criterion. Each level/metric connected to a criterion acts as a
useful value to assist decision-makers. Using the desirability curves approach, the experts
need to evaluate related levels/metrics for each criterion (desirability matrix) while giving
each metric a scaled quantitative value. This enables the normalization of the evaluation
results by experts across all the criteria (Phan, 2013; Estep and Daim, 2016; Gibson and
Daim, 2016; Estep, Daim and Shaygan, 2021)
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Table 27: Validated Technology Metrics

Data Management
What level of data management does this research center provide?
No measures are taken to assure and maintain data security, privacy, governance, or ethics
Initiatives and efforts are put into 1out of 4 (security, privacy, governance, ethics)
Initiatives and efforts are put into 2 out of 4 (security, privacy, governance, ethics)
Initiatives and efforts are put into 3 out of 4 (security, privacy, governance, ethics)
Initiatives and efforts to assure and maintain data security, privacy, governance, and ethics exist

Technology

Supporting Infrastructure
What level of socio-technical infrastructure does the research center provide in managing and
analysis of data and dissemination of knowledge?
No socio-technical infrastructure to handle data management, analysis, dissemination, and
integration of learned knowledge
Socio-technical infrastructure for 1 out of 4 (data management, data analysis, knowledge
dissemination, knowledge integration)
Socio-technical infrastructure for 2 out of 4 (data management, data analysis, knowledge
dissemination, knowledge integration)
Socio-technical infrastructure for 3 out of 4 (data management, data analysis, knowledge
dissemination, knowledge integration)
Socio-technical infrastructure in place for management and analysis of data and dissemination and
integration of learned knowledge
Real-time Knowledge Access and Sharing
Is the research center providing real-time data and knowledge access, sharing, and learning?
No real-time data access and sharing capabilities in place
Some real-time data capture, access, and sharing but no integration of learned knowledge
Data capture, access, and sharing of real-time data but no integration of learned knowledge
Real-time data and information capture, access, and sharing concurrent to the integration of learned
knowledge
User Experience
What is the quality of user experience provided by the research center to its stakeholders
(users)?
Technologies and IT products are not user-friendly
Technologies and IT products are somewhat user-friendly
Technologies and IT products are designed with optimization of user experience in mind
Technologies and IT products are designed and reviewed (periodically) with optimization of user
experience in mind
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Table 28: Validated Social Metrics

Stakeholder Trust
What is the level of stakeholder trust in the research center's initiatives and projects
(continuous learning)?
Not trusted by the overwhelming majority of stakeholders
Trusted by the minority of stakeholders
Trusted by half of the stakeholders
Trusted by the majority of stakeholders
Accessibility

Social

What is the level of benefit from and accessibility to new technologies?
Stakeholders are not benefiting from the clinical and research advantages of the research center
Only a minority of stakeholders are benefiting from the clinical and research advantages of the
research center
Half of the stakeholders are benefiting from the clinical and research advantages of the research
center
The majority of stakeholders are benefiting from the clinical and research advantages of the
research center
All stakeholders are benefiting from the clinical and research advantages of the research center
Stakeholder Engagement
What is the level of stakeholder engagement in research center’s projects and initiatives?
Stakeholders are opposed to participating in the research center's continuous improvement and
learning projects and initiatives
Stakeholders are reluctant to participate in the research center's continuous improvement and
learning projects and initiatives
Some of the stakeholders are eager to participate in the research center's continuous improvement
and learning projects and initiatives
The majority of the stakeholders are eager to participate in the research center's continuous
improvement and learning projects and initiatives
All stakeholders are eager to participate in the research center's continuous improvement and
learning projects and initiatives
Talent Acquisition and Retention
How is the research center performing in acquiring and retaining skilled and relevant
talents?
No acquisition and retention of skilled and diverse talent
Acquisition of skilled and diverse talent only in some areas
Acquisition and retention of skilled and diverse talent only in some areas
Acquisition and retention of skilled and diverse talent in all areas
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Organizational

Table 29: Validated Organizational Metrics

Leadership
What level of leadership support is bolstering technology maturity and continuous learning in
the research center?
There is leadership opposition to technology maturity and organizational learning
The leadership is indifferent to technology maturity and organizational learning
The leadership provides some support to technology maturity and organizational learning
The leadership provides good support and advocacy to technology maturity and organizational
learning
The leadership is enthusiastic about the support and advocacy of technology maturity and
organizational learning
Strategic Management
What level of strategic management is being implemented in the research center?
There is no strategic vision, plan, or management and implementation of technology maturity and
organizational learning
There are strategic vision and plan but no management and implementation of technology maturity
and organizational learning
There is some clear strategic vision/plan and management/implementation of technology maturity and
organizational learning
There is a clear and calculated strategic vision/plan and managed implementation of technology and
organizational learning
Culture and Transparency
What level of organizational culture (in terms of maturity and learning) has been adopted by
the employees of the research center?
Organizational Inertia
Support by the minority of employees
Support by half of the employees
Support by the majority of employees
Governance
What level of governance exists in the research center?
No governance
Simply documented governance with no communications among departments
Documented and Updated governance in separate departments towards the management of inputs,
structures, processes with goals of improving outcomes
Documented and periodically updated governance with some communication among departments
towards the management of inputs, structures, processes with goals of improving outcomes
Central governance promoting an integrated approach/best practices towards the management of
inputs, structures, processes to improve the outcome
Training
What level of training with goals of organizational maturity and continuous learning exists in
the research center?
There is no relevant or dedicated training in the research center
There are some non-multidisciplinary informal trainings the research center
There are some multidisciplinary informal trainings in the research center
There are multidisciplinary formal trainings in the research center
There are routine multidisciplinary formal trainings in the research center
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Regulatory

Table 30: Validated Regulatory Metrics

Standards Compliance
What is the level of the research center's adherence to and compliance with
standards and regulations?
There is no compliance with existing regulations
There is low compliance with existing regulations
The health organization is somewhat compliant with existing relevant regulations
The health organization is highly compliant with existing relevant regulations
The health organization is completely compliant with existing relevant regulations
Policy Preparedness and Adaption
To what extent is the research center flexible and ready in responding and
adapting to policy changes?
The research center has no readiness plans in terms of response and adaptation to
policy changes and only reacts post-change.
The research center aspires to increase flexibility and preparedness for policy changes
but has no plans for different scenarios yet.
The research center has plans for different policy change scenarios in terms of
readiness and adaptation.
The research center is proactive in terms of readiness and adaptation to policy changes
with a systematic plan which is periodically reviewed and modified.
Privacy
What level of privacy measures exists in the research center?
No privacy measures, metrics, or procedures
Privacy drove by regulatory framework including Ad-hoc vulnerability scanning, basic
metrics and processes.
Privacy protection is driven by the regulatory framework, risk management, IRBs, and
processes
Robust and continuous privacy protection driven by the regulatory framework, risk
management, IRBs, and efficient metrics-based processes
Informing Policy
What level of policy informing power existing in the research center?
Research center is not involved with informing policy
Research center is involved with 1 out of 3 (participating in expert panels, providing
evidence and comments regarding policies under consideration, securing contracts)
Research center is involved with 2 out of 3 (participating in expert panels, providing
evidence and comments regarding policies under consideration, securing contracts)
Research center is involved by participating in expert panels, providing evidence and
comments regarding policies under consideration, and securing contracts.
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Table 31: Validated Financial Metrics

Resource Allocation
How well is the research center performing in terms of resource allocation and their alignment with
technology maturity and continuous learning?

Prioritization of resources are not aligned with technology maturity and continuous
organizational learning
Prioritization of resources are minimally aligned with technology maturity and continuous
organizational learning
Prioritization of resources are somewhat aligned with technology maturity and continuous
organizational learning
Prioritization of resources are highly aligned with technology maturity and continuous
organizational learning
Prioritization of resources are completely aligned with technology maturity and continuous
organizational learning

Financial

Funding and Mission Alignment
What level of alignment exists between incentives and technology maturity and continuous
organizational learning?

Incentives and funding are not aligned with missions of technology maturity and continuous
organizational learning
Incentives and funding are minimally aligned with missions of technology maturity and
continuous organizational learning
Incentives and funding are somewhat aligned with missions of technology maturity and
continuous organizational learning
Incentives and funding are highly aligned with missions of technology maturity and
continuous organizational learning
Incentives and funding are completely aligned with missions of technology maturity and
continuous organizational learning
Cost Reduction
What level of success has the research center had in cutting costs?

The research center has had no success in cutting costs
The research center has had success in cutting costs through layoffs and waste elimination
The research center has had success in cutting costs as a result of waste eliminations with
compromising quality
The research center has had success in cutting costs as a result of waste eliminations
without compromising quality
The research center has had success in cutting costs as a result of increased maturity,
learning, continuous improvement, and waste eliminations without compromising quality
Financial Synergy with Policies and Priorities
What level of financial synergy does the research center have with policies and priorities?

The research center has had no success in meeting reimbursement programs’ goals or
accessing government, foundation, and other grants
The research center has had little success in meeting reimbursement programs’ goals or
accessing government, foundation, and other grants
The research center has had success in 1 out of 2 (meeting reimbursement programs’ goals,
accessing government, foundation, and other grants)
The research center is successful in meeting reimbursement programs’ goals and accessing
government, foundation, and other grants
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Table 32:Data Management Metrics Value

Data Management
Desirability
No measures are taken to assure and maintain data security, privacy,
0.00
governance, or ethics
Initiatives and efforts are put into 1out of 4 (security, privacy, governance,
11.36
ethics)
Initiatives and efforts are put into 2 out of 4 (security, privacy, governance,
36.82
ethics)
Initiatives and efforts are put into 3 out of 4 (security, privacy, governance,
73.91
ethics)
Initiatives and efforts to assure and maintain data security, privacy, governance,
100.00
and ethics exist

Figure 39: Data Management Metrics Value

Table 33: Supporting Infrastructure Metrics Value

Supporting Infrastructure
Desirability
No socio-technical infrastructure to handle data management, analysis,
0.00
dissemination, and integration of learned knowledge
Socio-technical infrastructure for 1 out of 4 (data management, data analysis,
15.55
knowledge dissemination, knowledge integration)
Socio-technical infrastructure for 2 out of 4 (data management, data analysis,
37.55
knowledge dissemination, knowledge integration)
Socio-technical infrastructure for 3 out of 4 (data management, data analysis,
70.91
knowledge dissemination, knowledge integration)
Socio-technical infrastructure in place for management and analysis of data and
100.00
dissemination and integration of learned knowledge
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Figure 40: Supporting Infrastructure Metrics Value

Table 34: Real-Time Knowledge Access and Sharing Metrics Value

Real-Time Knowledge Access and Sharing
Desirability
No real-time data access and sharing capabilities in place
0.00
Some real-time data capture, access, and sharing but no integration of learned
25.55
knowledge
Data capture, access, and sharing of real-time data but no integration of learned
59.18
knowledge
Real-time data and information capture, access, and sharing concurrent to
100.00
integration of learned knowledge

Figure 41: Real-Time Knowledge Access and Sharing Metrics Value
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Table 35: User Experience Metrics Value

User Experience

Desirability

Technologies and IT products are not user-friendly

0.00

Technologies and IT products are somewhat user-friendly
Technologies and IT products are designed with optimization of user experience in
mind

23.64

Technologies and IT products are designed and reviewed (periodically) with
optimization of user experience in mind

72.82
100.00

Figure 42:User Experience Metrics Value

Table 36: Stakeholder Trust Metrics Value

Stakeholder Trust

Desirability

Not trusted by the overwhelming majority of stakeholders

0.00

Trusted by the minority of stakeholders

11.36

Trusted by half of the stakeholders

45.73

Trusted by the majority of stakeholders

100.00
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Figure 43: Stakeholder Trust Metrics Value

Table 37: Accessibility Metrics Value

Accessibility
Desirability
Stakeholders are not benefiting from the clinical and research advantages of the
0.00
research center
Only a minority of stakeholders are benefiting from the clinical and research
14.45
advantages of the research center
Half of the stakeholders are benefiting from the clinical and research advantages
47.00
of the research center
The majority of stakeholders are benefiting from the clinical and research
81.27
advantages of the research center
All stakeholders are benefiting from the clinical and research advantages of the
100.00
research center

Figure 44: Accessibility Metrics Value
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Table 38: Stakeholder Engagement Metrics Value

Stakeholder Engagement

Stakeholders are opposed to participate in research center's continuous
improvement and learning projects and initiatives
Stakeholders are reluctant to participate in research center's continuous
improvement and learning projects and initiatives
Half of the stakeholders are eager to participate in research center's continuous
improvement and learning projects and initiatives
Majority of the stakeholders are eager to participate in research center's
continuous improvement and learning projects and initiatives
All stakeholders are eager to participate in research center's continuous
improvement and learning projects and initiatives

Desirability
0.00
6.09
49.18
83.09
100.00

Figure 45: Stakeholder Engagement Metrics Value

Table 39: Talent Acquisition and Retention Metrics Value

Talent Acquisition and Retention

Desirability

No acquisition and retention of skilled and diverse talent

0.00

Acquisition of skilled and diverse talent only in some areas

27.73

Acquisition and retention of skilled and diverse talent only in some areas

55.73

Acquisition and retention of skilled and diverse talent in most areas

96.82
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Figure 46: Talent Acquisition and Retention Metrics Value
Table 40: Leadership Metrics Value

Leadership

Desirability

There is leadership opposition to technology maturity and organizational learning

0.09

The leadership is indifferent to technology maturity and organizational learning

5.91

The leadership provides some support to technology maturity and organizational
learning
The leadership provides good support and advocacy to technology maturity and
organizational learning
The leadership is enthusiastic about the support and advocacy of technology maturity
and organizational learning

Figure 47: Leadership Metrics Value
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29.09

74.09

100.00

Table 41: Strategic Management Metrics Value

Strategic Management

Desirability

There is no strategic vision, plan, or management and implementation of technology
maturity and organizational learning
There are strategic vision and plan but no management and implementation of
technology maturity and organizational learning
There is some clear strategic vision/plan and management/implementation of
technology maturity and organizational learning
There is a clear and calculated strategic vision/plan and managed implementation of
technology and organizational learning

0.00
15.91
59.00
100.00

Figure 48: Strategic Management Metrics Value

Table 42: Culture and Transparency Metrics Value

Culture and Transparency

Desirability

Organizational Inertia

0.45

Support by minority of employees

17.36

Support by half of employees

51.45

Support by majority of employees

100.00
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Figure 49: Culture and Transparency Metrics Value

Table 43: Training Metrics Value

Training

There is no relevant or dedicated training in the research center
There are some non-multidisciplinary informal trainings the research center
There are some multidisciplinary informal trainings in the research center
There is multidisciplinary formal training in the research center
There is routine multidisciplinary formal training in the research center

Figure 50: Training Metrics Value
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Desirability
0.00
15.27
40.36
76.36
100.00

Table 44: Governance Metrics Value

Governance

Desirability

No governance

0.00

Simply documented governance with no communications among departments

13.00

Documented and Updated governance in separate departments towards the
management of inputs, structures, processes with goals of improving outcomes

44.00

Documented and periodically updated governance with some communication
among departments towards the management of inputs, structures, processes

71.64

with goals of improving outcomes
Central governance promoting an integrated approach/best practices towards
the management of inputs, structures, processes to improve the outcome

99.27

Figure 51: Governance Metrics Value
Table 45: Standards Compliance Metrics Value

Standards Compliance

Desirability

There is no compliance with existing regulations

0.00

There is low compliance with existing regulations

10.27

The research center is somewhat compliant with existing relevant regulations

32.09

The research center is highly compliant with existing relevant regulations

83.64

The research center is completely compliant with existing relevant regulations

100.00
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Figure 52: Standards Compliance Metrics Value
Table 46: Policy Preparedness and Adaptation Metrics Value

Policy Preparedness and Adaptation

The research center has no readiness plans in terms of response and adaptation
to policy changes and only reacts post-change.
The research center aspires to increase flexibility and preparedness for policy
changes but has no plans for different scenarios yet.
The research center has plans for different policy change scenarios in terms of
readiness and adaptation.
The research center is proactive in terms of readiness and adaptation to policy
changes with a systematic plan which is periodically reviewed and modified.

Figure 53: Policy Preparedness and Adaptation Metrics Value
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Desirability
0.00
16.18
63.27
100.00

Table 47: Privacy Metrics Value

Privacy

Desirability

No privacy measures, metrics, or procedures

0.00

Privacy driven by regulatory framework including Ad-hoc vulnerability
scanning, basic metrics and processes.
Privacy protection is driven by the regulatory framework, risk management,
IRBs, and processes
Robust and continuous privacy protection driven by the regulatory framework,
risk management, IRBs, and efficient metrics-based processes

27.91
73.73
100.00

Figure 54: Privacy Metrics Value

Table 48: Informing Policy Metrics Value

Informing Policy

Desirability

The research center is not involved with informing policy

0.00

The research center is involved with 1 out of 3 (participating in expert panels,
providing evidence and comments regarding policies under consideration,
securing contracts)
The research center is involved with 2 out of 3 (participating in expert panels,
providing evidence and comments regarding policies under consideration,
securing contracts)
The research center is involved by participating in expert panels, providing
evidence and comments regarding policies under consideration, and securing
contracts.
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35.00

73.91

100.00

Figure 55: Informing Policy Metrics Value

Table 49:Resource Allocation Metrics Value

Resource Allocation

Prioritization of resources are not aligned with technology maturity and
continuous organizational learning
Prioritization of resources are minimally aligned with technology maturity
and continuous organizational learning
Prioritization of resources are somewhat aligned with technology maturity
and continuous organizational learning
Prioritization of resources are highly aligned with technology maturity and
continuous organizational learning
Prioritization of resources are completely aligned with technology maturity
and continuous organizational learning

Figure 56: Resource Allocation Metrics Value
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Desirability
0.00
11.82
39.45
82.27
100.00

Table 50: Funding and Mission Alignment Metrics Value

Funding and Mission Alignment

Desirability

Incentives and funding are not aligned with missions of technology maturity and
continuous organizational learning
Incentives and funding are minimally aligned with missions of technology
maturity and continuous organizational learning
Incentives and funding are somewhat aligned with missions of technology
maturity and continuous organizational learning
Incentives and funding are highly aligned with missions of technology maturity
and continuous organizational learning
Incentives and funding are completely aligned with missions of technology maturity and
continuous organizational learning

0.00
10.73
44.55
81.91
100.00

Figure 57: Funding and Mission Alignment Metrics Value

Table 51: Cost Reduction Metrics Value

Cost Reduction

Desirability

Research center has had no success in cutting costs
Research center has had success in cutting costs through layoffs and waste
elimination
Research center has had success in cutting costs as a result of waste
eliminations with compromising quality
Research center has had success in cutting costs as a result of waste
eliminations without compromising quality
Research center has had success in cutting costs as a result of increased
maturity, learning, continuous improvement, and waste eliminations without
compromising quality

0.00
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14.64
26.64
77.73
100.00

Figure 58: Cost Reduction Metrics Value
Table 52: Financial Synergy with Policies and Priorities Metrics Value

Financial Synergy with Policies and Priorities

Desirability

Research center has had no success in meeting reimbursement programs’ goals
or accessing government, foundation, and other grants

0.00

Research center has had little success in meeting reimbursement programs’ goals
or accessing government, foundation, and other grants

11.00

Research center has had success in 1 out of 2 (meeting reimbursement programs’
goals, accessing government, foundation, and other grants)

70.82

Research center is successful in meeting reimbursement programs’ goals and
accessing government, foundation, and other grants

100.00

Figure 59: Financial Synergy with Policies and Priorities Metrics Value
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6.4. Model Quantification Results
The next part is quantifying the criteria and perspectives based on the pairwise
comparison done by the expert panel in the ETM HDM tool software. Each expert
performed the pairwise comparisons between the perspective and then each of the
underlying criteria for the respective perspective. The results were partly generated by
ETM HDM software and partly by manual calculation in Microsoft Excel in order to
obtain a better breakdown of the results and validation measurements. The perspective
and criteria weights are shown in Tables 49 and 50, respectively.

Table 53: Perspective Weights

Perspectives

Mean

%

Ranking

Technology

0.200

20

3

Social

0.217

22

2

Organizational

0.226

23

1

Regulatory

0.181

18

4

Financial

0.175

17

5

Inconsistency

0.013
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Organizational

23%

Social

22%

Technology

20%

Regulatory

18%

Financial

17%
Figure 60: Perspective Weights

Table 54: Technology Criteria Local Weights

Technology

Perspective

Criteria

Average

%

Data Management

0.264

27

Supporting Infrastructure

0.223

22

Real-time Knowledge Access and Sharing

0.275

28

User Experience

0.235

23

Technology
Real-time Knowledge Access and Sharing

28%

Data Management

27%

User Experience

23%

Supporting Infrastructure

22%

Figure 61: Technology Criteria Local Weights

Table 55: Social Criteria Local Weights
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Social

Perspective

Criteria

Average

%

Stakeholder Trust

0.226

23

Accessibility

0.196

20

Stakeholder Engagement

0.295

30

Talent Acquisition and Retention

0.281

28

Social
Stakeholder Engagement

30%

Talent Acquisition and Retention

28%

Stakeholder Trust

23%

Accessibility

20%

Figure 62: Social Criteria Local Weights

Table 56: Organizational Criteria Local Weights

Organizational

Perspective

Criteria

Average

%

Leadership

0.188

19

Strategic Management

0.238

24

Culture and Transparency

0.200

20

Training

0.191

19

Governance

0.181

18
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Organizational
Strategic Management

24%

Culture and Transparency

20%

Training

19%

Leadership

19%

Governance

18%
Figure 63: Organizational Criteria Local Weights

Table 57: Regulatory Criteria Local Weights

Regulatory

Perspective

Criteria

Average

%

Standards Compliance

0.240

24

Policy Preparedness and Adaptation

0.289

29

Privacy

0.232

23

Informing Policy

0.237

24

Regulatory
Policy Preparedness and Adaptation

29%

Informing Policy

24%

Standards Compliance

24%

Privacy

23%

Figure 64: Regulatory Criteria Local Weights
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Table 58: Financial Criteria Local Weights

Financial

Perspective

Criteria

Average

%

Resource Allocation

0.217

22

Funding and Mission Alignment

0.302

30

Cost Reduction

0.190

19

0.290

29

Financial Synergy with Policies and
Priorities

Financial
Funding and Mission Alignment

30%

Financial Synergy with Policies and Priorities

29%

Resource Allocation

22%

Cost Reduction

19%

Figure 65: Financial Criteria Local Weights

Table 59: Inconsistency and Disagreement Results

Validation Test

Value

Threshold

Disagreement

0.020

<=0.1

Inconsistency

0.017

<=0.1

As it can be seen from the table above the inconsistency for both perspective and criteria
are in the acceptable ratio being 0.013 and 0.017 respectively which are below 10% as
Kocaoglu established in 1983 as the acceptable threshold for the inconsistency in HDM
models (Kocaoglu, 1983).
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Moreover, the disagreement measure is in the acceptable range (0.020) (below 10% (0.1)
(Chan, 2013; Estep, 2017; Shaygan et al., 2017)). The inconsistency and disagreement
thresholds have been used as indicators for validating the HDM results according to the
literature (Iskin, 2014; Abbas, 2016; Estep, 2017; Shaygan, Ozdemir-Gungor, D. Kutgun
and Daneshi, 2017).
By looking at the universal weights (each criterions’ weights in the context of the whole
model), “Stakeholder Engagement” is the criteria with the highest weight as determined
by the expert panel followed by “Talent Acquisition and Retention”, and “Strategic
Management” with 0.064 (6.4%), 0.060 (6.0 %), and 0.057 (5.7%) respectively. The
global weights for the criteria and the sorted global weights are shown in Figure 67-69.
Based on the results of the experts’ pairwise comparisons, the Organizational perspective
plays the most important role in technology management in research centers with 23%
followed by the social aspect with 22%. By taking a deeper look into these two
perspectives in the criteria weights (local weights), we can see that “Strategic
Management” plays a very important role (24% of the organizational perspective) in the
maturity of research centers. This is aligned with the literature as it stresses the importance
of strategic management in healthcare systems maturity and implementation and adoption
of continuous learning (Bernstein et al., 2015; Brooks, El-Gayar and Sarnikar, 2015;
Demir, 2018) (This result can alleviate the gap that was mentioned the gap analysis
section about lack of literature on literature focusing mainly or solely on the management
side of the healthcare system maturity, continuous learning, and its socio-technological
infrastructure (Frenk et al., 2010;Pronovost et al., 2017)). In Second place, there is culture
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and transparency followed by training take place with 20% and 19% respectively. As for
culture and transparency which is defined as “The extent to which a research center’s
employees have adopted and are committed to a culture of continuous learning and
practice transparency to safeguard stakeholder trust in order to improve the health of
individuals, communities, and diverse populations.”, the resulted weight is in agreement
with the literature demonstrating this criterion as an important factor on the maturity of
healthcare organizations (Institute of Medicine (IOM), 2007; Saunders and Smith, 2013;
Bernstein et al., 2015; Curcin, 2016; Kraft et al., 2017). Examples of the importance of
training can be seen in health organizations training teams to train health medical and
nursing students and residents, together in cross-functional teams to enforce a more
effective transformation culture (Lynch et al., 2000; Gopee, 2002; Grossmann, Goolsby,
Olsen and McGinnis, 2011).
In terms of the Social perspective, Stakeholders’ engagement was found to be the most
important one with 30% of the local weight in the social aspect. This aligns with the
literature emphasizing the importance of healthcare organizations ability to engage
stakeholders (patients, providers, payers, policymaker, purchasers, and families) with
continuous learning and maturity initiatives with goals of improving patient satisfaction,
quality of care, reducing the costs (Mandl et al., 2014; Price-Haywood, 2015; Kraft et al.,
2017). Closely following is the talent acquisition and retention with 28%.
From the regulatory perspective, “Policy Preparedness and Adaptation” takes the top spot
with 29%. As expected, this criterion is very important as it is related to research centers’
flexibility and agility in responding and adapting to changes such as new regulations,
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legislations, and policies in terms of anticipation and readiness. This readiness and
anticipation can be in terms of resources, policies, strategies, and management. Moreover,
side by side to complying with policies and regulations (24%), academic health research
centers can have a significant impact on research and evidence-informed health policy
through taking part in new collaborative models of research (24%). In the second place,
due to the diffusion of meaningful use at state and federal levels, compliance with
standards is a big part of health organizations endeavors in continuous improvement and
maturity as the Quality Payment Program creates a new framework for rewarding
organizations/clinicians who provide higher-value care (HealthIT.gov, 2018). The close
range of percentages in perspectives such as regulatory shows how important each of the
criteria is for pursuing goals of maturity and continuous learning. As an example,
although the privacy aspect holds 23% of the local weight in this perspective (lowest
among the four), is crucial for every research center. In the world of healthcare, data
scientist and business intelligence professionals should guarantee the privacy of data such
as demographic information, medical histories, test and laboratory results, mental health
conditions, insurance information among others when analyzing, visualizing, or
publishing protected health data. For this reason, for actions such as data analysis,
visualization, creating predictive models, etc., there is a need for departments to request
those specific protected data/database/servers, etc. Again, as there is a good chance that
the data used in healthcare organizations is PHI data, it is critical for health organizations
or research centers to make sure that the privacy of data such as demographic information,
medical histories, test and laboratory results, mental health conditions, insurance
information among others are protected from being breached in email hacks and phishing
213

attacks. Penalties for HIPAA violations are tiered which is shown in Figure 66. In
conclusion in healthcare organizations, especially the ones which have the aim of
increasing their technology management maturity through continuous learning and
constant transformation of data into knowledge, privacy plays a pivotal part and a
backbone to a functioning knowledge-producing health system.

Figure 66: HIPAA Violation Penalty Tiers (compliancy-group, 2018)

In the Financial perspective, “Funding and Mission Alignment” was selected as the most
important criterion with 30% followed very closely by “Financial Synergy with Policies
and Priorities with 29%. Based on these results, the alignment of incentives and funding
with the encouragement of continuous learning and technology maturity and rewarding
high care value is important while there is a need for research centers to invest time and
skills into accessing funds such as grants and ensuring that they meet reimbursement
programs’ goals.
Last but not least, in the Technology Perspective, Real-time Knowledge Access and
Sharing was selected as the most important criterion with 28%. This criterion was mined
from the literature review and it is significant especially in the case where the focus of
maturity is on continuous learning as means to improve quality continuously. This
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criterion was defined as “Data systems and tools used to capture, share, and integrate data,
information, and knowledge gained from biomedical, clinical, and managerial research
into the organization in real-time” (Saunders and Smith, 2013; Bernstein et al., 2015;
Cahan and Cimino, 2017; Morain, Kass and Grossmann, 2017). The advances in
technology (tools and data systems) which expedite the transformation of data into
knowledge can bolster this element. In healthcare organizations, since many data
elements are patient-related, the access and sharing of these data can be tricky and more
research into the opportunities and implications caused by this criterion should be studied
further. Protected health information (PHI), also known as personal health information,
generally refers to demographic information, medical histories, test and laboratory
results, mental health conditions, insurance information, and other data that a healthcare
professional collects to identify an individual and determine appropriate care (Rouse,
2018). It should be stressed that a criterion such as data management (27%) and
supporting infrastructure (22%) are critical to the real-time knowledge access and sharing
among others as enablers of this important criterion.
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Figure 67: Global Weights
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Figure 68: The Model with Global Weights
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Figure 69: Global Weights Sorted
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7.

Case Studies

Following the validation, and quantification of the model and its desirability curve/state
values, the model is now applied to actual case studies in order to showcase the practical
side of the model. Two research centers in the United States were selected to take part in
this part of the research. The goal of this section is to show how the model can be applied
to real-life health research centers, pinpoint their strengths and opportunities, and look at
some ways that they can improve in terms of technology management maturity and
continuous learning. Experts within each of these two health research centers helped with
the quantification of the desirability scores based on their centers’ performance in the
relative criteria. Following this, the desirability scores for each criterion is multiplied by
the global weight of that criterion and the sum of these calculations for all of the criteria
would result in the center’s maturity score. This score is important in the sense of the
dialogues and initiatives it starts within the organization with goals of improving the
center’s maturity and continuous learning. These organizations will remain anonymous
to respect the privacy of these centers. Both centers are research centers within university
hospitals.
Meetings occurred with the people in these centers that had sufficient knowledge about
their centers’ performance in these specific criteria. The metrics within each criterion
helped these experts to be able to quantify where their center stands. These experts
included titles such as research center director and project managers.
The research gaps, questions, and goals were explained during these meetings and the
perspectives and criteria definitions, the hierarchical model, and the desirability metrics
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and their values were given to them in advance as well in order to give them more time
to think about them concerning the centers they are involved in. Figure 69 shows the way
these experts could quantify each criterion’s desirability value/state.

Figure 70:Snapshot of the Desirability Value Selection as a Part of the case study for testing the results.

The table below shows the results for the first studied case:
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Table 60: Case Study I Results
Perspective

P Weight

Technology

0.200

Social

0.217

Organizational

0.226

Regulatory

0.181

Financial

0.175

Criteria
Data Management
Supporting Infrastructure
Real-time Knowledge Access and Sharing
User Experience
Stakeholder Trust
Accessibility
Stakeholder Engagement
Talent Acquisition and Retention
Leadership
Strategic Management
Culture and Transparency
Training
Governance
Standards Compliance
Policy Preparedness and Adaptation
Privacy
Informing Policy
Resource Allocation
Funding and Mission Alignment
Cost Reduction
Financial Synergy with Policies and
Priorities

Local W Global W
0.264
0.052
0.223
0.047
0.275
0.054
0.235
0.047
0.226
0.052
0.196
0.042
0.295
0.064
0.281
0.060
0.188
0.043
0.238
0.057
0.200
0.046
0.191
0.042
0.181
0.040
0.240
0.045
0.289
0.052
0.232
0.043
0.237
0.040
0.217
0.038
0.302
0.055
0.190
0.032
0.290

0.050

D score
36.82
37.55
25.55
72.82
45.73
47
49.18
55.73
74.09
15.91
51.45
40.36
13
83.64
0
73.73
35
39.45
39.45
44.55

Score= GW*D
1.904
1.748
1.392
3.390
2.381
1.961
3.154
3.363
3.168
0.900
2.360
1.698
0.524
3.778
0.000
3.178
1.388
1.483
2.163
1.444

70.82

3.516

Comments

44.89

The second studied project’s maturity score and desirability values is shown in the table
below:
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Table 61: Case Study II Results
Perspective

P Weight

Technology

0.200

Social

0.217

Organizational

0.226

Regulatory

0.181

Financial

0.175

Criteria
Data Management
Supporting Infrastructure
Real-time Knowledge Access and Sharing
User Experience
Stakeholder Trust
Accessibility
Stakeholder Engagement
Talent Acquisition and Retention
Leadership
Strategic Management
Culture and Transparency
Training
Governance
Standards Compliance
Policy Preparedness and Adaptation
Privacy
Informing Policy
Resource Allocation
Funding and Mission Alignment
Cost Reduction
Financial Synergy with Policies and
Priorities

Local W Global W
0.264
0.052
0.223
0.047
0.275
0.054
0.235
0.047
0.226
0.052
0.196
0.042
0.295
0.064
0.281
0.060
0.188
0.043
0.238
0.057
0.200
0.046
0.191
0.042
0.181
0.040
0.240
0.045
0.289
0.052
0.232
0.043
0.237
0.040
0.217
0.038
0.302
0.055
0.190
0.032
0.290

0.050

D score
73.91
37.55
25.55
72.82
45.73
47
49.18
27.73
29.09
15.91
17.36
15.27
13
83.64
63.27
27.91
35
39.45
39.45
44.55

Score= GW*D
3.823
1.748
1.392
3.390
2.381
1.961
3.154
1.673
1.244
0.900
0.796
0.642
0.524
3.778
3.294
1.203
1.388
1.483
2.163
1.444

11.00

0.546
38.93

As can be seen from the table above, the maturity scores were calculated at 44.89 and
32.27 for cases I and II, respectively. This score, however, on its own is not the value of
this model. This initially calculated score can serve as a reference point for improving the
maturity of this organization/group. By referring to these values, organizations can get a
sense of self-awareness of where they are and what needs to be done in order for them to
increase their technology management maturity and continuous learning focus.
7.1. Strengths and Opportunities
In this section, the strengths, and opportunities for the two studied cases will be briefly
reviewed.
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7.1.1. Case Study I
In this case, study, based on the obtained results, the performance in the social and
financial perspectives are higher compared to the technology and organizational
perspectives. There is a particularly high improvement for this center in terms of criteria
such as policy preparedness and adaptation and governance. At the same time, this center
is performing well based on financial synergy with policies and priorities as they have a
good record with accessing government and state grants for their research. Moreover,
their products and research conduct tools are designed with user-friendliness in mind
leading to a good performance from the user experience criterion. Their leadership
provides good support and advocacy for goals of continuous learning and increasing
organizational maturity. The leadership in this center has even encouraged the use of
third-party firms to help with the assessment and improvement of organizational and
technology maturity in order to navigate the complex and multi-disciplinary nature of
healthcare organizations to mitigate challenges in terms of process and people
management, and information technology and systems.
One of the biggest opportunities for this center is to focus on its strategic management.
Currently, they are interested and aspire to strengthen their strategic management and
have a vision of positioning themselves as a top research center in their field in terms of
state and federal recognition. They are, however, lacking in an action plan and a roadmap
to take them from where they are to where they want to be. Initiatives to improve the
implementation, realization, and management of these steps can increase the technology
management maturity of this center as strategic management is the third highest-ranking
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criterion based on the model’s outputs. Setting strategic plans for different scenarios in
cases of policy changes can improve the center’s policy preparedness and adaptation as
well.
Another field that this center can increase its maturity score is through increasing its
stakeholder trust and engagement. Scientists, clinicians, funders, journals, academics,
regulators, and professional societies can make research more trustworthy and useful
through collaborations (Strech, Weissgerber and Dirnagl, 2020). As it can be seen
improvement in the strategic management section can improve the social aspect of this
research center through increased trustworthiness and engagement. Moreover, it is
important for research centers and healthcare organizations to realize that merely
providing access may not be enough, and efforts are needed to be in place to earn the trust
of communities (trust in vaccine racial and ethnic minorities as an example (Sinha, 2021).
From the patient's side as one of the stakeholders, some of the engagement hesitancy
regarding accessing healthcare or partaking in research can be imputed to lack of
information, fear of discrimination, and legal problems (such as undocumented
immigrants) which can be mitigated through ensuring that sufficient, transparent, and
comprehensive information about the research or health services are provided and are
accessible to patients. As it was discussed in the literature review section of this research
the United States is facing an increase in racial, ethnic, and socio-economic diversity
which makes these issues even more important. Health institutions should commit to
identifying ways to make sure that research learnings are used to improve care for all the
communities of patients who agreed to contribute data in addition to generating
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knowledge from their research. When the stakeholders such as patients are ensured that
their contribution and engagement will lead to findings that will benefit them and their
community, they will deem the research center more worthy of their trust and engagement
(Morain, Kass and Faden, 2018).
Lastly addressing their governance shortages can improve their maturity scores by having
documented and periodically updated governance and stewardship in the research center.
Moreover, engaging the right stakeholders, being on the same page in terms of objectives,
aligning incentives, engage in continuous improvement, and strategic management can
improve the governance of the center as it can set the grounds for better decision making,
resource allocation, and prioritization (LeSueur, 2017).
Here we will simulate the model to see what will happen if the organization addresses
some of the opportunities explained here. Improvements in strategic management,
governance, policy preparedness, while improving on their stakeholder trust and
engagement are provided to mitigate the center’s weaker points while improving on some
opportunities. The results increase the maturity score to almost 58 which is around 14
points increase (around 30%).
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Table 62: Recommended Improvements for Case Study I Simulation I

Criteria

Potential Improvement Action

Stakeholder Trust

Stakeholder Engagement
Policy Preparedness and
Adaptation
Strategic Management

Governance

Increasing the trustworthiness of the research center (majority
trusting). This trustworthiness can increase through research
results, dissemination, transparency, informing policy,
partnerships, …
Planning and implementation of initiatives aimed at increasing
the engagement of stakeholders. The stakeholders can range from
patients, providers, payors, policymaker, purchasers, families.
The research center has plans for different policy change
scenarios in terms of readiness and adaptation.
Developing clear strategic vision/plan and
management/implementation of technology maturity and
organizational learning
Documented and periodically updated governance with some
communication among departments towards management of
inputs, structures, processes with goals of improving outcomes
Table 63:Case Study I, Simulation I

Perspective

P Weight

Technology

0.200

Social

0.217

Organizational

0.226

Regulatory

0.181

Financial

0.175

Criteria
Data Management
Supporting Infrastructure
Real-time Knowledge Access and Sharing
User Experience
Stakeholder Trust
Accessibility
Stakeholder Engagement
Talent Acquisition and Retention
Leadership
Strategic Management
Culture and Transparency
Training
Governance
Standards Compliance
Policy Preparedness and Adaptation
Privacy
Informing Policy
Resource Allocation
Funding and Mission Alignment
Cost Reduction
Financial Synergy with Policies and
Priorities

Local W Global W
0.264
0.052
0.223
0.047
0.275
0.054
0.235
0.047
0.226
0.052
0.196
0.042
0.295
0.064
0.281
0.060
0.188
0.043
0.238
0.057
0.200
0.046
0.191
0.042
0.181
0.040
0.240
0.045
0.289
0.052
0.232
0.043
0.237
0.040
0.217
0.038
0.302
0.055
0.190
0.032
0.290

0.050

D score
36.82
37.55
25.55
72.82
99.55
47
83.09
55.73
74.09
59
51.45
40.36
71.64
83.64
63.27
73.73
35
39.45
39.45
44.55

Score= GW*D
1.904
1.748
1.392
3.390
5.183
1.961
5.329
3.363
3.168
3.337
2.360
1.698
2.890
3.778
3.294
3.178
1.388
1.483
2.163
1.444

70.82

3.516
57.97

In another simulation, only the top five weighted criteria are improved by one curve value
and as it can be seen it will take the maturity score to from 45 to 55.5 (23% increase).
Some of the proposed improvements for simulation II are shown in Table 64.
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Table 64:Recommended Improvements for Case Study I Simulation II

Criteria

Potential Improvement Action

Real-time Knowledge Access
and Sharing

Initiatives and projects towards enabling of data capture, access,
and sharing of real-time data. There is still room for improvement
towards the integration of learned knowledge.

Stakeholder Engagement
Talent Acquisition and
Retention
Strategic Management

Financial Synergy with Policies
and Priorities

Planning and implementation of initiatives aimed at increasing
the engagement of stakeholders. The stakeholders can range from
patients, providers, payors, policymaker, purchasers, families.
Working with other departments and leaders to find diverse skills,
looking internally for candidates, assigning mentors, recognition
programs, and supporting advancement opportunities.
Planning and implementation of initiatives aimed at increasing
the engagement of stakeholders. The stakeholders can range from
patients, providers, payors, policymaker, purchasers, families.
Initiatives aiming at grants (training, grants writing workshops,
partnerships…) or reimbursement programs and incentives
(closely monitoring the metrics and planning for hitting the
goals).
Table 65: Case Study I, Simulation II

Perspective

P Weight

Technology

0.200

Social

0.217

Organizational

0.226

Regulatory

0.181

Financial

0.175

Criteria
Data Management
Supporting Infrastructure
Real-time Knowledge Access and Sharing
User Experience
Stakeholder Trust
Accessibility
Stakeholder Engagement
Talent Acquisition and Retention
Leadership
Strategic Management
Culture and Transparency
Training
Governance
Standards Compliance
Policy Preparedness and Adaptation
Privacy
Informing Policy
Resource Allocation
Funding and Mission Alignment
Cost Reduction
Financial Synergy with Policies and
Priorities

Local W Global W
0.264
0.052
0.223
0.047
0.275
0.054
0.235
0.047
0.226
0.052
0.196
0.042
0.295
0.064
0.281
0.060
0.188
0.043
0.238
0.057
0.200
0.046
0.191
0.042
0.181
0.040
0.240
0.045
0.289
0.052
0.232
0.043
0.237
0.040
0.217
0.038
0.302
0.055
0.190
0.032
0.290

0.050

D score
36.82
37.55
59.18
72.82
45.73
47
83.09
100
74.09
59
51.45
40.36
13
83.64
0
73.73
35
39.45
39.45
44.55

Score= GW*D
1.904
1.748
3.224
3.390
2.381
1.961
5.329
6.034
3.168
3.337
2.360
1.698
0.524
3.778
0.000
3.178
1.388
1.483
2.163
1.444

100.00

4.966
55.46

As it was shown in the simulations, it is important to not only focus on the high weighted
criteria based on the model, but it is also important to address the weakest areas in the
research center to reach a higher maturity score. In this model especially, since the criteria
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weights are closer to each other, this becomes more important. At the same time, it shows
how connected are many of these criteria and addressing some may bolster other criteria
as well (the case of stakeholder trust and engagement or strategic management and policy
preparedness). The decision makers need to initiate conversations based on the results of
the model when creating a roadmap as the model can give them a better sense of
organizational self-awareness of where they, where they want to be, and how to better get
there.

7.1.2. Case Study II
In this case, study, based on the obtained results, this center is performing with less
success in criteria such as financial synergy with policies and priorities, privacy, policy
preparedness, and talent acquisition and retention, and with their organizational criteria
in general. This research center can increase its maturity score by starting projects and
improvement initiatives around training, governance, and strategic management. The
creation of routine multidisciplinary training in the research center around continuous
learning and encouraging its culture not only will improve the center's curve/state value
on training but also it will potentially improve it in the culture and transparency section.
From another aspect, training around grant writing and grant writing seminars can
increase the center’s success in terms of financial synergy with policies and priorities.
Financial synergy with funding and policies in this center can increase with initiatives
aiming at grants or reimbursement programs and incentives. As an example, the Oregon
Health Authority is using quality health metrics to show how well Coordinated Care
Organizations (CCOs) are improving care, making quality care accessible, eliminating
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health disparities, and curbing the rising cost of health care in different areas such as
immunization, depression screening, drug, and alcohol use, and diabetes among others
(Oregon Health Authority, 2021). When participating health organizations meet certain
thresholds on specific quality measures, they will be eligible for incentives. These
different quality measures are around different data sources, patient populations, and have
different measure stewards. Health organizations and centers aiming for any of these
measure incentives can plan to reach the thresholds through relevant strategies and
initiatives. As an example, for the childhood immunization status quality measures,
initiatives such as checking immunization records at each visit, using benchmark report
in ALERT data system to monitor the immunization rates for all patients, scheduling the
next well visit before the patient leaving the office, implementing a well-visit
reminder/recall system, and immunizing as part of a sick visit in order to improve that
measure. Another example may be improving the depression screening and follow-up
measure by screening patients for depression at least once a year with standardize
depression screening tools and capturing structured data in their electronic health records
(Wooden, 2021). Although these kinds of initiatives are more common in hospitals and
health centers, health research centers may find the relevant reimbursement programs and
plan to meet the incentive thresholds.
In terms of talent acquisition and retention, this research center can improve its
performance by strengthening the culture and reputation based on the values and missions
of the center. Some of the practices within healthcare organizations for improving
acquisition and retention include working with other departments and leaders to find
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diverse skills, looking internally for candidates, assigning mentors, recognition programs,
and supporting advancement opportunities.
In general, based on the organizational perspective performance of this research, more
excitement from the leadership and management can lead to improvements in this section
while encouraging planning and vision for strategic management. These actions can
significantly improve the center’s outlook on the culture of continuous improvement and
learning.
The simulation below will look at the results of maximizing the top highest-ranking
criteria for this research center. As it can be seen, the maturity score increases by around
54% alone when the top 5 criteria are maximized (maturity score of 39 to almost 60).
Table 66: Case Study II Simulation
Perspective

P Weight

Technology

0.200

Social

0.217

Organizational

0.226

Regulatory

0.181

Financial

0.175

Criteria
Data Management
Supporting Infrastructure
Real-time Knowledge Access and Sharing
User Experience
Stakeholder Trust
Accessibility
Stakeholder Engagement
Talent Acquisition and Retention
Leadership
Strategic Management
Culture and Transparency
Training
Governance
Standards Compliance
Policy Preparedness and Adaptation
Privacy
Informing Policy
Resource Allocation
Funding and Mission Alignment
Cost Reduction
Financial Synergy with Policies and Priorities
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Local W Global W
0.264
0.052
0.223
0.047
0.275
0.054
0.235
0.047
0.226
0.052
0.196
0.042
0.295
0.064
0.281
0.060
0.188
0.043
0.238
0.057
0.200
0.046
0.191
0.042
0.181
0.040
0.240
0.045
0.289
0.052
0.232
0.043
0.237
0.040
0.217
0.038
0.302
0.055
0.190
0.032
0.290
0.050

D score
73.91
37.55
100
72.82
45.73
47
100
100
29.09
100
17.36
15.27
13
83.64
63.27
27.91
35
39.45
39.45
44.55
100.00

Score= GW*D
3.823
1.748
5.448
3.390
2.381
1.961
6.414
6.034
1.244
5.655
0.796
0.642
0.524
3.778
3.294
1.203
1.388
1.483
2.163
1.444
4.966
59.780

Table 67: Recommended Improvements for Case Study II Simulation I

Criteria

Potential Improvement Action

Real-time Knowledge Access
and Sharing

Real-time data and information capture, access, and sharing
concurrent to integration of learned knowledge

Stakeholder Engagement
Talent Acquisition and
Retention
Strategic Management

Financial Synergy with Policies
and Priorities

Planning and implementation of initiatives aimed at increasing
the engagement of stakeholders. The stakeholders can range from
patients, providers, payors, policymaker, purchasers, families.
Working with other departments and leaders to find diverse skills,
looking internally for candidates, assigning mentors, recognition
programs, and supporting advancement opportunities.
Planning and implementation of initiatives aimed at increasing
the engagement of stakeholders. The stakeholders can range from
patients, providers, payors, policymaker, purchasers, families.
Initiatives aiming at grants (training, grants writing workshops,
partnerships…) or reimbursement programs and incentives
(closely monitoring the metrics and planning for hitting the
goals).

It is important to note that even by achieving the maximum curve values for the five top
factors in the model, case study II is still far from the desired 100 points. Two lessons can
be learned from this:
•

As mentioned in the first case study, it is not sufficient to focus solely on the most
important criteria and expect to achieve excellence in the whole process. This is
even more important in this model and in the world of healthcare where criteria
are more connected and are closer to each other in terms of weights in the model
output.

•

The model can be seen as a maturity model, as it shows the maximum level of
performance for each factor as the most desirable outcome. Reaching the
maximum level of curve value for every single criterion may not be feasible,
realistic, or even worthwhile (in terms of resources and efforts) for research
centers. Having said that, this information is still informative and beneficial to
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research centers in terms of leading and guiding them towards continuous
improvement and learning.
It is important to note that this model assists decision makers in their decision-making
process and it should not be used as the sole decision-making factor. Each research center
should have discussion and dialogues based on the results of this model and choose the
path and create the roadmap they see to be the best fitting based on the research center’s
resources, improvements’ feasibility, and other unique factors pertaining to that specific
healthcare research center. This research used arbitrary simulations to showcase how the
model works.

8. Scenario Analysis
In this model, in order to analyze the impacts of potential changes in the values at levels
of the model, Scenario Analysis is used. The scenario-focused sensitivity analysis used
here is a method that can be used to perform analysis on how different
perspectives/criteria of the model will change in scenarios where there is a change in
value/weight of model elements. In other words, this type of analysis helps decisionmakers determine how much a given model depends on its input factors (Saltelli,
Tarantola and Chan, 1999). It also facilitates the process of understanding model behavior
and the extent to which its different factors interplay. Lilburne and Trantola (2008) define
sensitivity analysis as “the study of how uncertainty in model predictions is determined
by uncertainty in model inputs.” (Lilburne and Tarantola, 2009).
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For this purpose, using the maturity scores calculated in the case study section as the
baseline score, five different extreme situations are analyzed for both case studies in this
section. In each of these five extreme scenarios, the maximum available weight is given
to one perspective and the maturity score is calculated based on the desirability scores
obtained by the studied health department. In other words, in each of these 5 scenarios,
one perspective gets 96% of the importance while the other four only get 1% each.
For “Case Study I”, the research center will yield better results in social and financial
extreme scenarios since they had a better average performance in those perspectives. In
“Case Study II”, the center’s maturity score will decrease in the organizational focused
extreme scenario since the center had the biggest opportunities in that perspective while
it seems to be most ready for regulatory and technology-heavy extreme scenarios due to
having more strengths in those areas. Tables 65 to 67 demonstrate the detailed results for
each of the mentioned scenarios.

Table 68: Scenario Analysis Allocated Weights

Scenarios

Baseline
Tech
Social
Org
Reg
Fin

Technology
0.20
0.96
0.01
0.01
0.01
0.01

Social
0.22
0.01
0.96
0.01
0.01
0.01

Organizational
0.23
0.01
0.01
0.96
0.01
0.01
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Regulatory
0.18
0.01
0.01
0.01
0.96
0.01

Financial
0.18
0.01
0.01
0.01
0.01
0.96

Table 69: Scenario Analysis for Case I
Scenarios

Technology

Social

Organizational

Regulatory

Financial

Change

0.18

Maturity
Score
44.89

Baseline

0.20

0.22

0.23

0.18

Tech

0.96

0.01

0.01

0.01

0.01

58.82

13.92

Social

0.01

0.96

0.01

0.01

0.01

65.25

20.35

Org

0.01

Reg

0.01

0.01

0.96

0.01

0.01

55.23

10.34

0.01

0.01

0.96

0.01

61.60

16.71

Fin

0.01

0.01

0.01

0.01

0.96

65.05

20.15

0

Table 70: Scenario Analysis for Case II

Change

0.18

Maturity
Score
38.93

0.01

0.01

64.45

25.52

0.01

0.01

0.01

55.70

16.77

0.96

0.01

0.01

35.19

-3.73

0.01

0.01

0.96

0.01

65.40

26.47

0.01

0.01

0.01

0.96

47.34

8.41

Scenarios

Technology

Social

Organizational

Regulatory

Financial

Baseline

0.20

0.22

0.23

0.18

Tech

0.96

0.01

0.01

Social

0.01

0.96

Org

0.01

0.01

Reg

0.01

Fin

0.01

0

The biggest value these scenario analyses offer the decision-makers is to inform them on
how to proceed with their efforts towards improving their path towards technology
management and continuous learning goals. These will also help health centers with better
preparation in terms of criteria such as strategic management and policy preparedness and
adaptation, and resource allocation.
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9. Discussions
As mentioned in the problem statement of this research, there is a need for a tool that
gives health organizations a sense of self-awareness in terms of continuous integration,
implementation, and management of the learned knowledge and new technologies. This
tool needs to be able to identify potential common factors that have a major impact on the
maturity of continuous learning while being able to assess the health organizations’
performance against each of those factors. Moreover, this model can help these
organizations in identifying the opportunities while giving the organization a sense of
self-awareness and direction. This direction can eventually assist decision-makers in their
strategic management and roadmaps. As a result of the conversation and dialogues based
on the results of the model, health organizations (health research centers in the case of
this study) can get a better sense of direction in order to prioritize their improvement paths
and agenda while having a better grip on their performance and maturity in terms of
continuous learning leading them to be more mature organizations.
As part of the gap analysis (gaps I and II specifically), it was discussed that the criteria
for assessing technology management maturity and continuous learning in healthcare
organizations are not organized and classified into categories/perspectives while there is
no quantified, validated, multi-dimensional, and repeatable way of assessing maturity in
healthcare organizations. Discussion with experts from each of the validation and
quantification panels confirmed these findings as many of them confirmed the need for
such a model for assessing technology management maturity and continuous learning in
healthcare organizations. These experts were from different backgrounds related to
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healthcare organizations, health-related academic institutes, and research centers,
including directors, officers, vice presidents, project managers, data scientists, academic
researchers, public health experts, and academicians.
From the usability perspective of this model in other sectors, although the criteria and
perspectives identified in this research may apply to measuring maturity and continuous
learning in other fields, the literature review and subject matter experts in this model are
heavily focused on the field of healthcare. However, this model can be used as a base of
research for other areas with more discussions (validation) and pair-wise comparison of
the model elements with the relative expert domain based on the research goal at hand.

9.1.Research and Practical Implications
One of the interesting findings of this research is the fact that it shows although there are
some perspectives and criteria that ranked higher than the rest, it shows that each
identified criterion is very important to the maturity of the center and its goal towards
continuous learning. This confirms that not only the external factors in different
perspectives related to healthcare organizations are interconnected (chapter 2.2.2), but
also the internal factors affecting the success and maturity of healthcare organizations are
interconnected as well. This interconnectedness was briefly discussed in the case studies
analyses. Although these criteria are in different perspectives, initiatives around one
improvement opportunity may improve the center’s performance in other areas (either
within the same perspective or not). As an example. increased stakeholder trust may
trigger an increase in their engagement and the increased stakeholder engagement
(patients as an example) may increase health center or health organization’s success in
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their regulatory and financial goals. An example of this can be a scenario where the
increase in stakeholder engagement bolsters the collaboration to generate evidence that
informs health policy. This can create creates a very powerful and exciting research path
forward. As a result of the research centers and health organizations being part of these
new collaborative models of research, there will be an inevitable rise in the impact of
healthcare research entities in optimizing evidence-informed health policy. As the result
of this bolstered impact, stakeholder trust and health center’s trustworthiness can increase
completing one of the many possible continuous improvement circles.
In this section, each of the top five criteria will be reviewed in the context of this research.
Many of these findings align with the literature review done in this research. Among the
top-ranking criteria, some are the factors that were introduced to the model during the
validation process which shows the importance of perspective and criteria validation as a
part of the research framework of this study. The elements of this model were fine-tuned
through different validation phases and filters through the literature review and validation
in the comprehensive exam, proposal, and dissertation phases.
9.1.1. Stakeholder Engagement
The most important criterion based on the expert panel is “Stakeholder engagement”
which was defined based on the literature defined as: “The degree to which a health
research center can engage stakeholders (patients, providers, payors, policymaker,
purchasers, families) to participate in continuous improvement and learning projects and
initiatives.” (Price-Haywood, 2015; Kraft et al., 2017). As much public health-related
research is going on in the world of continuous learning in healthcare organizations, this
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criterion’s importance of expected. There was a strong emphasis from the experts on the
social aspect of technology management maturity in healthcare. Although some of the
experts participating in validating and quantifying this model were public health
professionals, the stress on the stakeholders’ role was not solely based on their results. In
contrast, many technology management professionals and project managers gave higher
weights to stakeholders’ engagement as a critical factor in health organization's maturity
and continuous learning initiatives.
9.1.2. Talent Acquisition and Retention
The Second highest weighted criterion was “Talent acquisition and Retention”. The word
retention was added to the title and the definition of this criterion in the validation process.
This
criterion was surprising as there is not a lot of literature around it. A limited supply of
skilled individuals was mentioned as one of the six challenges discussed by (Morain, Kass
and Grossmann, 2017) as origins of continuous learning and learning health systems
transformations for healthcare organizations. Moreover, it is very important for health
research centers and health organizations, in general, to not only acquire skilled and
diverse workforce but also to retain them in the organizations. Based on the results of this
research, centers’ ability to acquire and retain talented and diverse staff in different areas
can play an important role in their technology management maturity and adoption of
continuous learning.
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9.1.3. Strategic Management
The Third important weight shown by the data is strategic management. Nowadays,
hospitals and healthcare organizations are operating in an extremely competitive
environment, with ever-increasing pressure to better their quality and reduce expenses. In
response to this dynamic environment, organizations require to have the drive and plan
to organize delivery around the needs of patients (Speziale, 2015). Successful health care
organizations have leaders who understand the nature and implications of external
change, the ability to develop effective strategies that account for change, and the will as
well as the ability to actively manage the momentum of the organization. Activities such
as strategic decisions, management of competing priorities, internal and external
partnerships/collaborations, problem identification, and finding solutions are collectively
referred to as “strategic management.” Strategic management is pivotal in leading
organizations in volatile environments. Strategic management provides the momentum
needed for change (Ginter, Duncan and Swayne, 2013).
9.1.4. Funding and Mission Alignment
The fourth important criterion is from the financial perspective and is defined as “The
extent to which incentives and funding are aligned with the encouragement of technology
maturity, continuous learning and improvement, waste elimination, and rewarding high
care value.”. Based on the literature, securing grants that are aligned with the
encouragement of continuous learning is important in the realization of learning health
systems rather than inspiring it (Morain, Kass and Grossmann, 2017). Furthermore,
funding agencies and programs are also key components of this kind of encouragement
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from the scientific pillar, with more flexible, rapid cycle and applied research funding
programs serving as accelerators (Menear et al., 2019). External funding and its alignment
with goals of continuous learning were also mentioned in the literature as one of the
themes related to the creation of learning health systems.
9.1.5. Real-time Knowledge Access and Sharing
The fifth-highest ranking is from the technology perspective. It is defined as “Data
systems and tools used to capture, share, and integrate data, information, visualizations,
and knowledge gained from research into the organization in real-time”. As reviewed in
the literature review section about learning health systems, the technology side, and
especially the real-time capabilities that allow best practice knowledge in different areas
to be captured, compiled, protected, learned from, integrated, and disseminated. As
revised in the validation phase, health centers need to ensure the learned knowledge is
subsequently integrated into practices and processes to bolster the path towards aimed
and promised improvements. Although the learned knowledge is valuable, it is not
enough for research centers to put it out in the world and hope someone will do something
with it. This sharing of knowledge can be within a healthcare organization or with external
groups of research clusters in order to strengthen efforts in instances such as infection
prevention efforts during viral outbreaks such as Covid-19 (Nathavitharana et al., 2020).
9.2.Generalizability
This external validation determines whether the created model in this research can be used
for different types of healthcare departments. In other words, although this research
focused on assessing the maturity and continuous learning in healthcare research centers
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within university hospitals and used two research centers as case studies, is it possible to
use this for other research centers or other types of healthcare departments?
Generalizability was addressed in two ways:
•

Panels of subject matter experts from different types of healthcare organizations,
in a spectrum of positions, took part in the validation of this model’s perspectives,
criteria, and desirability/value curves.

•

During some communications with some of the participating experts, they
confirmed that this model may be used for any type of healthcare organization.
The use of desirability/value curves allows for the model to be reused without the
need for subject matter experts as these values allow the model to be reusable.

This assessment tool can be taught in academic settings (or in form of organizational
training within centers) to be used in different healthcare settings instead of using thirdparty firms for maturity assessment.
It is important to note that while the model is validated and reusable due to subject matter
experts and value curves, it is important to update the model’s criteria and their weights
after a certain time to ensure its timeliness and appropriateness.
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10. Conclusion
Following the research results, case studies, and discussions, this chapter will focus on
addressing the research objective, questions, and gaps while discussing the research and
practice contributions. Moreover, the limitations and future research will be reviewed.

10.1. Conclusion and Contributions
The objective of this research is to develop a framework for assessing technology
management maturity in research institutes within university hospitals in the United
States. Initially, literature research was performed in areas ranging from performing a
landscape analysis on the external forces affecting the healthcare organizations in the
United States, Learning Health Systems, and Maturity Models, to Healthcare Research
Centers. As a result of these reviews, an initial hierarchical model was created consisting
of the elements which have an impact on technology management maturity and
continuous learning in health research centers. This model was later validated, finalized,
and quantified by healthcare experts. Desirability curves/values were used as an extension
to the HDM model to allow for the model to be used multiple times without the need to
recreate the expert panels and re-quantify the model. Moreover, two case studies are
provided to see to the model in practice followed by scenario analyses to observe the
model’s sensitivity to extreme perspective conditions.

This research contributes to the technology management body of knowledge on
technology management maturity assessment in the healthcare industry while delving
deeper into how healthcare research centers can achieve a sense of self-awareness in terms
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of where they are and where they need to be in dealing with their technology management
and continuous learning issues. More specifically, this research aims at increasing the
knowledge on how healthcare research centers assess their maturity and maintain
continuous learning in the whole organization by proposing a technology management
maturity model assessment tool. According to the literature review and gap analysis
conducted in this study, there is a lack of structured and comprehensive understanding of
the managerial issues around the maturity assessment of technology management in
healthcare generally and more specifically in the growing and imminent field of learning
health systems which can bolster the continuous quality improvement goals of the
healthcare organizations. This research will provide a quantified, validated, repeatable,
and multi-perspective tool for measuring technology management maturity in healthcare
research centers with a focus on continuous learning. This maturity model may result in
better decision-making in healthcare research centers (and healthcare organizations) and
can be used as a step in the right direction in reaching better results regarding patient
satisfaction, quality care, cost of care, and resource allocation. This model can assist
healthcare managers and decision-makers in identifying strength and opportunity areas
within the firm (in the context of maturity in continuous learning), while helping health
organizations in classifying and organizing their priorities and bolsters their judgment in
terms of proactiveness in achieving the goals of continuous learning and improvement.
Knowledge of the health care system and its development is essential for the effective
management of health care organizations. By keeping up to date on community needs,
technological progress, stakeholder demands, and economic prospects, managers can be
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in a better position to fulfill their organizational missions to enhance access, improve
service quality, and achieve efficiency in the delivery of services.
COVID-19 is a great example that shown how important mature continuously learning
healthcare systems are as they need to rapidly collect data, learn from it and for
communities to address the problems they are facing through combining discovery, data
analysis, and taking action (Ellis, 2021).
Table 68 shows how this research has addressed the gaps identified by the literature
review.
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Table 71: Addressing the Research Gaps

Research Gaps

Addressed By

RG I: The criteria for assessing technology
management maturity and continuous learning
healthcare research centers are not organized and
classified into categories/perspectives.

This study identified and categorized
the most important factors influencing
technology management maturity and
continuous learning while
demonstrating their relative
importance/weights.

RG II: There is no quantified, validated, multiperspective, and repeatable way of assessing
maturity in healthcare research centers.

The proposed hierarchical model
offers a quantified, validated, multiperspective, and repeatable tool for
assessing maturity and continuous
learning in healthcare research
centers.

RG III: Despite technology management’s
importance in healthcare, there is a lack of studies
on the technology management side of healthcare
maturity and continuous learning

The literature review, model
components, identified weights, and
case studies add to the literature
surrounding the technology
management side of healthcare
maturity and continuous learning,
especially in research centers.

RG IV: There is very little to no literature around
the structure and management of research centers
within university hospitals.

This study’s focus on health research
centers, its literature review, and
results, add to the body of knowledge
on the structure and management of
these research centers.

This study’s responses to the research questions posed earlier in this dissertation are
shown in Table 69.
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Table 72: Addressing the Research Questions

Research Questions

Addressed By

RQ I: What are the main perspectives and
criteria in the assessment of technology
management maturity in healthcare research
centers?

The literature review followed by the
hierarchical decision-making model created
in this research identifies the main
perspectives and criteria in the assessment
of technology management maturity in
healthcare research centers.

RQ II: What are the weights of criteria and
sub-criteria related to the assessment of
maturity and continuous learning in
healthcare research centers?

The results of the HDM model demonstrate
the weights of criteria and sub-criteria
related to the assessment of maturity and
continuous learning in healthcare research
centers.

RQ III: Does the proposed framework offer
an effective and practical way to assess
technology management maturity in
research centers within university hospitals?

The validated model and the demonstration
of its use in the form of two case studies and
the following analysis offer an effective and
practical way to assess technology
management maturity in healthcare research
centers.

In summary, this research offers both research and practical implications. From the
research side, this research contributes to the technology management body of knowledge
and maturity models in healthcare while focusing on the management of continuous
learning and focusing on a more specific unit of study (healthcare research centers).
Furthermore, from the practical aspect, this study offers a framework and tool to
healthcare research centers in particular and healthcare organizations in general to assess
their maturity and continuous learning. The results of this research and the framework it
offers can help healthcare managers to pinpoint their center’s strengths points and
opportunities and improve their vision in creating roadmaps and allocating resources.
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As mentioned before, this tool can serve as a helping tool to decision-makers and should
not be treated as the main decision-making factor. The results of this model can create
and spark dialogues between the decision-makers, managers, and stakeholders on the
organization’s next steps.

10.2. Limitations
The first limitation of this study is imputed to the fact that this model was created,
validated, and quantified with a focus on healthcare organizations (healthcare research
centers specifically) and the help of healthcare experts. This means that, if there is an
intent to use the model in other fields, the model elements and their weights need to be
re-validated and re-quantified with experts from intended sectors and fields.
The Seconds limitation is caused by the use of expert panels. Although the experts who
participated in this research were selected systematically and carefully to make sure that
their expertise is relevant, experts are humans and as such, their judgment could be
affected by bias and subjectivity that cannot always be detected. In order to address this,
the results of the model were validated in terms of disagreement and inconsistency
analysis. Furthermore, user-friendly instructions and further clarification (where needed)
were provided to the experts to minimize this potential limitation.
Thirdly, as mentioned in the methodology section, when using HDM, in scenarios that
there is a difference of more than 1 between the number of criteria under different
perspectives it may lead to smaller weights for the criteria under the perspectives with a
higher number of criteria. A remedy for this limitation is to try to keep the criteria under
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each perspective close to the others. The perspectives in this research contain 4-5 criteria
which minimize this limitation. The methodology-related limitations of this study have
been discussed in detail in the HDM limitations section (4.1.2).
Lastly, although this model can detail the weights related to technology management and
continuous learning based on the specific perspective they are in, it is not able to
numerically address the effect of changes in one criterion on other criteria. This issue is
discussed in both the case study and discussion sections of this research. Although the
consequences of changes in criterion may be hard to pinpoint numerically, decisionmakers and managers can address this potential change in their strategic plans and
roadmaps during the important conversations following the results of this model. Further
studies can focus on addressing this research opportunity.

10.3. Future Research
The discussions around the limitations of this study pose research opportunities for future
research. Firstly, the creation of this maturity assessment model can be iterated in other
fields and sectors with a focus on continuous learning and technology management
maturity. Following this, it will be interesting to compare the resulting models with the
model created in this research and discuss the similarities and differences. Even without
changing industries, there is a great opportunity to study this maturity assessment tool in
the context of other healthcare entities such as different departments, administrative, and
information technology groups within hospitals and compare the results and model
elements with this research.
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As mentioned before, the healthcare environment in the United States is a very dynamic
one and there will be a need to refresh this model’s elements and weights periodically to
maintain its usefulness and relevance.
From the methodology standpoint, there are opportunities to investigate and mitigate
some of the methodology limitations which were discussed in the previous section. As an
example, the creation of a mathematical coefficient based on the number of criteria within
each perspective may mitigate that limitation in cases where there are big differences (±2)
in the number of criteria within perspectives.
Moreover, additional research with a focus on each of the identified perspectives and their
criteria can shed additional light on the nuances of each of these perspectives, and their
impact on continuous learning and centers’ maturity. Another route to pursue with future
research in the context of this research is to study the impact of the model’s criteria on
each other. One possible opportunity may be to create the mental landscape of continuous
learning in healthcare organizations (or more specifically, healthcare research centers)
and understand more about the strength of the impact of these criteria on each other
regardless of the perspective group they are included.
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